{"meta":{"query_hash":"21f2b16fd884","filters":{"venue":"Clinical Pharmacokinetics"},"cohort_total":145,"direct_labels_cover":0,"predictions_cover":145,"exported":145,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/21f2b16fd884","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Pharmacokinetics"},"results":[{"id":"W1477312507","doi":"10.1007/s40262-015-0321-z","title":"A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Saliva; Antibiotics; Pharmacokinetics; Medicine; Drug; Distribution (mathematics); Pharmacology; Intensive care medicine; Internal medicine; Microbiology; Biology","score_opus":0.5099288036103374,"score_gpt":0.6233919368026989,"score_spread":0.11346313319236145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1477312507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027432833,0.9792943,0.000020092502,0.0029202034,0.0024476182,0.007174622,0.00039848394,0.00010430675,0.0048970734],"genre_scores_gemma":[0.010680204,0.9825339,0.00039772718,0.0033324147,0.0020282122,0.00004613237,0.00023194829,0.00035311643,0.00039639248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98131853,0.004595155,0.009317514,0.0019858174,0.0014722313,0.0013107775],"domain_scores_gemma":[0.9829937,0.01016078,0.0028572453,0.0021835244,0.00083018286,0.00097454886],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.011265882,0.0016813753,0.0074704313,0.0009645403,0.0001006261,0.000045715464,0.0017865356,0.0009971623,0.0002677976],"category_scores_gemma":[0.00378434,0.0012130347,0.0023026748,0.0029291548,0.0012702644,0.00006615738,0.0005505954,0.0069050007,0.00034218954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007744131,0.013275961,0.0032825985,0.049619872,0.001680423,0.00042751277,0.0004678421,0.00012228309,0.00003789192,0.0011143086,0.055198807,0.8739981],"study_design_scores_gemma":[0.0066048517,0.0021275186,0.0015276993,0.094300486,0.0063880156,0.000029207173,0.000102221384,0.00019256517,0.00007405201,0.00012667761,0.8872844,0.0012423381],"about_ca_topic_score_codex":0.000010216489,"about_ca_topic_score_gemma":0.0000016437541,"teacher_disagreement_score":0.87275577,"about_ca_system_score_codex":0.0004046321,"about_ca_system_score_gemma":0.001147334,"threshold_uncertainty_score":0.9995933},"labels":[],"label_agreement":null},{"id":"W1564744230","doi":"10.1007/bf03261932","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Population; Pharmacokinetics; Context (archaeology); NONMEM; Physiologically based pharmacokinetic modelling; Terminology; Medicine; Computer science; Intensive care medicine; Pharmacology; Biology","score_opus":0.9077627310124843,"score_gpt":0.7051695231200288,"score_spread":0.2025932078924555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564744230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016985472,0.9554203,0.03465593,0.000020241507,0.0056159175,0.002370764,0.00052411587,0.00017893821,0.001196795],"genre_scores_gemma":[0.00005284596,0.7303368,0.26613507,0.00010755526,0.0027526452,0.00008674423,0.000060042385,0.00023499156,0.00023329911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.983573,0.0045163305,0.009006326,0.0010402087,0.000977359,0.0008867279],"domain_scores_gemma":[0.90653527,0.08730275,0.0039990395,0.0011544361,0.00033382318,0.00067468366],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0091296015,0.0010401479,0.0072859363,0.00028411552,0.00007790951,0.000037766687,0.0011527186,0.001190355,0.0020107583],"category_scores_gemma":[0.019878281,0.00086326833,0.002544611,0.00067882746,0.0005040525,0.00009986925,0.0005312286,0.0020866562,0.000208625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004322931,0.00096473657,0.00001847271,0.023812026,0.00072098087,0.000007811625,0.000009380868,0.000023827539,5.503449e-7,0.0034122304,0.0023963081,0.96859044],"study_design_scores_gemma":[0.0012978602,0.00017009668,0.0000028616328,0.0063244146,0.016638463,0.000013445707,0.0000028773193,0.0011234215,0.0000067378332,0.10517152,0.86831796,0.0009303692],"about_ca_topic_score_codex":0.0000062787562,"about_ca_topic_score_gemma":1.8802426e-7,"teacher_disagreement_score":0.96766007,"about_ca_system_score_codex":0.00012762232,"about_ca_system_score_gemma":0.00012250197,"threshold_uncertainty_score":0.9993818},"labels":[],"label_agreement":null},{"id":"W16164951","doi":"10.2165/00003088-200241090-00002","title":"Lithium in Bipolar Disorder","year":2002,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Lithium (medication); Mania; Bipolar disorder; Therapeutic index; Medicine; Depression (economics); Internal medicine; Adverse effect; Gastroenterology; Pharmacology; Drug","score_opus":0.14085561981592512,"score_gpt":0.4608201781186104,"score_spread":0.31996455830268533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W16164951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000073401675,0.9937474,0.000013200562,0.0001834642,0.0008797194,0.0014099207,0.00006660501,0.00008688578,0.003605454],"genre_scores_gemma":[0.00001598866,0.9947812,0.00025157825,0.000273373,0.0007300487,0.000100775505,0.00021686815,0.00013559262,0.003494576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99620867,0.00035944837,0.0018604416,0.00074585,0.00031850493,0.0005071064],"domain_scores_gemma":[0.9980249,0.0005289236,0.00030249447,0.00068498537,0.00005856041,0.00040014577],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00043079405,0.0006145172,0.0028612625,0.00026763952,0.000035241123,0.000020092768,0.00026913427,0.0007268877,0.0012240056],"category_scores_gemma":[0.00019481708,0.0004621073,0.001255363,0.00059579156,0.00018580536,0.000030244742,0.00014963487,0.0018978085,0.0012220803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000140322345,0.0020653766,0.005494385,0.0065851775,0.00037029802,0.00010677958,0.000011320258,1.7549635e-7,2.7381754e-8,0.000013565819,0.0034642278,0.98187464],"study_design_scores_gemma":[0.0024696868,0.00030190844,0.00079189666,0.0039949124,0.003993793,0.00007532766,0.0000020028274,0.00004095427,1.485785e-7,0.00001726605,0.9879224,0.00038970963],"about_ca_topic_score_codex":0.000013137447,"about_ca_topic_score_gemma":0.000012144414,"teacher_disagreement_score":0.98445815,"about_ca_system_score_codex":0.000098869685,"about_ca_system_score_gemma":0.0001833445,"threshold_uncertainty_score":0.99978304},"labels":[],"label_agreement":null},{"id":"W178626500","doi":"10.2165/00003088-200746020-00002","title":"Efavirenz and Nevirapine in HIV-1 Infection","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Nevirapine; Efavirenz; Medicine; Virology; Pharmacotherapy; Human immunodeficiency virus (HIV); Reverse-transcriptase inhibitor; Antiretroviral therapy; Pharmacology; Viral load; Internal medicine","score_opus":0.21109861450931747,"score_gpt":0.5207145243752711,"score_spread":0.30961590986595366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W178626500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021969211,0.995216,0.00003904053,0.00027671695,0.00060374144,0.0011429383,0.000014421787,0.000069229274,0.0024181798],"genre_scores_gemma":[0.000028794364,0.98985153,0.0008346971,0.00030286793,0.00074911787,0.00004619729,0.00028651496,0.00006708029,0.007833171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702847,0.00017526493,0.001641171,0.00056776445,0.0002349448,0.00035240175],"domain_scores_gemma":[0.9984717,0.00058057345,0.0002876108,0.00027487977,0.000052460637,0.00033278958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008719611,0.00046745376,0.0020649435,0.00038803593,0.000032107924,0.00001756722,0.000080059974,0.0004893997,0.00020284318],"category_scores_gemma":[0.00019615826,0.0003591553,0.0004216733,0.0004993443,0.00015543509,0.000035436202,0.00011352224,0.0010834028,0.00038242026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029441191,0.00050595903,0.0059652086,0.004843266,0.000260704,0.00026857248,0.000013183575,9.81449e-8,1.10622025e-7,0.000013724408,0.0082414895,0.9798582],"study_design_scores_gemma":[0.0026068776,0.00011689137,0.0011871317,0.006242055,0.0021413458,0.0000778764,0.0000010554594,0.000019782818,0.0000014277033,0.000010862531,0.9872961,0.0002985701],"about_ca_topic_score_codex":0.0000029228959,"about_ca_topic_score_gemma":0.0000036606618,"teacher_disagreement_score":0.97955966,"about_ca_system_score_codex":0.0001230555,"about_ca_system_score_gemma":0.000203013,"threshold_uncertainty_score":0.99988604},"labels":[],"label_agreement":null},{"id":"W186511383","doi":"10.2165/0003088-200847120-00002","title":"Does Oxcarbazepine Warrant Therapeutic Drug Monitoring?","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Oxcarbazepine; Medicine; Therapeutic drug monitoring; Carbamazepine; Drug; Therapeutic effect; Active metabolite; Pharmacotherapy; Intensive care medicine; Pharmacology; Pharmacokinetics; Epilepsy; Internal medicine; Psychiatry","score_opus":0.1793149649316613,"score_gpt":0.5085096684981516,"score_spread":0.3291947035664903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W186511383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011636974,0.99318165,0.0000075251073,0.00044895642,0.0030094357,0.0019604373,0.000081020946,0.00017812758,0.0010164591],"genre_scores_gemma":[0.00029646064,0.98660874,0.00039422655,0.0002738024,0.005292724,0.00021008446,0.0001793274,0.00017813336,0.0065664863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99500614,0.0005524565,0.0019148443,0.0009337058,0.0007954263,0.00079742057],"domain_scores_gemma":[0.9958782,0.0014548289,0.00042145787,0.0010074774,0.00021892872,0.0010190655],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004789799,0.0007857982,0.0034358844,0.0001999425,0.0001182141,0.000031200143,0.0004550676,0.00045509363,0.00048854196],"category_scores_gemma":[0.00029860312,0.00038849108,0.0020385697,0.0004034132,0.0004384956,0.000036812417,0.00020305128,0.0022200341,0.0008641499],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009126646,0.0012205723,0.0036023431,0.0062097395,0.0017556094,0.0011080876,0.000016197899,8.660508e-8,6.901619e-7,0.000004069254,0.00911616,0.9768752],"study_design_scores_gemma":[0.0023459136,0.00047594012,0.00062624057,0.0063251327,0.0034268724,0.00015657768,0.0000036534855,0.000008837046,0.000024146948,0.00003218772,0.9861612,0.0004133437],"about_ca_topic_score_codex":0.000008695782,"about_ca_topic_score_gemma":3.6408008e-7,"teacher_disagreement_score":0.977045,"about_ca_system_score_codex":0.00017793139,"about_ca_system_score_gemma":0.0006984129,"threshold_uncertainty_score":0.9999138},"labels":[],"label_agreement":null},{"id":"W1965458832","doi":"10.2165/00003088-200544050-00001","title":"Pharmacokinetics of Proton Pump Inhibitors in Children","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lansoprazole; Omeprazole; Pantoprazole; Esomeprazole; CYP2C19; Pharmacokinetics; Pharmacology; Rabeprazole; Proton-pump inhibitor; Medicine; Enteric coating; CYP3A4; Population; Oral administration; Gastroenterology; Chemistry; Internal medicine; Cytochrome P450; Dosage form; Metabolism","score_opus":0.09888409871956902,"score_gpt":0.4787984253831883,"score_spread":0.37991432666361924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965458832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056720185,0.98613465,0.0000037854293,0.000036508256,0.0006034713,0.006148313,0.00017438778,0.0000771646,0.0011497037],"genre_scores_gemma":[0.008774308,0.9870327,0.0006083138,0.0002039376,0.0019184527,0.00026470044,0.00042588965,0.00017839903,0.00059326686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99374235,0.0003943907,0.0036126177,0.0009184738,0.0006524223,0.0006797335],"domain_scores_gemma":[0.997044,0.00038802362,0.0011186863,0.0007173815,0.0001581202,0.00057376066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000721806,0.0008748362,0.004001889,0.00048652783,0.0000278107,0.000015932423,0.00044939097,0.0007148763,0.00042125143],"category_scores_gemma":[0.0002920657,0.0006853525,0.0014953201,0.0007369322,0.00033837135,0.000056248402,0.00025555675,0.0019355911,0.0002346727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058173242,0.0025394848,0.03740158,0.0063193543,0.0008589033,0.0002583086,0.000007856471,0.0000031035622,0.0000012464353,0.00000266054,0.0009489303,0.9516004],"study_design_scores_gemma":[0.007823872,0.0009844045,0.0046312823,0.00735164,0.007752055,0.00019318982,8.85726e-7,0.000033533484,0.00013712833,0.000009635992,0.97068906,0.00039330806],"about_ca_topic_score_codex":0.0000037621369,"about_ca_topic_score_gemma":2.357453e-7,"teacher_disagreement_score":0.96974015,"about_ca_system_score_codex":0.00017006055,"about_ca_system_score_gemma":0.00046090194,"threshold_uncertainty_score":0.99955976},"labels":[],"label_agreement":null},{"id":"W1968114154","doi":"10.1007/s40262-013-0110-5","title":"Clinical Pharmacokinetic Drug Interactions Associated with Artemisinin Derivatives and HIV-Antivirals","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Nevirapine; Dihydroartemisinin; Artemether; Lumefantrine; Artesunate; Artemether/lumefantrine; Pharmacology; Artemisinin; Pharmacokinetics; Medicine; Drug; Ritonavir; Malaria; Plasmodium falciparum; Virology; Human immunodeficiency virus (HIV); Immunology; Viral load; Antiretroviral therapy","score_opus":0.15551299804731164,"score_gpt":0.47791693531647056,"score_spread":0.32240393726915895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968114154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005182815,0.98080575,0.000055890225,0.0010850246,0.0013422949,0.005357811,0.0001337267,0.00030215658,0.005734543],"genre_scores_gemma":[0.00045828457,0.9298705,0.0017516294,0.0005857026,0.0009857545,0.00043453308,0.0007272311,0.00020357818,0.06498278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99251217,0.0012385948,0.0035866685,0.0013733411,0.0005782323,0.0007109953],"domain_scores_gemma":[0.9926155,0.003975292,0.0015137248,0.0006377562,0.00033906606,0.0009186303],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012780395,0.0011502852,0.004614129,0.00029790762,0.00015722946,0.00009847611,0.00033610145,0.00039939815,0.0010094643],"category_scores_gemma":[0.0009086423,0.00078063674,0.0010313276,0.0005947187,0.00086688483,0.00015608832,0.00029642816,0.002516978,0.00085042464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007486885,0.0031573772,0.0039268616,0.002326121,0.004252729,0.00028121515,0.0000776057,1.8636582e-7,7.9839145e-7,0.000009310287,0.080605134,0.904614],"study_design_scores_gemma":[0.025602583,0.00040406233,0.0004673693,0.011365227,0.011921978,0.000081958126,0.000031054515,0.000089752575,0.0000045703628,0.000011096967,0.94923663,0.00078370527],"about_ca_topic_score_codex":0.0000010932067,"about_ca_topic_score_gemma":0.0000017553239,"teacher_disagreement_score":0.9038303,"about_ca_system_score_codex":0.00013734102,"about_ca_system_score_gemma":0.0006022887,"threshold_uncertainty_score":0.9999275},"labels":[],"label_agreement":null},{"id":"W1973260414","doi":"10.2165/00003088-200038040-00001","title":"Metabolism and Pharmacokinetics of Oxazaphosphorines","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Ifosfamide; Pharmacology; Pharmacokinetics; Metabolite; Metabolism; Chemistry; Cyclophosphamide; Prodrug; Drug metabolism; Drug; Active metabolite; Nitrogen mustard; Pharmacodynamics; Metabolic pathway; Cytochrome P450; Hydroxylation; Biochemistry; Biology; Enzyme; Medicine; Chemotherapy; Internal medicine; Etoposide","score_opus":0.11347648268276742,"score_gpt":0.4578059872238493,"score_spread":0.3443295045410819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973260414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002076102,0.99382013,0.000018235933,0.00018679688,0.0008872852,0.0014905266,0.00014216435,0.00011299062,0.0012657779],"genre_scores_gemma":[0.00026532137,0.99378127,0.001881765,0.00066908426,0.0020655526,0.000030428047,0.00015993573,0.00021755844,0.0009290775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951491,0.00028921224,0.0027502892,0.0008465488,0.00052430347,0.00044059835],"domain_scores_gemma":[0.99677134,0.0008179715,0.00093576196,0.00070433697,0.00020832787,0.0005622722],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006177198,0.0007762664,0.0040619,0.0002910368,0.000044881104,0.000024508081,0.00034110935,0.0007611088,0.0011792548],"category_scores_gemma":[0.0002930061,0.00066131534,0.0010677696,0.0006590784,0.0005973761,0.000056704575,0.00014997143,0.0015010198,0.00008121124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009099126,0.00046106265,0.000028224411,0.010627699,0.00072049705,0.000031829335,0.00002743692,3.7512675e-7,0.0001636694,0.000019051968,0.005147673,0.9826815],"study_design_scores_gemma":[0.0028324146,0.00021143697,0.00008574717,0.00411638,0.008877275,0.00014143431,0.0000034824689,0.000043883218,0.0023785664,0.000067877394,0.9807291,0.00051240367],"about_ca_topic_score_codex":0.0000044020157,"about_ca_topic_score_gemma":2.4766553e-7,"teacher_disagreement_score":0.9821691,"about_ca_system_score_codex":0.00004795527,"about_ca_system_score_gemma":0.00035036862,"threshold_uncertainty_score":0.9997338},"labels":[],"label_agreement":null},{"id":"W1980131079","doi":"10.1007/s40262-015-0256-4","title":"A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; Western University; SickKids Foundation; BC Children's Hospital; Child and Family Research Institute","funders":"","keywords":"Morphine; Medicine; Codeine; Pharmacokinetics; Analgesic; Acetaminophen; Opioid; Oral administration; Anesthesia; Pharmacology; Internal medicine","score_opus":0.10864416972639676,"score_gpt":0.4092486706350109,"score_spread":0.3006045009086141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980131079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576706,0.0019497089,0.00019249218,0.00074929395,0.00017682134,0.00079199555,0.000045144232,0.00003768808,0.00028977176],"genre_scores_gemma":[0.99506235,0.00023685108,0.0021927531,0.0014658594,0.0003249009,0.00005138428,0.00015040961,0.000019027813,0.00049645663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998565,0.00008669227,0.000558335,0.00033348193,0.00019312173,0.0002633798],"domain_scores_gemma":[0.9991828,0.00015732499,0.000088456334,0.00016735167,0.00008689516,0.00031714645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007523566,0.00016890107,0.0005781085,0.00020625358,0.000017529697,0.00002671954,0.00008758811,0.00006609035,0.000084127605],"category_scores_gemma":[0.00028151952,0.000143563,0.00019779171,0.00042806444,0.000080925434,0.00006719019,0.00010667996,0.00017150122,0.000014034562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000973382,0.00083270465,0.9930702,0.000027781482,0.0007221006,0.000020929998,0.000073157185,0.00003888058,0.00021204757,0.000022077895,0.00325848,0.0007482461],"study_design_scores_gemma":[0.010146653,0.00035260728,0.9556122,0.00001624997,0.003107894,0.000002351494,0.000022371467,0.02697131,0.00023180405,0.00014805555,0.0032157213,0.00017282424],"about_ca_topic_score_codex":0.000007763654,"about_ca_topic_score_gemma":0.000020472009,"teacher_disagreement_score":0.037458055,"about_ca_system_score_codex":0.000026964966,"about_ca_system_score_gemma":0.000019255243,"threshold_uncertainty_score":0.5854329},"labels":[],"label_agreement":null},{"id":"W1981591556","doi":"10.2165/11318040-000000000-00000","title":"Evaluation of Bioequivalence for Highly Variable Drugs with Scaled Average Bioequivalence","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Sample size determination; Replicate; Econometrics; Sample (material); Computer science; Statistics; Medicine; Mathematics; Pharmacology; Bioavailability","score_opus":0.7578223706805757,"score_gpt":0.6614144956818232,"score_spread":0.09640787499875247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981591556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019104338,0.82364863,0.16009195,0.0000918084,0.0027595614,0.0088424,0.0016303152,0.00020994984,0.002706309],"genre_scores_gemma":[0.000012279008,0.56762743,0.43055502,0.00010955624,0.0010395357,0.00031065068,0.00002784563,0.00012777816,0.00018990831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98058337,0.00691065,0.0071914177,0.001701819,0.0027052897,0.00090743497],"domain_scores_gemma":[0.8532971,0.13797042,0.0041044937,0.00165705,0.0024684465,0.00050246925],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.042942632,0.0010757386,0.006603289,0.00025265006,0.000113438866,0.00006692501,0.0016882693,0.0012136652,0.0005457761],"category_scores_gemma":[0.1423966,0.0007949614,0.0015125058,0.0010702135,0.0010301855,0.00010473994,0.0002763679,0.0014555565,0.000043519998],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019385059,0.0010309056,0.0000011356926,0.017970178,0.0007804944,0.0000055481723,0.000012416075,0.000014612037,0.000002517342,0.011458744,0.004152772,0.9643768],"study_design_scores_gemma":[0.005954741,0.0017660821,0.0000015523185,0.017804425,0.04246612,0.000011455007,0.0000053049484,0.00229963,0.00006265448,0.4481629,0.4802573,0.0012078021],"about_ca_topic_score_codex":0.0000018266566,"about_ca_topic_score_gemma":3.0416493e-7,"teacher_disagreement_score":0.96316904,"about_ca_system_score_codex":0.00021962365,"about_ca_system_score_gemma":0.0016107035,"threshold_uncertainty_score":0.99945015},"labels":[],"label_agreement":null},{"id":"W1981592939","doi":"10.2165/00003088-200140090-00005","title":"Comparison of the Plasma Pharmacokinetics of Lamivudine During Twice and Once Daily Administration in Patients with HIV","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Cmin; Pharmacokinetics; Cmax; Lamivudine; Medicine; Pharmacology; Trough Concentration; Internal medicine; Gastroenterology; Immunology; Virus","score_opus":0.038506566473534634,"score_gpt":0.3774059128336198,"score_spread":0.3388993463600852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981592939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997565,0.00009100747,0.000016512979,0.0010047489,0.00012626576,0.0005297373,0.000014520836,0.000013534498,0.0006386916],"genre_scores_gemma":[0.9978844,0.0002659088,0.000900801,0.00007700896,0.00006247895,0.000007288389,0.00002764858,0.000019155112,0.00075534545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981564,0.00008384464,0.0009382148,0.00025172177,0.00037615275,0.00019365798],"domain_scores_gemma":[0.99894345,0.00021680062,0.00035101667,0.00020923864,0.00015979951,0.00011969944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001934864,0.00017939034,0.0004949343,0.0000752671,0.000034378514,0.0000055555906,0.000116686875,0.00007303367,0.00005175224],"category_scores_gemma":[0.00010065596,0.00012173926,0.000064279615,0.0003409281,0.00023610679,0.000044575303,0.00008009621,0.0002931581,0.0000031890556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021263752,0.0018480021,0.9914307,0.00012487694,0.00010969178,0.000012436309,0.00020762131,0.00006112464,0.0010254381,0.000007962359,0.0004174923,0.0026282535],"study_design_scores_gemma":[0.014505776,0.00053493574,0.95472986,0.00023718893,0.00034017643,0.000005181294,0.000050208797,0.001724812,0.02570093,0.0000045238503,0.002038782,0.00012761548],"about_ca_topic_score_codex":0.0000013514768,"about_ca_topic_score_gemma":0.0000059433055,"teacher_disagreement_score":0.036700856,"about_ca_system_score_codex":0.00003069234,"about_ca_system_score_gemma":0.0000761991,"threshold_uncertainty_score":0.4964383},"labels":[],"label_agreement":null},{"id":"W1981902086","doi":"10.1007/s40262-015-0236-8","title":"Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Memorial University of Newfoundland; St. Michael's Hospital; University of Ottawa; University of Toronto; Sunnybrook Health Science Centre; University of Waterloo; University of Manitoba; Children's & Women's Health Centre of British Columbia; Ottawa Hospital","funders":"National Medical Research Council; National Health and Medical Research Council; University of Ottawa","keywords":"Medicine; Statement (logic); Pharmacotherapy; Intensive care medicine; MEDLINE; Pharmacokinetics; Medical physics; Pharmacology; Internal medicine; Chemistry; Political science","score_opus":0.9819514435848298,"score_gpt":0.8061165991694247,"score_spread":0.1758348444154051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981902086","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07450545,0.016911766,0.6845375,0.09616826,0.09601659,0.020118073,0.00075698143,0.002227613,0.008757791],"genre_scores_gemma":[0.008401227,0.008513419,0.9461553,0.017725434,0.016174622,0.0005749264,0.000010908801,0.00023355393,0.0022105973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9675571,0.0037751421,0.024546776,0.0015542408,0.0014482834,0.001118503],"domain_scores_gemma":[0.5948593,0.36982,0.017171744,0.0037997514,0.011908523,0.002440673],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.12497096,0.00071021024,0.003134754,0.00008227797,0.000271652,0.00010567666,0.0014441209,0.0004346201,0.00017026934],"category_scores_gemma":[0.79539394,0.0004567719,0.001789691,0.000497484,0.0015460781,0.00010997926,0.00081989355,0.0015519289,0.00011633202],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007745354,0.0009626026,0.0026218076,0.00024629847,0.0016456305,0.000049643942,0.00011822622,0.00012415226,0.000014002471,0.0039138114,0.83091915,0.15861012],"study_design_scores_gemma":[0.008575973,0.0011103759,0.00017752578,0.00015685741,0.0022542276,0.000013634971,0.00040634267,0.008078618,0.0002445902,0.44969478,0.52867466,0.0006124381],"about_ca_topic_score_codex":0.000003202215,"about_ca_topic_score_gemma":0.0000012812984,"teacher_disagreement_score":0.670423,"about_ca_system_score_codex":0.00012313052,"about_ca_system_score_gemma":0.0004722393,"threshold_uncertainty_score":0.9997884},"labels":[],"label_agreement":null},{"id":"W1983727955","doi":"10.2165/0003088-200948010-00001","title":"Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":525,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Rivaroxaban; Apixaban; Dabigatran; Discovery and development of direct thrombin inhibitors; Pharmacodynamics; Medicine; Fondaparinux; Pharmacology; Thrombin; Pharmacokinetics; Anticoagulant; Warfarin; Internal medicine; Venous thromboembolism; Atrial fibrillation; Thrombosis; Platelet","score_opus":0.2171734329349795,"score_gpt":0.4745278795971007,"score_spread":0.25735444666212115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983727955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02109346,0.9747596,0.00002987267,0.000053466167,0.0009872236,0.0020748382,0.00010669811,0.00007568429,0.00081920816],"genre_scores_gemma":[0.025715182,0.97136587,0.0020604169,0.00024228756,0.00020366338,0.00004795277,0.00013695196,0.00009761188,0.00013003667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948235,0.0004956903,0.0028347727,0.0008776781,0.00050582463,0.0004625033],"domain_scores_gemma":[0.9972748,0.0007917935,0.00090039684,0.00030567148,0.00018576521,0.0005415397],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048137142,0.0008134012,0.004508284,0.00042076517,0.00007225779,0.000021922182,0.00021302188,0.0005349645,0.00012562943],"category_scores_gemma":[0.00010784976,0.00070064986,0.00039678207,0.0005727667,0.00058228517,0.000072230774,0.00032950976,0.0013294129,0.00001561084],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013473484,0.0017914064,0.0011548125,0.008768224,0.0013926072,0.00009846011,0.0005205395,0.0000041810667,0.00030247227,0.00003813121,0.0018037888,0.98399067],"study_design_scores_gemma":[0.0071229334,0.0004895332,0.0017654392,0.0059033437,0.0026013625,0.00017024341,0.000029972807,0.0010397502,0.0016690482,0.000018883813,0.97826105,0.0009284315],"about_ca_topic_score_codex":0.000005425949,"about_ca_topic_score_gemma":0.000004150001,"teacher_disagreement_score":0.9830622,"about_ca_system_score_codex":0.00009584633,"about_ca_system_score_gemma":0.00047539556,"threshold_uncertainty_score":0.99954444},"labels":[],"label_agreement":null},{"id":"W1983958707","doi":"10.2165/11538690-000000000-00000","title":"Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"NONMEM; Medicine; Pharmacokinetics; Covariate; Population; Statistics; Dosing; Confidence interval; Area under the curve; Internal medicine; Mathematics","score_opus":0.10715141225350172,"score_gpt":0.39380757758989754,"score_spread":0.2866561653363958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983958707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536127,0.00030769306,0.002833524,0.000035159854,0.00016409853,0.00062486756,0.000009933362,0.000017116994,0.0006463171],"genre_scores_gemma":[0.9953689,0.00053374993,0.0038293914,0.00009085934,0.000078652796,0.0000137386805,0.000034915007,0.000016727137,0.000033064833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981667,0.0001900244,0.00072895136,0.00032717315,0.0004149578,0.00017223091],"domain_scores_gemma":[0.999153,0.0001296602,0.00019529175,0.00017516421,0.00019060906,0.00015626903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010028309,0.00014389982,0.00035095846,0.00009472261,0.00002543008,0.0000051848956,0.00006634039,0.00009107496,0.00040998886],"category_scores_gemma":[0.0001274741,0.000118011514,0.00006243131,0.00017532644,0.00013628897,0.00010491295,0.000016002514,0.00024052449,0.0000052853406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019604554,0.00059258175,0.95945096,0.00011133794,0.000031077772,0.000020727264,0.0001990484,0.000029923109,0.003010022,0.000027278224,0.00002298671,0.034543615],"study_design_scores_gemma":[0.00433379,0.0004650394,0.9539333,0.00025681587,0.000455452,0.000012481484,0.000014925282,0.033419173,0.0067917723,0.00018853905,0.000011031068,0.00011769075],"about_ca_topic_score_codex":0.000056361634,"about_ca_topic_score_gemma":0.00001525379,"teacher_disagreement_score":0.034425925,"about_ca_system_score_codex":0.000039262748,"about_ca_system_score_gemma":0.000056360343,"threshold_uncertainty_score":0.48123696},"labels":[],"label_agreement":null},{"id":"W1985187934","doi":"10.1007/s40262-013-0090-5","title":"Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Bayer HealthCare; Bayer","keywords":"Medicine; Rivaroxaban; Physiologically based pharmacokinetic modelling; Dosing; Population; Pharmacokinetics; Clinical trial; Pharmacology; Intensive care medicine; Internal medicine; Warfarin","score_opus":0.08869458188294198,"score_gpt":0.3721436355699694,"score_spread":0.2834490536870274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985187934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993003,0.00008465636,0.004845448,0.00047686853,0.00039530775,0.00074731914,0.000018996729,0.00002459477,0.00040380604],"genre_scores_gemma":[0.9665849,0.000044646615,0.032462154,0.0006664588,0.00009489837,0.000015761683,0.00001825419,0.000027576883,0.00008533088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972206,0.00010283403,0.0017171669,0.00022180032,0.0005491221,0.00018851107],"domain_scores_gemma":[0.997926,0.00026628852,0.0007516168,0.00040882739,0.0004808521,0.00016641637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044023906,0.00017678355,0.000582848,0.00011195045,0.00003548149,0.0000033889205,0.00026329735,0.00013507932,0.0003894824],"category_scores_gemma":[0.00022118389,0.00012941961,0.00030841827,0.00041135354,0.00014132776,0.00003219945,0.000108212516,0.0002594393,0.000008941616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003282299,0.005474007,0.31293643,0.0014534766,0.0006586658,9.075224e-7,0.0004740157,0.022472883,0.6028009,0.0013999896,0.003025275,0.04897523],"study_design_scores_gemma":[0.005948563,0.00019639594,0.25502717,0.00015227175,0.0008458963,9.112329e-7,0.000026050207,0.3575872,0.37873322,0.000836501,0.00042413504,0.00022168455],"about_ca_topic_score_codex":0.000009370612,"about_ca_topic_score_gemma":0.0000012813014,"teacher_disagreement_score":0.33511433,"about_ca_system_score_codex":0.000019739919,"about_ca_system_score_gemma":0.00027854185,"threshold_uncertainty_score":0.5277579},"labels":[],"label_agreement":null},{"id":"W1986077106","doi":"10.2165/00003088-200038050-00001","title":"Choosing the Right Nonsteroidal Anti-Inflammatory Drug for the Right Patient","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacokinetics; Enterohepatic circulation; Volume of distribution; Pharmacology; Free fraction; Albumin; Distribution (mathematics); Drug; Chemistry; Medicine; Internal medicine; Metabolism","score_opus":0.04598313820310822,"score_gpt":0.3963797105658518,"score_spread":0.3503965723627436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986077106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076644245,0.9824982,0.000048003687,0.0006133662,0.007997208,0.006404711,0.0001289129,0.00012962095,0.0014135292],"genre_scores_gemma":[0.00030394548,0.9871564,0.000097525226,0.0022565208,0.008183364,0.0004924504,0.000119243705,0.00020341895,0.001187158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99409115,0.00087514025,0.0026796763,0.00083062204,0.00068248785,0.00084094086],"domain_scores_gemma":[0.9902881,0.0067865592,0.0009281732,0.0013252657,0.00018725664,0.0004846916],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023081962,0.00091048755,0.002705251,0.00012606128,0.00054199854,0.00009560545,0.00083955546,0.0005784355,0.00080244563],"category_scores_gemma":[0.00045270254,0.00042406973,0.0023772898,0.0003025857,0.0007467182,0.000058764523,0.0001940524,0.00239195,0.00043572666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011367067,0.0002281593,0.000050039183,0.006679072,0.0006747337,0.00016415777,0.000066508954,0.000004746852,0.0000010204366,0.000030700194,0.12323022,0.86875695],"study_design_scores_gemma":[0.0017833331,0.00019645142,0.00004807468,0.005337218,0.0071595283,0.00012417884,0.000006046475,0.00040811696,0.00004133699,0.000019187895,0.9843664,0.0005101025],"about_ca_topic_score_codex":0.0000014862064,"about_ca_topic_score_gemma":0.0000014802772,"teacher_disagreement_score":0.86824685,"about_ca_system_score_codex":0.00009681149,"about_ca_system_score_gemma":0.0006539303,"threshold_uncertainty_score":0.9999096},"labels":[],"label_agreement":null},{"id":"W1989930316","doi":"10.2165/00003088-200847030-00006","title":"Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; McGill University Health Centre","funders":"","keywords":"Rivaroxaban; Medicine; Pharmacodynamics; Pharmacokinetics; Population; Anesthesia; Internal medicine; Pharmacology; Warfarin; Atrial fibrillation","score_opus":0.11709606034631777,"score_gpt":0.40146987980002125,"score_spread":0.2843738194537035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989930316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682426,0.00017969897,0.00005838251,0.00033277,0.0014569231,0.0007902283,0.000045917925,0.000101683036,0.00021010866],"genre_scores_gemma":[0.9942471,0.0030514158,0.0007784495,0.00049439614,0.0009180781,0.0000030835329,0.00023702769,0.000066615634,0.00020385662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647605,0.0003215846,0.001721269,0.0005292524,0.00056404644,0.0003877672],"domain_scores_gemma":[0.9974983,0.0011342035,0.00050865975,0.00028242698,0.0001974416,0.0003789693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006368428,0.00033988024,0.0009839684,0.00040651273,0.00009128303,0.000016748194,0.00011742124,0.00017971685,0.00016576174],"category_scores_gemma":[0.0007316776,0.00032474767,0.0003264754,0.0005388788,0.00022104479,0.00027192716,0.00013586285,0.00038241188,0.000008564445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008598923,0.000308868,0.98112386,0.00021719903,0.00012637688,0.000020367765,0.00006121739,0.00011353098,0.0006145447,0.000009761361,0.0010852515,0.0154591305],"study_design_scores_gemma":[0.009238888,0.00041782833,0.98051447,0.000098403856,0.000365952,0.000003635528,0.000012458697,0.0057329535,0.0007277954,0.000026267195,0.0025268418,0.00033448357],"about_ca_topic_score_codex":0.000030458768,"about_ca_topic_score_gemma":0.000010701407,"teacher_disagreement_score":0.015124647,"about_ca_system_score_codex":0.00006486162,"about_ca_system_score_gemma":0.00009816759,"threshold_uncertainty_score":0.9999205},"labels":[],"label_agreement":null},{"id":"W1994438706","doi":"10.2165/00003088-200241080-00001","title":"Impact of Stereoselectivity on the Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs","year":2002,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Propafenone; Mexiletine; Flecainide; Stereoselectivity; Chemistry; Pharmacology; Debrisoquine; Verapamil; Pharmacokinetics; Quinidine; Disopyramide; Procainamide; Antiarrhythmic agent; Enantiomer; CYP2D6; Metabolism; Medicine; Internal medicine; Stereochemistry; Cytochrome P450; Biochemistry; Calcium","score_opus":0.29272726509544517,"score_gpt":0.5554188054718815,"score_spread":0.2626915403764363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994438706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03914014,0.9483514,0.00003451677,0.000119682096,0.003603026,0.002955485,0.0024949003,0.00009628056,0.0032046014],"genre_scores_gemma":[0.049942914,0.94705206,0.000099909324,0.00056088757,0.0014965285,0.000121910925,0.000084860214,0.00026571253,0.00037518892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98725605,0.0047577773,0.00446516,0.0014043106,0.0008407372,0.0012759505],"domain_scores_gemma":[0.9846331,0.009274603,0.0034791508,0.0011430979,0.000543099,0.0009269713],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0039648693,0.0017450365,0.0050342614,0.00062208675,0.00026937787,0.000045662382,0.0018289838,0.001428585,0.002528336],"category_scores_gemma":[0.00057121576,0.0012083624,0.003017697,0.0013761239,0.0022100266,0.000104559156,0.0008040101,0.005496875,0.00011810736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039130784,0.002315743,0.000346763,0.004793521,0.0042711915,0.00004367333,0.00017841438,0.00022217995,0.0004412854,0.0002285942,0.010853188,0.9759141],"study_design_scores_gemma":[0.0041406425,0.00084727595,0.00015780823,0.0013337698,0.010950298,0.00008008509,0.000011404317,0.008415483,0.0007987333,0.00015249634,0.9718636,0.0012483803],"about_ca_topic_score_codex":0.000013287065,"about_ca_topic_score_gemma":5.266087e-7,"teacher_disagreement_score":0.97466576,"about_ca_system_score_codex":0.00013895592,"about_ca_system_score_gemma":0.0005342328,"threshold_uncertainty_score":0.9998678},"labels":[],"label_agreement":null},{"id":"W1996261168","doi":"10.2165/00003088-200443110-00004","title":"Risperidone Does Not Affect Steady-State Pharmacokinetics of Divalproex Sodium in Patients with Bipolar Disorder","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Centre for Addiction and Mental Health; University of Alberta Hospital; Alberta Hospital Edmonton; University of Toronto","funders":"","keywords":"Risperidone; Cmax; Divalproex; Pharmacokinetics; Placebo; Bipolar disorder; Medicine; Anticonvulsant; Pharmacology; Drug interaction; Carbamazepine; Internal medicine; Mania; Psychiatry; Schizophrenia (object-oriented programming); Lithium (medication); Epilepsy","score_opus":0.02271253406040022,"score_gpt":0.33944674164337013,"score_spread":0.3167342075829699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996261168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942808,0.0019546659,0.0003207957,0.0009547615,0.00052996184,0.0014757335,0.0001710636,0.000079521065,0.000232672],"genre_scores_gemma":[0.99567544,0.002027528,0.0011877114,0.00055778114,0.00015496991,0.00003576066,0.000103766906,0.00009362801,0.00016341532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676585,0.00015672705,0.0011892525,0.0006353614,0.0006680906,0.00058468967],"domain_scores_gemma":[0.9982856,0.00022221693,0.00031486613,0.0005313242,0.00025783875,0.00038817138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038210108,0.00046313778,0.00093202747,0.00019664786,0.00005566845,0.000017045468,0.0002400454,0.00015935066,0.00015707397],"category_scores_gemma":[0.00010885535,0.00030786014,0.0002671092,0.00046410368,0.000460487,0.00009324974,0.00014306964,0.0007428946,0.000045197412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003087297,0.0077466965,0.9613859,0.00025967398,0.00041904638,0.000033829936,0.00019985499,0.00030066218,0.000926591,0.000020501457,0.000065814915,0.025554147],"study_design_scores_gemma":[0.04863127,0.002965188,0.9227294,0.00019203179,0.000873166,0.000004044505,0.000026643342,0.00016137352,0.016091667,0.00011735747,0.007774428,0.00043344276],"about_ca_topic_score_codex":0.00008380618,"about_ca_topic_score_gemma":0.000065684,"teacher_disagreement_score":0.045543972,"about_ca_system_score_codex":0.000086291526,"about_ca_system_score_gemma":0.00014593842,"threshold_uncertainty_score":0.99993736},"labels":[],"label_agreement":null},{"id":"W2000092715","doi":"10.2165/11319320-000000000-00000","title":"Multiple Peaking Phenomena in Pharmacokinetic Disposition","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Gastrointestinal tract; Enterohepatic circulation; Drug; Xenobiotic; Secretion; Reabsorption; Pharmacology; Chemistry; Distribution (mathematics); Medicine; Internal medicine; Biochemistry; Mathematics; Metabolism","score_opus":0.10447947642254363,"score_gpt":0.4522095953047637,"score_spread":0.34773011888222005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000092715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027164564,0.98970306,0.00020307803,0.00010329332,0.003520549,0.0022640417,0.000091024136,0.0001670465,0.0036762853],"genre_scores_gemma":[0.0008290119,0.9914682,0.0011208305,0.0004657789,0.003959827,0.00015726098,0.0006324254,0.00021469948,0.0011519616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947915,0.00025362667,0.002665637,0.0010279581,0.0005177959,0.0007434977],"domain_scores_gemma":[0.99734104,0.00066695455,0.00063543604,0.0006758432,0.000113278744,0.00056743383],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009938941,0.0008081615,0.0032899552,0.00041480327,0.00007080327,0.00003553645,0.00046475563,0.00091562275,0.0005745878],"category_scores_gemma":[0.00017110955,0.000651339,0.0013733896,0.0006754056,0.0002598213,0.00006623724,0.00010174395,0.0038261581,0.0002521337],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013070944,0.0009487205,0.00021843852,0.0109452605,0.00016368403,0.0004982527,0.000021970634,0.000002232047,0.000059052953,0.000026748325,0.00035655996,0.98662835],"study_design_scores_gemma":[0.0037508986,0.00015513052,0.0002173716,0.010028413,0.0037633642,0.00006390782,0.0000054033326,0.00030618676,0.00002236808,0.00003017292,0.9810142,0.0006426174],"about_ca_topic_score_codex":0.0000041280177,"about_ca_topic_score_gemma":0.000012477309,"teacher_disagreement_score":0.98598576,"about_ca_system_score_codex":0.00012340979,"about_ca_system_score_gemma":0.00033355525,"threshold_uncertainty_score":0.9995938},"labels":[],"label_agreement":null},{"id":"W2000740780","doi":"10.2165/00003088-200544070-00001","title":"Buprenorphine","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Buprenorphine; Pharmacology; (+)-Naloxone; Sublingual administration; Medicine; Opioid; Bioavailability; Thebaine; Pharmacokinetics; Partial agonist; Morphine; Anesthesia; Agonist; Codeine; Internal medicine; Receptor","score_opus":0.1657355958720424,"score_gpt":0.5085472259869853,"score_spread":0.3428116301149429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000740780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000070458345,0.9909833,0.000012695027,0.00033935852,0.001357566,0.0016549097,0.00009651583,0.00020455797,0.005344057],"genre_scores_gemma":[0.000004009736,0.98700446,0.001590274,0.00093154405,0.0039255065,0.000111142625,0.0006156749,0.00018761797,0.0056298007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961305,0.00019708973,0.0020347415,0.0007918635,0.0003825637,0.0004631986],"domain_scores_gemma":[0.9973323,0.0005824764,0.00047824957,0.0009178224,0.00011099405,0.00057816284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00035023197,0.0006986583,0.0034232927,0.00016724895,0.000040178475,0.00002243734,0.00032673532,0.00061339483,0.0020309405],"category_scores_gemma":[0.00025635338,0.0005163708,0.0018181612,0.00034536206,0.00017545112,0.000027086755,0.00019523781,0.0014126231,0.0033945376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021630784,0.0012914947,0.000033191038,0.0072182044,0.00074910815,0.00013249027,0.000006972819,3.0775684e-7,4.661996e-8,0.000012046092,0.032716643,0.95781785],"study_design_scores_gemma":[0.0019614482,0.00035130949,0.00003888179,0.0053672832,0.012266647,0.00010029864,0.0000015128835,0.000019100671,3.687808e-7,0.000010268731,0.97948104,0.0004018097],"about_ca_topic_score_codex":0.0000017178086,"about_ca_topic_score_gemma":2.8995981e-7,"teacher_disagreement_score":0.95741606,"about_ca_system_score_codex":0.00014304956,"about_ca_system_score_gemma":0.0005430445,"threshold_uncertainty_score":0.9997288},"labels":[],"label_agreement":null},{"id":"W2001075984","doi":"10.2165/11587240-000000000-00000","title":"Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia?","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; Fraser Health; University of British Columbia","funders":"","keywords":"Olanzapine; Therapeutic drug monitoring; Medicine; Adverse effect; Schizophrenia (object-oriented programming); Antipsychotic; Pharmacokinetics; Population; Pharmacology; Drug; Pharmacotherapy; Atypical antipsychotic; Antipsychotic Agent; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.2435201226149672,"score_gpt":0.5125452565259843,"score_spread":0.26902513391101707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001075984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016590221,0.9861448,0.000012107196,0.00021048977,0.0071736234,0.0035092558,0.00012229722,0.00025197258,0.00091645744],"genre_scores_gemma":[0.0006691711,0.9849169,0.0037635711,0.00017690114,0.008088706,0.00041197607,0.00021114439,0.00031363673,0.0014479589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881683,0.0016678431,0.00575274,0.002065119,0.0008731576,0.0014728339],"domain_scores_gemma":[0.9927972,0.002374185,0.000991446,0.0015702717,0.00028137054,0.0019855534],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.002922583,0.0014177945,0.0063369013,0.00076653674,0.000101168494,0.00006808284,0.0010353359,0.0012549723,0.0013566352],"category_scores_gemma":[0.0013353872,0.0008136757,0.0029961402,0.0010658888,0.0006997209,0.00010733805,0.00061243534,0.005763806,0.0014846517],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00462885,0.0028672214,0.00409805,0.0070316056,0.0014466309,0.0019789913,0.000012923034,2.8155827e-7,9.429207e-7,0.000033641947,0.0012458195,0.97665507],"study_design_scores_gemma":[0.019204583,0.0010883515,0.003752082,0.014215217,0.0058180755,0.0001438528,0.0000060614807,0.000050788905,0.00001737119,0.00012642672,0.95465267,0.00092453405],"about_ca_topic_score_codex":0.00002618838,"about_ca_topic_score_gemma":0.000008171407,"teacher_disagreement_score":0.9757305,"about_ca_system_score_codex":0.00028330114,"about_ca_system_score_gemma":0.001557149,"threshold_uncertainty_score":0.9998572},"labels":[],"label_agreement":null},{"id":"W2001348958","doi":"10.2165/00003088-200443030-00004","title":"Bayesian Pharmacokinetics of Gentamicin in a Haemodialysis Population","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; St. Boniface Hospital; University of Manitoba","funders":"Abbott Laboratories","keywords":"Medicine; Pharmacokinetics; Gentamicin; Pharmacotherapy; Intensive care medicine; Population pharmacokinetics; Population; Pharmacology; Anesthesia; Internal medicine; Antibiotics; Chemistry","score_opus":0.05083563210827415,"score_gpt":0.41038753714105847,"score_spread":0.35955190503278434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001348958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899499,0.00039242185,0.004540967,0.0017228503,0.00079521723,0.0007950957,0.000030514204,0.00007879258,0.0016942595],"genre_scores_gemma":[0.9891764,0.002215335,0.006064505,0.001617212,0.00061069126,0.0000050292615,0.00011151806,0.00007583786,0.00012344986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615514,0.00013431757,0.0020194324,0.0006010851,0.0005533716,0.0005366378],"domain_scores_gemma":[0.99820215,0.00021736558,0.000419646,0.0004908986,0.00022500442,0.00044493037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078555685,0.0003623196,0.0010031789,0.0004147423,0.000043930067,0.00001646032,0.00027721026,0.00024745325,0.00032123414],"category_scores_gemma":[0.00028670227,0.0003532719,0.0004582666,0.00090336386,0.0002799258,0.00007195603,0.00013740234,0.00077330146,0.000046053923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002445365,0.009659252,0.7631485,0.0008399947,0.0007906756,0.000638342,0.0004628307,0.040195093,0.093554415,0.0012627447,0.002547153,0.08445568],"study_design_scores_gemma":[0.04179339,0.0014691163,0.8133658,0.0006106754,0.0023919775,0.000094304036,0.00008413941,0.045956656,0.083972506,0.0021347478,0.007063946,0.0010627046],"about_ca_topic_score_codex":0.00011373223,"about_ca_topic_score_gemma":0.000011005767,"teacher_disagreement_score":0.08339297,"about_ca_system_score_codex":0.000121926765,"about_ca_system_score_gemma":0.00013817726,"threshold_uncertainty_score":0.99989194},"labels":[],"label_agreement":null},{"id":"W2002514824","doi":"10.2165/00003088-200039020-00003","title":"Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant Recipients","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Therapeutic drug monitoring; Immunosuppression; Pharmacokinetics; Pharmacology; Therapeutic index; Bioavailability; Drug; Therapeutic window; Dose; Intensive care medicine; Internal medicine","score_opus":0.14315532254687366,"score_gpt":0.49168334381813805,"score_spread":0.34852802127126437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002514824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2354473,0.76141024,0.000004966705,0.0000086472755,0.00020322122,0.001980708,0.00042257388,0.000014809248,0.0005075021],"genre_scores_gemma":[0.045641035,0.95362467,0.00014673758,0.000018242148,0.00008103989,0.000012659952,0.0003903127,0.000037018453,0.000048280825],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99721766,0.00019287012,0.0018084367,0.00034930013,0.00024907876,0.00018266593],"domain_scores_gemma":[0.9983853,0.0007306738,0.0004615882,0.00023050424,0.00004158153,0.00015035592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032521732,0.0003359611,0.0020151627,0.00019942227,0.000011049403,0.0000029569017,0.000094629715,0.0002632028,0.00012078721],"category_scores_gemma":[0.00002373425,0.00021559722,0.0007028553,0.0002364829,0.00009970697,0.00001880762,0.0000061900773,0.0004880435,0.0000076740325],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036012696,0.0017570789,0.035311785,0.0043468312,0.000759056,0.000054333126,0.00003286137,0.000025947777,0.000006900613,0.0000051821085,0.0000040864493,0.95409465],"study_design_scores_gemma":[0.0637,0.014081468,0.71265864,0.14258406,0.0075089624,0.00013813259,0.000002926419,0.000097677184,0.00018609525,0.000032063814,0.058064416,0.00094558374],"about_ca_topic_score_codex":0.000009772383,"about_ca_topic_score_gemma":2.409122e-7,"teacher_disagreement_score":0.9531491,"about_ca_system_score_codex":0.000050390132,"about_ca_system_score_gemma":0.0001254209,"threshold_uncertainty_score":0.8791799},"labels":[],"label_agreement":null},{"id":"W2005328285","doi":"10.2165/00003088-200038010-00003","title":"Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":907,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Pharmacology; Drug interaction; Ritonavir; CYP3A4; Ketoconazole; Triazolam; Pharmacokinetics; Dextromethorphan; Medicine; Chemistry; Benzodiazepine; Cytochrome P450; Internal medicine","score_opus":0.2913135195647739,"score_gpt":0.5702358397399223,"score_spread":0.2789223201751484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005328285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006089405,0.9767166,0.00005013891,0.00026825487,0.0060423864,0.0033004167,0.0021567002,0.00029747744,0.0050786315],"genre_scores_gemma":[0.0036456683,0.9872383,0.00066299096,0.0023154016,0.003970219,0.00023356416,0.0004393148,0.00035280953,0.0011417588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97963136,0.006635923,0.008560146,0.0025573946,0.00090522785,0.0017099362],"domain_scores_gemma":[0.9856516,0.0072808997,0.0035054549,0.001064398,0.0004903994,0.0020072144],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0058700712,0.002085371,0.006860445,0.0007183107,0.0003738953,0.00008692648,0.0016321352,0.002788246,0.0049633123],"category_scores_gemma":[0.0008468408,0.0019310478,0.00266761,0.0012573928,0.0068409694,0.00026085318,0.0008243652,0.0073650447,0.0006516532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005062792,0.0017243288,0.00009375693,0.0067375368,0.0023055866,0.00035588368,0.00004630492,0.00005086628,0.00071415986,0.00016691658,0.0102929305,0.9770054],"study_design_scores_gemma":[0.0064515,0.00048088585,0.000088755056,0.0023230738,0.0153845465,0.00028706805,0.000009714678,0.0013937037,0.00048870785,0.0005204145,0.97077703,0.0017946151],"about_ca_topic_score_codex":0.000011263573,"about_ca_topic_score_gemma":0.000002778233,"teacher_disagreement_score":0.97521085,"about_ca_system_score_codex":0.00012437094,"about_ca_system_score_gemma":0.001087233,"threshold_uncertainty_score":0.9991888},"labels":[],"label_agreement":null},{"id":"W2007492343","doi":"10.2165/11531820-000000000-00000","title":"Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":259,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pharmacokinetics; Cmax; Resveratrol; Tolerability; Chemistry; Pharmacology; Medicine; Adverse effect","score_opus":0.04732261035777299,"score_gpt":0.3892470478806883,"score_spread":0.34192443752291535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007492343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304974,0.0014621108,0.00006893693,0.00275154,0.0005050226,0.0013332926,0.00005609598,0.000060291924,0.0007129876],"genre_scores_gemma":[0.99255466,0.0024475295,0.0012470519,0.0028749628,0.0005883793,0.000029829222,0.000025605688,0.00007355259,0.00015843907],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99589306,0.00033307145,0.0017012599,0.0008525586,0.00058126845,0.00063877774],"domain_scores_gemma":[0.9972208,0.0007466199,0.00034582638,0.00055903674,0.00030467758,0.0008230089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017815558,0.00046987098,0.0013100462,0.00022274729,0.00009874389,0.000026841422,0.00021458724,0.000310104,0.00019909952],"category_scores_gemma":[0.00024694912,0.00036017658,0.00012949423,0.00039771112,0.0013831479,0.000084703664,0.0000885332,0.0021858974,0.0000020091284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015465321,0.0032409537,0.42861328,0.0017133392,0.00049379864,0.00029932358,0.002054417,0.00009833547,0.51639676,0.000062919666,0.0012234999,0.030338075],"study_design_scores_gemma":[0.1178864,0.032864716,0.7753301,0.0008799642,0.0020905084,0.00043586033,0.00044739185,0.0064472444,0.035974197,0.00035734285,0.025753846,0.0015323784],"about_ca_topic_score_codex":0.00010023306,"about_ca_topic_score_gemma":0.00017068036,"teacher_disagreement_score":0.48042253,"about_ca_system_score_codex":0.000033964516,"about_ca_system_score_gemma":0.00026419453,"threshold_uncertainty_score":0.999885},"labels":[],"label_agreement":null},{"id":"W2008616614","doi":"10.2165/00003088-200342150-00004","title":"Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stereoselectivity; Chemistry; Pharmacology; Pharmacokinetics; Enantiomer; Primaquine; Mefloquine; Plasmodium falciparum; Chloroquine; Stereochemistry; Medicine; Biochemistry; Malaria","score_opus":0.2544438096591189,"score_gpt":0.5451954329062285,"score_spread":0.2907516232471096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008616614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007128352,0.9714599,0.000025604131,0.00036379322,0.010881707,0.0039312313,0.000802272,0.00005956021,0.0053475657],"genre_scores_gemma":[0.008552659,0.9845306,0.00015062682,0.0039148866,0.0018504825,0.00020120003,0.00006184904,0.00019538288,0.0005422991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9816342,0.010628044,0.003994854,0.0014057964,0.0009256698,0.0014114629],"domain_scores_gemma":[0.99113166,0.0048386236,0.0021052342,0.0011396908,0.00025154126,0.000533253],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0076345997,0.0014977913,0.0035585747,0.00037922166,0.00041062618,0.00009626475,0.0030791005,0.00149407,0.00043723703],"category_scores_gemma":[0.0004862931,0.0009575601,0.0017177331,0.0019181181,0.002005239,0.00013164866,0.0009662195,0.008034522,0.000044121494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002194836,0.0020374632,0.00074730493,0.004466463,0.0010419434,0.000058746464,0.0004489559,0.000095392454,0.00011594409,0.00067077024,0.008023738,0.9820738],"study_design_scores_gemma":[0.0051144124,0.00012226263,0.00017622081,0.00060156424,0.007425477,0.00012262903,0.000034379173,0.0017271863,0.00018868363,0.00038704582,0.9831204,0.0009797289],"about_ca_topic_score_codex":0.000010297154,"about_ca_topic_score_gemma":0.0000045473266,"teacher_disagreement_score":0.98109406,"about_ca_system_score_codex":0.000103639715,"about_ca_system_score_gemma":0.0007451358,"threshold_uncertainty_score":0.9998022},"labels":[],"label_agreement":null},{"id":"W2009004874","doi":"10.1007/s40262-014-0178-6","title":"Population Pharmacokinetic Analysis of Abiraterone in Chemotherapy-Naïve and Docetaxel-Treated Patients with Metastatic Castration-Resistant Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Abiraterone acetate; Pharmacokinetics; Docetaxel; Medicine; Prostate cancer; Chemotherapy; Pharmacology; Abiraterone; Oncology; Population; Internal medicine; Cancer; Androgen deprivation therapy; Androgen receptor","score_opus":0.036582942117500156,"score_gpt":0.40118511546433133,"score_spread":0.3646021733468312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009004874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978052,0.00044028196,0.00002648042,0.00047360282,0.000060302704,0.0009752547,0.00009725772,0.000022273522,0.00009938651],"genre_scores_gemma":[0.9972945,0.001343201,0.00040135765,0.000268211,0.000048091384,0.00006148487,0.0003446324,0.00003123194,0.00020730867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978725,0.00018968404,0.0008216856,0.00041858334,0.00039761234,0.00029993962],"domain_scores_gemma":[0.99879867,0.00020929628,0.0002716687,0.00021274331,0.00029265988,0.0002149793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039770544,0.0002298097,0.00078484777,0.0003505441,0.00003618646,0.00001933393,0.00007197901,0.000058459937,0.00019246196],"category_scores_gemma":[0.000055064196,0.00016093804,0.00010340886,0.0010102794,0.00020837896,0.0000779675,0.000026128613,0.0002392428,0.0000017671731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038050318,0.00090363785,0.96385396,0.00018547714,0.0015363588,0.00001178379,0.00012563234,0.00071236835,0.0032972784,0.00000531092,0.00006540548,0.025497777],"study_design_scores_gemma":[0.017255764,0.00095011713,0.96423787,0.00009970482,0.0031647305,4.943319e-7,0.000012803332,0.011503987,0.0023685861,0.000020239364,0.00022293818,0.00016274108],"about_ca_topic_score_codex":0.0002715215,"about_ca_topic_score_gemma":0.00010470055,"teacher_disagreement_score":0.025335036,"about_ca_system_score_codex":0.00006960269,"about_ca_system_score_gemma":0.000055613564,"threshold_uncertainty_score":0.6562863},"labels":[],"label_agreement":null},{"id":"W2012456279","doi":"10.2165/00003088-200746060-00002","title":"A Systematic Review of Limited Sampling Strategies for Platinum Agents Used in Cancer Chemotherapy","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Carboplatin; Pharmacokinetics; Dosing; Nedaplatin; Pharmacology; Pharmacodynamics; Blood sampling; Cisplatin; Body surface area; Therapeutic drug monitoring; Drug; Oncology; Area under the curve; Intensive care medicine; Chemotherapy; Internal medicine","score_opus":0.34252929319881403,"score_gpt":0.5544087444008821,"score_spread":0.21187945120206803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012456279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003302875,0.9885267,0.00062543695,0.00018848435,0.00043092083,0.009639162,0.00012121216,0.000061507075,0.000076273434],"genre_scores_gemma":[0.00006415101,0.99389404,0.0016609988,0.0028318292,0.00059962925,0.00038737696,0.00025915593,0.00018944399,0.00011334988],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9932762,0.00030422703,0.0048562423,0.0006230396,0.0005070919,0.0004332424],"domain_scores_gemma":[0.9938148,0.0027729026,0.0022439328,0.00064695015,0.0003014467,0.00021995419],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002358206,0.0006158247,0.0060815257,0.00031356103,0.000024321063,0.000020571833,0.00036240966,0.0006604368,0.00022208015],"category_scores_gemma":[0.0013636987,0.000505336,0.0013232791,0.0008472295,0.00013940212,0.000055973607,0.000041153453,0.0009579826,0.0000100214065],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049489576,0.00038039085,0.000018051975,0.9003472,0.0006619935,0.0000063510483,0.000058628622,0.0000010479054,0.000053294552,0.0000070090646,0.0007156881,0.09770086],"study_design_scores_gemma":[0.0032469588,0.00022401426,0.000015474317,0.8923331,0.005729814,0.000013804208,0.000025113788,0.00012242742,0.00016862464,0.000031218708,0.09767753,0.00041192604],"about_ca_topic_score_codex":0.0000066436446,"about_ca_topic_score_gemma":0.0000043332943,"teacher_disagreement_score":0.09728893,"about_ca_system_score_codex":0.00028955657,"about_ca_system_score_gemma":0.00075093814,"threshold_uncertainty_score":0.9997398},"labels":[],"label_agreement":null},{"id":"W2013067955","doi":"10.2165/00003088-200645090-00004","title":"Lack of Effect of Sex and Disease State on the Pharmacokinetics of Porfimer Sodium","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QLT (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Urology; Confidence interval; Surgery; Gastroenterology; Pharmacology; Anesthesia; Internal medicine","score_opus":0.059697676918916,"score_gpt":0.4408096437659001,"score_spread":0.3811119668469841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013067955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482346,0.0012023315,0.000020007026,0.0016533048,0.00015410701,0.0008929709,0.00017791222,0.00001873699,0.0010571557],"genre_scores_gemma":[0.9957549,0.0028040516,0.000049848397,0.0005035612,0.00017036182,0.0000152413195,0.000013185681,0.00003258628,0.0006562739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744725,0.0004148252,0.0010121514,0.00028172878,0.0005595244,0.00028449754],"domain_scores_gemma":[0.99573505,0.0030178614,0.0003631428,0.00040916237,0.0002262574,0.00024855175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012978452,0.00023105141,0.0007899344,0.00008685282,0.000031642514,0.000003974126,0.00020658017,0.000054741336,0.00012503253],"category_scores_gemma":[0.00080843945,0.00014177008,0.00024240706,0.00022273377,0.0012769875,0.000018589673,0.00015692352,0.00042334068,0.0000037653688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023709433,0.004114505,0.27125737,0.0035401806,0.0020171811,0.00012887086,0.00027067988,0.00041520174,0.6147608,0.00027917366,0.045188397,0.034318175],"study_design_scores_gemma":[0.016891764,0.0056170323,0.21502662,0.0004153627,0.0015109918,0.0000052098712,0.000032951502,0.006403602,0.74358153,0.0012856028,0.00888549,0.00034384397],"about_ca_topic_score_codex":0.000019309242,"about_ca_topic_score_gemma":6.2361846e-7,"teacher_disagreement_score":0.12882072,"about_ca_system_score_codex":0.000014190037,"about_ca_system_score_gemma":0.00008347146,"threshold_uncertainty_score":0.57812166},"labels":[],"label_agreement":null},{"id":"W2013783025","doi":"10.2165/00003088-200038050-00004","title":"Methods for Clinical Monitoring of Cyclosporin in Transplant Patients","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Therapeutic drug monitoring; Medicine; Therapeutic index; Intensive care medicine; Clinical Practice; Pharmacotherapy; Pharmacodynamics; Pharmacology; Drug; Pharmacokinetics; Internal medicine","score_opus":0.30568029841200633,"score_gpt":0.6088180192785816,"score_spread":0.30313772086657526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013783025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014577442,0.99021035,0.0005928865,0.00003485,0.003575735,0.0032774578,0.00025218667,0.00005161241,0.00054719124],"genre_scores_gemma":[0.00031757966,0.9661125,0.030656725,0.00010711058,0.0020242238,0.000042050793,0.00032748983,0.00018856385,0.00022376557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99108374,0.0008521682,0.006012753,0.001025558,0.00035634072,0.0006694612],"domain_scores_gemma":[0.9930022,0.004378506,0.0010916325,0.0006883244,0.00025382006,0.00058555236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031740838,0.00073678425,0.0053456556,0.00033239875,0.000035507157,0.000014239898,0.0005623408,0.0010192438,0.00013894311],"category_scores_gemma":[0.0007066522,0.0006161954,0.0026491375,0.00051637145,0.00035195213,0.00003219862,0.00010184829,0.0019966555,0.000031335316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046288635,0.0028641322,0.015789172,0.01245559,0.00051032635,0.000026662456,0.000014080476,0.000002838976,8.461092e-7,0.000007751524,0.0010011521,0.9668646],"study_design_scores_gemma":[0.0069921017,0.000964712,0.0045818286,0.011341257,0.0063905967,0.000008070897,0.0000021207131,0.00021559827,0.00002274911,0.00002430259,0.96892715,0.0005295106],"about_ca_topic_score_codex":0.0000022515867,"about_ca_topic_score_gemma":9.3341235e-8,"teacher_disagreement_score":0.967926,"about_ca_system_score_codex":0.00006471489,"about_ca_system_score_gemma":0.00037807843,"threshold_uncertainty_score":0.99962896},"labels":[],"label_agreement":null},{"id":"W2021943338","doi":"10.2165/00003088-200342060-00004","title":"Pharmacokinetics of Rofecoxib","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Rofecoxib; Pharmacology; Pharmacokinetics; Medicine; Volume of distribution; Drug interaction; Enterohepatic circulation; Bioavailability; Internal medicine; Chemistry; Cyclooxygenase; Metabolism; Enzyme; Biochemistry","score_opus":0.16322765445455747,"score_gpt":0.5030552790391593,"score_spread":0.3398276245846018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021943338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015922496,0.98681384,0.000049853956,0.000023903653,0.005209023,0.0020503572,0.00009528121,0.00009846009,0.00550003],"genre_scores_gemma":[0.00004391989,0.9939519,0.00072168047,0.00063378655,0.0023332234,0.00007297906,0.00015194462,0.00023019584,0.0018603667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99351096,0.0008272558,0.0035152608,0.00081075565,0.00066507875,0.0006707166],"domain_scores_gemma":[0.99495816,0.0015281034,0.0014032779,0.00096563576,0.00032474243,0.0008200503],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016802391,0.00088715967,0.0052214344,0.00032627766,0.00004837294,0.000014133628,0.0004450203,0.0010058164,0.0013418741],"category_scores_gemma":[0.00070071017,0.0007043853,0.0023829744,0.0006456942,0.00047353827,0.000036736157,0.0001646928,0.0021258628,0.0005023099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007067073,0.0007182673,0.00012348007,0.046910774,0.0008834498,0.0002703975,0.000008928953,8.993971e-7,0.000009226068,0.000044193133,0.04371321,0.90724653],"study_design_scores_gemma":[0.0026924782,0.0005333675,0.000016536638,0.007906242,0.010569649,0.00014796169,0.00000182833,0.000050485363,0.00010374081,0.0000145815075,0.9773959,0.00056721346],"about_ca_topic_score_codex":9.341952e-7,"about_ca_topic_score_gemma":1.2423344e-7,"teacher_disagreement_score":0.9336827,"about_ca_system_score_codex":0.0000877505,"about_ca_system_score_gemma":0.00088042323,"threshold_uncertainty_score":0.999571},"labels":[],"label_agreement":null},{"id":"W2025835403","doi":"10.2165/00003088-200443010-00001","title":"Treatment of the Metabolic Disturbances Caused by Antipsychotic Drugs","year":2004,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"Medicine; Antipsychotic; Drug; Pharmacodynamics; Pharmacotherapy; Pharmacology; Olanzapine; Population; Intensive care medicine; Schizophrenia (object-oriented programming); Pharmacokinetics; Psychiatry","score_opus":0.12697458387138072,"score_gpt":0.48007362954940447,"score_spread":0.35309904567802375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025835403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004721537,0.99394166,0.0000037305188,0.0005051518,0.001894914,0.002327715,0.00025027955,0.000052436706,0.0005519588],"genre_scores_gemma":[0.002531008,0.9947548,0.0000324448,0.0004770363,0.00074671005,0.00011295243,0.000046955727,0.000057996345,0.0012401113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646133,0.00046505127,0.001629213,0.00061756885,0.00041502496,0.00041182383],"domain_scores_gemma":[0.9969631,0.0013075947,0.00080172735,0.00055218075,0.000090834284,0.00028456628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026076013,0.0006505277,0.004026469,0.00005506591,0.00009944409,0.000013233757,0.0003886901,0.00034474552,0.00010759636],"category_scores_gemma":[0.0002321912,0.00030329247,0.0021729919,0.00048106245,0.00080458284,0.00001944376,0.00012396759,0.0006594839,0.000037480797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000788871,0.0034833907,0.00014617061,0.008157739,0.0027238897,0.00003452375,0.000039667608,0.0000010359952,0.000015692922,0.00004260558,0.011865104,0.9734113],"study_design_scores_gemma":[0.0038885581,0.00086699345,0.00029504378,0.0031199849,0.014104992,0.000011279699,0.0000030867789,0.000006477443,0.00010719354,0.000036353053,0.9772837,0.00027633677],"about_ca_topic_score_codex":0.0000069136045,"about_ca_topic_score_gemma":3.1180548e-7,"teacher_disagreement_score":0.97313493,"about_ca_system_score_codex":0.00010959547,"about_ca_system_score_gemma":0.0002718026,"threshold_uncertainty_score":0.99994195},"labels":[],"label_agreement":null},{"id":"W2038460944","doi":"10.2165/00003088-200544080-00001","title":"Sirolimus","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sirolimus; Therapeutic drug monitoring; Ciclosporin; Pharmacokinetics; Medicine; Pharmacology; Trough level; Transplantation; Immunosuppressive drug; Therapeutic index; Adverse effect; Trough Concentration; Drug; Internal medicine; Urology; Tacrolimus","score_opus":0.2698213307202227,"score_gpt":0.5539225902184918,"score_spread":0.2841012594982691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038460944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000024315518,0.990297,0.000028272429,0.000090851245,0.00082731165,0.0007987456,0.00008613889,0.00008796938,0.0077812704],"genre_scores_gemma":[0.000009090671,0.98989475,0.001105423,0.0009802746,0.0019057143,0.000033904736,0.0004058231,0.00008398986,0.005581009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974514,0.000133205,0.0014217743,0.0004444691,0.00026893895,0.00028018322],"domain_scores_gemma":[0.99824506,0.000591989,0.0003139862,0.00037825646,0.000058104695,0.00041259156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019869112,0.0004163187,0.0022087246,0.00010676274,0.000031753752,0.000016600967,0.00016271035,0.00038220925,0.0008533466],"category_scores_gemma":[0.000058155154,0.00028192205,0.0014967949,0.00019108827,0.00009546207,0.000022110606,0.00003501776,0.00079564005,0.0016830408],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026980677,0.00041250477,0.00007573167,0.010449176,0.00073544506,0.0002857993,0.0000023403413,3.4031714e-7,2.5807097e-8,0.000012741618,0.0015066733,0.9864922],"study_design_scores_gemma":[0.0021425614,0.00018963392,0.000079096324,0.0077385823,0.009767911,0.00021676435,3.4759552e-7,0.000009774901,3.0778023e-7,0.000005232497,0.97962517,0.00022463979],"about_ca_topic_score_codex":5.8729654e-7,"about_ca_topic_score_gemma":1.11259425e-7,"teacher_disagreement_score":0.9862676,"about_ca_system_score_codex":0.00005398745,"about_ca_system_score_gemma":0.00019338263,"threshold_uncertainty_score":0.9999633},"labels":[],"label_agreement":null},{"id":"W2045786281","doi":"10.1007/s40262-013-0055-8","title":"A Review of the Pharmacokinetic Implications of Schistosomiasis","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Oxamniquine; Schistosomiasis; Pharmacokinetics; Praziquantel; Adverse effect; Internal medicine; Pharmacology; Intensive care medicine; Immunology","score_opus":0.1561153974858897,"score_gpt":0.4961730662207778,"score_spread":0.3400576687348881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045786281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012975011,0.99219555,0.000013109311,0.00031567825,0.0023242312,0.0015499479,0.00054982683,0.00002361126,0.003015049],"genre_scores_gemma":[0.000032681328,0.99638385,0.00006918547,0.0009034862,0.000119727985,0.00018161979,0.00015154901,0.000044162403,0.002113755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562454,0.000885873,0.0027595041,0.00039724717,0.000055812205,0.00027699504],"domain_scores_gemma":[0.99495184,0.0014647308,0.002193615,0.0010009927,0.00033739986,0.000051435483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042629833,0.0003849381,0.0023245143,0.000103928935,0.00008228564,0.0000042924853,0.00121569,0.0004018906,0.0040810457],"category_scores_gemma":[0.000564015,0.00024232057,0.001994245,0.0005046873,0.00071145094,0.00003383199,0.00034035573,0.0012479693,0.0007072592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004207445,0.0003564754,0.000030006653,0.037333626,0.0007642295,1.489466e-7,0.0000040233876,1.927988e-7,0.00026928075,0.0000988874,0.19253714,0.7686018],"study_design_scores_gemma":[0.000348828,0.000053378608,0.000069516944,0.04338425,0.0051339143,0.000043603137,0.0000010514041,3.7842912e-7,0.00014941636,0.000021405976,0.95059514,0.00019912845],"about_ca_topic_score_codex":0.0000120673485,"about_ca_topic_score_gemma":5.434494e-7,"teacher_disagreement_score":0.76840264,"about_ca_system_score_codex":0.00003498517,"about_ca_system_score_gemma":0.00028157598,"threshold_uncertainty_score":0.99682933},"labels":[],"label_agreement":null},{"id":"W2050422640","doi":"10.1007/s40262-015-0243-9","title":"A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Helminth infection and control","field":"Veterinary","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"World Health Organization","keywords":"Albendazole; Mebendazole; Pharmacology; Medicine; Pharmacokinetics; Anthelmintic; Carbamazepine; Surgery; Epilepsy; Biology","score_opus":0.1736120260924888,"score_gpt":0.5138472965560672,"score_spread":0.3402352704635784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050422640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003455109,0.98786914,0.00007041633,0.0025159905,0.0011877876,0.002911643,0.00020626072,0.000101897494,0.005102311],"genre_scores_gemma":[0.000405698,0.99336046,0.0000936086,0.0030255439,0.0008587424,0.0006385562,0.00010482992,0.00011763523,0.0013949388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943045,0.0014981477,0.002471145,0.00073597097,0.00055404514,0.0004362199],"domain_scores_gemma":[0.9941022,0.0022216693,0.0016063781,0.0009920639,0.0005502014,0.00052749296],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023771366,0.0006909038,0.0025171677,0.00019232409,0.00016332367,0.0000433543,0.00082058733,0.0001235726,0.002008679],"category_scores_gemma":[0.00038407807,0.00041707986,0.0007300465,0.00069327897,0.00083523104,0.0001146175,0.00034007552,0.0018065291,0.00033621804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037404697,0.0005132028,0.0000023545476,0.030811807,0.0008813788,0.000025787733,0.00006484057,4.536411e-7,8.9488873e-7,0.000037875194,0.21857107,0.7487163],"study_design_scores_gemma":[0.004674286,0.00026566256,0.000002701466,0.032867014,0.0067691025,0.00033455374,0.00003296874,0.00013486906,0.0000010117859,0.000012098472,0.95447516,0.00043055668],"about_ca_topic_score_codex":0.000020216217,"about_ca_topic_score_gemma":0.000010258931,"teacher_disagreement_score":0.7482857,"about_ca_system_score_codex":0.00006837683,"about_ca_system_score_gemma":0.0005877285,"threshold_uncertainty_score":0.9998281},"labels":[],"label_agreement":null},{"id":"W2052170838","doi":"10.1007/s40262-014-0202-x","title":"Population Pharmacokinetic Analysis of Tesamorelin in HIV-Infected Patients and Healthy Subjects","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical; Theratechnologies (Canada); Université de Montréal","funders":"Fonds de recherche du Québec – Nature et technologies; Health Canada; Mitacs","keywords":"Pharmacokinetics; NONMEM; Volume of distribution; Population; Medicine; Pulsatile flow; Population pharmacokinetics; Covariate; Internal medicine; Pharmacology; Endocrinology; Mathematics; Statistics","score_opus":0.026222276686788455,"score_gpt":0.38063108022323616,"score_spread":0.3544088035364477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052170838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979154,0.0002556969,0.0003657174,0.0004450457,0.00015811498,0.00037654385,0.000017867278,0.000032094893,0.00043353133],"genre_scores_gemma":[0.9967555,0.00067566306,0.00045976005,0.0016814809,0.00010003321,0.0000059739295,0.00027343593,0.000021755892,0.00002641146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997856,0.0001890324,0.0010771302,0.0003518558,0.00027011367,0.00025582506],"domain_scores_gemma":[0.9985743,0.0005277489,0.00027123344,0.00019375466,0.00015757578,0.00027535675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049426494,0.00017681227,0.00076017954,0.00040802977,0.000025157795,0.00000584424,0.000073208284,0.000121900805,0.000105742336],"category_scores_gemma":[0.00063932646,0.0001575815,0.00018891178,0.0010292407,0.0001184843,0.000039646777,0.000056884903,0.00029746426,0.000005475074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080778974,0.0008646975,0.9708718,0.00008411286,0.00019396943,0.0000024981907,0.00003378897,0.0004801738,0.00019342452,0.00003133681,0.0005081496,0.025928274],"study_design_scores_gemma":[0.0073327357,0.0006661622,0.9099775,0.000025456313,0.0015230417,6.3463466e-7,0.000006949792,0.07948607,0.000055520595,0.00006579102,0.0007261157,0.00013403717],"about_ca_topic_score_codex":0.00007362435,"about_ca_topic_score_gemma":0.000020559932,"teacher_disagreement_score":0.0790059,"about_ca_system_score_codex":0.000022808503,"about_ca_system_score_gemma":0.000022844892,"threshold_uncertainty_score":0.6425987},"labels":[],"label_agreement":null},{"id":"W2055116166","doi":"10.1007/s40262-013-0053-x","title":"Telaprevir: Clinical Pharmacokinetics, Pharmacodynamics, and Drug–Drug Interactions","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Drug; Medicine; Telaprevir; Pharmacology; Pharmacotherapy; Internal medicine","score_opus":0.24765078272731922,"score_gpt":0.5643196578562294,"score_spread":0.3166688751289102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055116166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046791113,0.97674316,0.00008343647,0.0013144423,0.007032176,0.0057244636,0.0005395288,0.00040698124,0.007687912],"genre_scores_gemma":[0.00023357154,0.96810395,0.0022207343,0.002343442,0.0077471887,0.00045957472,0.00063360325,0.0005239239,0.017734043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98376197,0.003484142,0.007348761,0.0025084794,0.0013222999,0.0015743326],"domain_scores_gemma":[0.9851689,0.007386037,0.0016881959,0.0016941162,0.00091926515,0.0031434987],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.004433849,0.0017044286,0.006821992,0.00076630444,0.0002589463,0.00025183614,0.0012840112,0.0007114925,0.005984701],"category_scores_gemma":[0.0027978963,0.0014469976,0.002996092,0.0009624436,0.0019402569,0.00030226645,0.0015414816,0.009797786,0.004755992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007861991,0.0011528188,0.0010640207,0.008947868,0.001665665,0.00027901068,0.000018099076,6.054248e-7,0.0000038444036,0.000013574008,0.2559035,0.7308724],"study_design_scores_gemma":[0.004243509,0.00022655434,0.00009050051,0.0067055053,0.010137656,0.00020150047,0.000011497401,0.0024734125,0.0000073586207,0.000028960145,0.9746614,0.0012121496],"about_ca_topic_score_codex":0.00006067716,"about_ca_topic_score_gemma":0.000013575991,"teacher_disagreement_score":0.7296602,"about_ca_system_score_codex":0.0003163554,"about_ca_system_score_gemma":0.0012221466,"threshold_uncertainty_score":0.9995702},"labels":[],"label_agreement":null},{"id":"W2056835200","doi":"10.2165/00003088-200443080-00003","title":"Pharmacokinetic Profile of Intramuscular Fulvestrant in Advanced Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Fulvestrant; Medicine; Pharmacokinetics; Breast cancer; Cancer; Oncology; Pharmacotherapy; Pharmacology; Internal medicine; Tamoxifen","score_opus":0.013715583939819137,"score_gpt":0.3546423921816309,"score_spread":0.34092680824181176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056835200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389327,0.0038943393,0.00018695607,0.00041620238,0.000596748,0.00047955103,0.00006870112,0.000019621335,0.0004446097],"genre_scores_gemma":[0.9917972,0.006393491,0.00087384786,0.00036298973,0.0003641627,0.000045710327,0.000050436392,0.0000419897,0.00007013457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980916,0.00012104662,0.00075421087,0.00046604648,0.00018897437,0.0003781486],"domain_scores_gemma":[0.99917597,0.000032454842,0.00018300413,0.000298224,0.00010917718,0.00020118512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032527867,0.00024149212,0.0003541584,0.000065916356,0.000026533318,0.000007264589,0.00029814005,0.000260382,0.000096053955],"category_scores_gemma":[0.000056426412,0.0002187302,0.00022524448,0.0002503593,0.00025850392,0.0000060922084,0.00010451479,0.00042939238,0.000015948266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008271089,0.0009966287,0.0108458605,0.00011421421,0.00019635363,0.000050237395,0.000031534815,0.012203732,0.93002135,0.0000665107,0.0005055079,0.04414098],"study_design_scores_gemma":[0.0139722405,0.0009569296,0.055823106,0.00020982319,0.00022073383,0.000064186475,0.000027815135,0.0005932811,0.9218423,0.00017039648,0.0055134324,0.00060575904],"about_ca_topic_score_codex":0.000018919793,"about_ca_topic_score_gemma":0.0000038197136,"teacher_disagreement_score":0.044977244,"about_ca_system_score_codex":0.000022724233,"about_ca_system_score_gemma":0.00016861514,"threshold_uncertainty_score":0.8919559},"labels":[],"label_agreement":null},{"id":"W2056954418","doi":"10.1007/s40262-014-0152-3","title":"A Comprehensive Review on the Pharmacokinetics of Antibiotics in Interstitial Fluid Spaces in Humans: Implications on Dosing and Clinical Pharmacokinetic Monitoring","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacokinetics; Piperacillin; Dosing; Pharmacology; Medicine; Antibiotics; Volume of distribution; Distribution (mathematics); Intensive care medicine; Internal medicine; Biology; Microbiology","score_opus":0.2205027227140201,"score_gpt":0.5156797864411059,"score_spread":0.2951770637270858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056954418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01237863,0.9767981,0.000038120546,0.002155301,0.0023753254,0.004953342,0.00012967212,0.0000759428,0.0010955296],"genre_scores_gemma":[0.038229514,0.95570725,0.0002854469,0.0034281216,0.0019343001,0.00001715627,0.000094987954,0.00023487398,0.00006834161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9883443,0.0019594599,0.0062277634,0.0016831226,0.00080058194,0.0009847648],"domain_scores_gemma":[0.987597,0.008130853,0.0018652768,0.0013932807,0.00039136218,0.0006222586],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030414737,0.0013659166,0.0057188133,0.0007702599,0.000119585806,0.00007188445,0.0010548932,0.0007317644,0.00012817878],"category_scores_gemma":[0.0014729336,0.0010088129,0.0014617367,0.0013670435,0.0013355651,0.000054418837,0.00056314236,0.0046895696,0.00008156052],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060757215,0.00453642,0.005884222,0.07221243,0.001127517,0.00022741368,0.000060907547,0.000106795815,0.0001438188,0.0003886191,0.007823022,0.9068813],"study_design_scores_gemma":[0.0057079727,0.0016893035,0.0045173876,0.12770538,0.005858934,0.000050606566,0.000021488131,0.00093473884,0.000128822,0.00002801773,0.8523492,0.0010081407],"about_ca_topic_score_codex":0.000010014399,"about_ca_topic_score_gemma":0.0000011862708,"teacher_disagreement_score":0.9058731,"about_ca_system_score_codex":0.00017449644,"about_ca_system_score_gemma":0.00032475562,"threshold_uncertainty_score":0.99990916},"labels":[],"label_agreement":null},{"id":"W2057321814","doi":"10.1007/s40262-014-0160-3","title":"Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of General Medical Sciences","keywords":"Physiologically based pharmacokinetic modelling; Pharmacology; Oseltamivir; Active metabolite; Pharmacokinetics; Prodrug; Carboxylesterase; In vivo; Chemistry; Metabolite; Drug metabolism; Drug; Medicine; Enzyme; Biology; Biochemistry; Internal medicine; Genetics","score_opus":0.05865650321010264,"score_gpt":0.38554346208410956,"score_spread":0.3268869588740069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057321814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935149,0.00007790631,0.0040486045,0.0005959948,0.0004970345,0.00070719584,0.00003393678,0.00012565499,0.0003987741],"genre_scores_gemma":[0.99006873,0.00014343088,0.00033107202,0.008008256,0.0012274369,0.000043939737,0.00008473702,0.00005630495,0.000036113175],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971967,0.0006351665,0.0007543502,0.00063861307,0.00042287202,0.00035233557],"domain_scores_gemma":[0.9971741,0.0014408013,0.00023873443,0.00047579285,0.00023980474,0.0004307819],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036932476,0.00037619457,0.0008201633,0.00012922304,0.00006633893,0.000016932268,0.00016919502,0.00014571188,0.000062088126],"category_scores_gemma":[0.00061582087,0.0003022925,0.00049585366,0.0002474349,0.00014371675,0.000063367435,0.000061024984,0.00049059425,0.000026890297],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005248699,0.0040219408,0.0068629556,0.00071547664,0.00017347312,0.000077183686,0.000022644843,0.017861601,0.9076073,0.000024617597,0.0007871341,0.056596957],"study_design_scores_gemma":[0.008573142,0.0029644857,0.043543316,0.00035548452,0.0007512686,0.000004197674,0.0000016917799,0.6692144,0.2738847,0.0000514645,0.00033308033,0.00032274405],"about_ca_topic_score_codex":0.0000030931212,"about_ca_topic_score_gemma":3.0208133e-7,"teacher_disagreement_score":0.6513528,"about_ca_system_score_codex":0.000028742155,"about_ca_system_score_gemma":0.000073224895,"threshold_uncertainty_score":0.9999429},"labels":[],"label_agreement":null},{"id":"W2057831073","doi":"10.1007/s40262-012-0026-5","title":"Pharmacokinetic Profile of Artemisinin Derivatives and Companion Drugs Used in Artemisinin-Based Combination Therapies for the Treatment of Plasmodium falciparum Malaria in Children","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Malaria Research and Control","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Artemisinin; Medicine; Malaria; Amodiaquine; Mefloquine; Piperaquine; Lumefantrine; Plasmodium falciparum; Pharmacokinetics; Artesunate; Population; Pharmacology; Sulfadoxine; Intensive care medicine; Pyrimethamine; Environmental health; Immunology","score_opus":0.10039458079513733,"score_gpt":0.4317332631590931,"score_spread":0.3313386823639558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057831073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046915002,0.9377417,0.0001648445,0.0013771143,0.00021823098,0.013188391,0.00030614767,0.000022843013,0.000065748645],"genre_scores_gemma":[0.19350906,0.80445826,0.00030643676,0.000058924867,0.00015209582,0.0010826252,0.00027856044,0.000057971585,0.00009609878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957488,0.0007512212,0.0021203137,0.00053313095,0.0004134954,0.00043303127],"domain_scores_gemma":[0.9936514,0.004678102,0.00086202275,0.0004211685,0.00020390321,0.00018338651],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010655051,0.00050006126,0.0026579837,0.00033428724,0.000036694248,0.000022550768,0.0002968091,0.000322983,0.00015689974],"category_scores_gemma":[0.00026589306,0.00031841025,0.00051579665,0.0003960401,0.0004965751,0.000042006017,0.00004516048,0.0005409248,0.000004115328],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011450852,0.0053041354,0.013548888,0.006844053,0.0013354426,0.000004857246,0.00031017172,0.000028647839,0.0002372046,0.00016129138,0.00049838057,0.9705818],"study_design_scores_gemma":[0.2011973,0.019355286,0.24394357,0.023592923,0.013424015,0.00003682349,0.00045740133,0.094683744,0.0038667398,0.0004464252,0.39668503,0.00231074],"about_ca_topic_score_codex":0.000032726985,"about_ca_topic_score_gemma":0.000002384117,"teacher_disagreement_score":0.9682711,"about_ca_system_score_codex":0.000094229435,"about_ca_system_score_gemma":0.00039845746,"threshold_uncertainty_score":0.9999268},"labels":[],"label_agreement":null},{"id":"W2060839842","doi":"10.1007/s40262-014-0170-1","title":"Review of Evidence for Measuring Drug Concentrations of First-Line Antitubercular Agents in Adults","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Drug; Observational study; Tuberculosis; Dosing; Therapeutic drug monitoring; Intensive care medicine; Clinical trial; Pharmacotherapy; Pharmacology; First line; MEDLINE; Internal medicine; Pathology","score_opus":0.466190475329744,"score_gpt":0.544976112923545,"score_spread":0.07878563759380097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060839842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001325596,0.993969,0.00044152018,0.0003640266,0.00078085513,0.004029318,0.00013448512,0.000021257283,0.00012693032],"genre_scores_gemma":[0.002585271,0.99478257,0.0009075395,0.00066992454,0.00062528276,0.000041838146,0.00021558598,0.0000930052,0.000079002515],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99358004,0.00034975892,0.0044826474,0.0006816702,0.00048952055,0.00041637628],"domain_scores_gemma":[0.99372447,0.0027326054,0.0017156951,0.0007491748,0.00076052174,0.00031755847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025977702,0.0005175225,0.0043289834,0.00019939346,0.00003390787,0.0000069133366,0.00052589056,0.00029742025,0.00013229695],"category_scores_gemma":[0.0046719187,0.00039609623,0.0016226099,0.0005799391,0.00032417127,0.000043355558,0.00016782721,0.00078115537,0.000014694573],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012742744,0.000911283,0.0007277404,0.673956,0.000333387,0.000013344744,0.000013374725,0.000026603278,0.0000026695147,0.000037115096,0.008640997,0.31521007],"study_design_scores_gemma":[0.0020904508,0.00021908054,0.00006672459,0.398466,0.0043624677,0.0000074053696,8.406172e-7,0.001455923,0.000048269656,0.00000582622,0.5930379,0.00023913223],"about_ca_topic_score_codex":0.000008021548,"about_ca_topic_score_gemma":0.0000027522744,"teacher_disagreement_score":0.5843969,"about_ca_system_score_codex":0.000062984924,"about_ca_system_score_gemma":0.00036677477,"threshold_uncertainty_score":0.9998491},"labels":[],"label_agreement":null},{"id":"W2061459550","doi":"10.1007/s40262-013-0065-6","title":"The Integration of Allometry and Virtual Populations to Predict Clearance and Clearance Variability in Pediatric Populations over the Age of 6 Years","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Blackberry (Canada); University of Waterloo","funders":"","keywords":"Allometry; Biology; Pharmacotherapy; Medicine; Demography; Ecology; Internal medicine","score_opus":0.16065767397032374,"score_gpt":0.47878067063202867,"score_spread":0.31812299666170496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061459550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515676,0.0011261299,0.00048875797,0.0008377645,0.001261474,0.00083370006,0.00006365577,0.000014985645,0.00021679155],"genre_scores_gemma":[0.9936342,0.0042766696,0.0006523813,0.0009944952,0.00030049495,0.00004638841,0.000008508269,0.000017831988,0.00006903569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997098,0.0010506761,0.0010634735,0.0003060926,0.00020695683,0.00027475145],"domain_scores_gemma":[0.9972446,0.0018848355,0.00026874634,0.00027142998,0.0001462802,0.00018411159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025453495,0.00016971982,0.0003295951,0.000105212115,0.00014264378,0.000025033012,0.0003170482,0.00018445453,0.00010403634],"category_scores_gemma":[0.0010799186,0.00012265347,0.000086862834,0.00052605575,0.00055133057,0.00008835603,0.00019937544,0.00075930037,0.000007931733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004583059,0.0006169865,0.78639346,0.000055167286,0.000078582234,0.000002832283,0.0008835482,0.0029617923,0.01691192,0.0046654926,0.0032714547,0.18370047],"study_design_scores_gemma":[0.0012176632,0.00009863665,0.9740002,0.000008542171,0.0001723332,0.0000012064189,0.000041164407,0.014686953,0.00043669075,0.0024369974,0.0067766835,0.00012290194],"about_ca_topic_score_codex":0.00005178148,"about_ca_topic_score_gemma":0.00003922757,"teacher_disagreement_score":0.18760678,"about_ca_system_score_codex":0.000012600948,"about_ca_system_score_gemma":0.000037748086,"threshold_uncertainty_score":0.50016636},"labels":[],"label_agreement":null},{"id":"W2062889937","doi":"10.2165/00003088-200544020-00001","title":"Interactions Between Antiretrovirals and Antineoplastic Drug Therapy","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; St. Michael's Hospital","funders":"","keywords":"Pharmacology; Drug interaction; Medicine; CYP2B6; Taxane; Docetaxel; Efavirenz; Drug; Ifosfamide; Pharmacokinetics; Reverse-transcriptase inhibitor; Abacavir; CYP3A4; Oncology; Cancer; Chemotherapy; Internal medicine; Cytochrome P450; Antiretroviral therapy; Immunology; Human immunodeficiency virus (HIV); Viral load; Breast cancer","score_opus":0.19453442601007181,"score_gpt":0.5078662005472501,"score_spread":0.31333177453717825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062889937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008366479,0.99461496,0.000016742595,0.000872164,0.00074125105,0.0011849711,0.00008281133,0.00012210819,0.0015283258],"genre_scores_gemma":[0.00048447176,0.9745906,0.00096979184,0.00027553434,0.0027124423,0.000047089896,0.00039662348,0.00010408958,0.020419382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967001,0.00025140654,0.0016974421,0.0006777577,0.00028488092,0.0003883945],"domain_scores_gemma":[0.99675167,0.0018643343,0.00047021284,0.00037101534,0.00008736177,0.00045542122],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043829085,0.0006200488,0.0027166642,0.00025167808,0.00009058394,0.000046271947,0.00017621205,0.00025258012,0.0005141514],"category_scores_gemma":[0.00018604886,0.00044201312,0.0007085437,0.00030819597,0.00021173616,0.00006107961,0.00013268844,0.001149409,0.00053338526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022428325,0.00035740001,0.0036433432,0.0013714731,0.0010644279,0.00006561529,0.000024080164,2.9384848e-8,2.2627378e-7,0.000003851531,0.026936349,0.9665108],"study_design_scores_gemma":[0.0021544367,0.00011444957,0.00071023713,0.003845155,0.004371929,0.00006246118,0.0000034391244,0.000009315803,0.0000028253173,0.000004886502,0.9883417,0.00037919835],"about_ca_topic_score_codex":9.762679e-7,"about_ca_topic_score_gemma":5.632354e-7,"teacher_disagreement_score":0.96613157,"about_ca_system_score_codex":0.00006646384,"about_ca_system_score_gemma":0.00028158783,"threshold_uncertainty_score":0.9998032},"labels":[],"label_agreement":null},{"id":"W2063035659","doi":"10.2165/00003088-200140110-00001","title":"Pharmacogenetics","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Therapeutic drug monitoring; Drug; Pharmacology; CYP2D6; CYP2C19; Pharmacogenomics; Intensive care medicine; Bioinformatics; Internal medicine; Biology; Cytochrome P450; Genotype; Genetics","score_opus":0.5455348796245921,"score_gpt":0.6286190238947967,"score_spread":0.08308414427020461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063035659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004168735,0.94766384,0.00013868259,0.00011859276,0.020741249,0.0025151195,0.00089176703,0.00056152185,0.027327543],"genre_scores_gemma":[0.000019006413,0.9747266,0.00054638047,0.003991864,0.011360194,0.0003792041,0.00052712613,0.0005759499,0.007873671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98484665,0.004403388,0.005364603,0.0022663448,0.00084539416,0.0022736078],"domain_scores_gemma":[0.99011075,0.0034568787,0.0020200512,0.0014072389,0.0004194782,0.0025856085],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.003870181,0.002298019,0.0058225202,0.0006897087,0.00047975924,0.00013756921,0.0031027785,0.0032515214,0.0122276],"category_scores_gemma":[0.0005274066,0.002084641,0.0036439528,0.001908106,0.0011611908,0.00013319528,0.0011636526,0.008218967,0.0073414524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007554422,0.0011784079,0.000061657156,0.0037011025,0.0018515626,0.00050485577,0.00002551484,0.000039546438,0.000009368084,0.00011448428,0.08346148,0.9089765],"study_design_scores_gemma":[0.0030811916,0.000150437,0.0000049606865,0.0009763546,0.015333974,0.00028648574,0.0000065751233,0.0005085869,0.000043488475,0.00019370347,0.9772929,0.0021213316],"about_ca_topic_score_codex":0.0000040152613,"about_ca_topic_score_gemma":0.00000111185,"teacher_disagreement_score":0.90685517,"about_ca_system_score_codex":0.00018952876,"about_ca_system_score_gemma":0.0009514117,"threshold_uncertainty_score":0.9989759},"labels":[],"label_agreement":null},{"id":"W2071991687","doi":"10.2165/00003088-200544050-00003","title":"Pharmacokinetic Profile of Ganciclovir After its Oral Administration and From its Prodrug, Valganciclovir, in Solid Organ Transplant Recipients","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Valganciclovir; Ganciclovir; Pharmacokinetics; Medicine; Prodrug; NONMEM; Population; Dosing; Pharmacology; Internal medicine; Human cytomegalovirus; Immunology; Virus","score_opus":0.06633831168241856,"score_gpt":0.42403871865701737,"score_spread":0.3577004069745988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071991687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933806,0.0022122092,0.000030493571,0.0016175292,0.00030450863,0.001334908,0.00031669045,0.000050720904,0.000752344],"genre_scores_gemma":[0.99215144,0.0038800226,0.0008798476,0.0010900112,0.00079242326,0.00008152183,0.00009574788,0.00006673338,0.00096223276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99624544,0.00023888018,0.0015474318,0.0007203277,0.0006648708,0.0005830396],"domain_scores_gemma":[0.9982725,0.00031582135,0.0002228101,0.0003281527,0.00030057458,0.0005601533],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008454137,0.00034825737,0.0008257627,0.0002174684,0.000043306878,0.000031709413,0.00022095793,0.000259892,0.0024801125],"category_scores_gemma":[0.00025913323,0.00031551276,0.00016891498,0.00045770674,0.00022905944,0.0001869406,0.000103073995,0.00093761977,0.00023626101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018790865,0.0063595967,0.3684236,0.00077779335,0.0004333751,0.00056240504,0.0012159409,0.000045811044,0.3418815,0.000026059866,0.0037580095,0.25772503],"study_design_scores_gemma":[0.015863258,0.0013888993,0.49315307,0.0005401728,0.000532978,0.000043257867,0.000025783136,0.014885256,0.43567377,0.000024639963,0.037293162,0.0005757486],"about_ca_topic_score_codex":0.000019042507,"about_ca_topic_score_gemma":0.00006138909,"teacher_disagreement_score":0.25714928,"about_ca_system_score_codex":0.00008536134,"about_ca_system_score_gemma":0.0002892206,"threshold_uncertainty_score":0.99992967},"labels":[],"label_agreement":null},{"id":"W2076217357","doi":"10.1007/bf03261928","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"Society for Academic Emergency Medicine","keywords":"Pharmacokinetics; Pharmacotherapy; Medicine; Population; Population pharmacokinetics; Intensive care medicine; Pharmacology; Internal medicine; Environmental health","score_opus":0.5505319429749933,"score_gpt":0.5812774078301474,"score_spread":0.03074546485515406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076217357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000098073055,0.992599,0.00021145717,0.00013466278,0.0019176595,0.0014981959,0.00009849,0.000078010286,0.0033644296],"genre_scores_gemma":[0.001718214,0.99291587,0.0013171472,0.0007082107,0.0024599065,0.00005037508,0.000296474,0.0001265418,0.00040726925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947683,0.00051915285,0.0029183,0.00059116515,0.00058487605,0.0006181811],"domain_scores_gemma":[0.99530745,0.0019174315,0.0014194645,0.0004713739,0.00022183137,0.0006624775],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013650679,0.0006391389,0.0035564266,0.00016963683,0.00008135148,0.000019250716,0.00030228007,0.00047670645,0.0014389282],"category_scores_gemma":[0.00023457457,0.0004949015,0.0014929317,0.00046779003,0.0002451566,0.000118075084,0.00028871163,0.0015902056,0.00023766044],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119456134,0.00088636525,0.00020074692,0.021591915,0.0012122388,0.000017363347,0.000010540959,0.000032087853,0.000002223967,0.000028248813,0.0016072149,0.9742916],"study_design_scores_gemma":[0.0012941931,0.00019491531,0.000026186752,0.0035739206,0.023339536,0.000055990662,0.000004397344,0.0013751048,0.000007122284,0.000025349133,0.9696865,0.00041678455],"about_ca_topic_score_codex":0.000014336945,"about_ca_topic_score_gemma":1.626384e-7,"teacher_disagreement_score":0.9738748,"about_ca_system_score_codex":0.00009993406,"about_ca_system_score_gemma":0.0000926846,"threshold_uncertainty_score":0.99975026},"labels":[],"label_agreement":null},{"id":"W2081433798","doi":"10.2165/11531190-000000000-00000","title":"Rate and Extent of Drug Accumulation after Multiple Dosing Revisited","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; Pharmacokinetics; Drug; Pharmacology; Bolus (digestion); Medicine; Plasma concentration; Analyte; Intensive care medicine; Chemistry; Internal medicine","score_opus":0.3070457126826455,"score_gpt":0.5598952058502331,"score_spread":0.2528494931675876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081433798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008556254,0.9831538,0.000057827343,0.00007778263,0.0050914367,0.0017761867,0.0006531453,0.000092036,0.00054149213],"genre_scores_gemma":[0.007533439,0.9874971,0.0006842718,0.0011444452,0.002141212,0.00013981303,0.00018898053,0.00016508964,0.0005056513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917299,0.002850666,0.0032673627,0.0010927984,0.00031815472,0.0007411264],"domain_scores_gemma":[0.9920069,0.004513793,0.0016577122,0.0006588267,0.00033336354,0.000829422],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0040225317,0.0009552637,0.0030592885,0.0003473172,0.0001657863,0.000054706736,0.00069873413,0.0014510499,0.0012285569],"category_scores_gemma":[0.00084831077,0.0008360976,0.0010515314,0.0005002997,0.0008044244,0.00011285495,0.0005948611,0.0043067113,0.00012176886],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026039334,0.0005211839,0.0007791688,0.005453069,0.00050890696,0.00004983997,0.00007542695,0.000017527233,0.00040728692,0.0000378889,0.0022906684,0.98959863],"study_design_scores_gemma":[0.002721434,0.000051254236,0.00037455573,0.0011652227,0.0065556937,0.00002291166,0.0000037746804,0.0020861235,0.00043452866,0.000117027994,0.9856801,0.0007873595],"about_ca_topic_score_codex":0.0000040353534,"about_ca_topic_score_gemma":0.0000020602881,"teacher_disagreement_score":0.98881125,"about_ca_system_score_codex":0.000034639903,"about_ca_system_score_gemma":0.00023318904,"threshold_uncertainty_score":0.99984527},"labels":[],"label_agreement":null},{"id":"W20820324","doi":"10.2165/00003088-200847100-00001","title":"Disposition of Drugs in Block Copolymer Micelle Delivery Systems","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Bioavailability; Drug delivery; Pharmacology; Drug; Biodistribution; Micelle; Distribution (mathematics); Therapeutic index; Medicine; Chemistry; Nanotechnology; Materials science; Organic chemistry; In vitro; Aqueous solution","score_opus":0.06246443151503158,"score_gpt":0.37933505012734087,"score_spread":0.3168706186123093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W20820324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047668528,0.9479641,0.0000075318494,0.000012291162,0.0028419194,0.00096194056,0.00023639182,0.00006439736,0.0002429505],"genre_scores_gemma":[0.010035556,0.98873425,0.00011433542,0.000072501396,0.0006274455,0.000067357774,0.000057931877,0.00008100735,0.0002096248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99382234,0.0011849178,0.0031858757,0.00074652955,0.0005455978,0.00051474426],"domain_scores_gemma":[0.9958683,0.0019238236,0.001143632,0.0006455,0.00016468544,0.0002540361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009371704,0.00049738446,0.002419416,0.00023108201,0.00005393639,0.000034889905,0.00074532116,0.0004600286,0.00022180818],"category_scores_gemma":[0.00013242714,0.00044216446,0.000646887,0.0005313376,0.0004758341,0.00010350506,0.00027206045,0.0006404848,0.0007628206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008099738,0.009609649,0.00035630853,0.06786997,0.00062862044,0.00093602133,0.0004599284,0.0017270445,0.026422594,0.00014029769,0.0884037,0.8026359],"study_design_scores_gemma":[0.0022575352,0.0002614385,0.000011123868,0.0113692945,0.0013259221,0.00007399602,0.000021635806,0.0009402351,0.0061217723,0.000005672833,0.9766284,0.0009829329],"about_ca_topic_score_codex":0.000087794135,"about_ca_topic_score_gemma":0.0000015802138,"teacher_disagreement_score":0.8882247,"about_ca_system_score_codex":0.00013038747,"about_ca_system_score_gemma":0.0003840315,"threshold_uncertainty_score":0.999803},"labels":[],"label_agreement":null},{"id":"W2085312586","doi":"10.2165/00003088-200544060-00003","title":"Application and Impact of Population Pharmacokinetics in the Assessment of Antiretroviral Pharmacotherapy","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Dosing; Population; Pharmacokinetics; Pharmacotherapy; Drug; Pharmacodynamics; Intensive care medicine; Pharmacology; Clinical trial; Therapeutic drug monitoring; Internal medicine; Environmental health","score_opus":0.09711398041052753,"score_gpt":0.533612792953196,"score_spread":0.4364988125426684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085312586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012403656,0.98310536,0.00014097305,0.00021119816,0.00019611281,0.0033339246,0.00012867186,0.00002769318,0.00045241337],"genre_scores_gemma":[0.06567445,0.93155605,0.0014642896,0.0000960574,0.00041970538,0.000089741465,0.0004913879,0.000058099125,0.0001502404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958965,0.00048842543,0.0023411245,0.0004752477,0.0005098618,0.00028883966],"domain_scores_gemma":[0.9974242,0.00076363113,0.0011278897,0.00041955922,0.00011711188,0.000147623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011987246,0.0004981937,0.00222604,0.00032351218,0.000029178927,0.000012574049,0.0002827332,0.0002707762,0.000105590756],"category_scores_gemma":[0.000048850186,0.0003093018,0.0008117983,0.00062092737,0.00019614401,0.00005133007,0.000067287154,0.000766791,0.000004917979],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060348884,0.0013261891,0.04478496,0.0029778525,0.0006521295,0.000010979637,0.000052724146,0.000014755,0.00003392828,0.00002877845,0.0011349609,0.9489224],"study_design_scores_gemma":[0.009090177,0.0011458729,0.05260727,0.0036994258,0.008374135,0.000069120826,0.0000152286575,0.0052836197,0.000025094254,0.00003413932,0.9190292,0.0006267158],"about_ca_topic_score_codex":0.000018272247,"about_ca_topic_score_gemma":9.850829e-7,"teacher_disagreement_score":0.94829565,"about_ca_system_score_codex":0.00015938487,"about_ca_system_score_gemma":0.00029278456,"threshold_uncertainty_score":0.9999359},"labels":[],"label_agreement":null},{"id":"W2088788142","doi":"10.2165/00003088-200241100-00005","title":"Enterohepatic Circulation","year":2002,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":655,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Enterohepatic circulation; Bioavailability; Reabsorption; Pharmacology; Pharmacokinetics; Chemistry; Efflux; Drug metabolism; Glucuronidation; Transporter; Internal medicine; Metabolism; Endocrinology; Biology; Drug; Biochemistry; Enzyme; Medicine; Kidney","score_opus":0.22230048817132525,"score_gpt":0.47425539050488663,"score_spread":0.2519549023335614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088788142","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018266648,0.9925876,0.00029978197,0.000060861046,0.0021144003,0.0011062976,0.000029762708,0.00013027118,0.003652722],"genre_scores_gemma":[0.00009617899,0.9935675,0.000526378,0.00035678333,0.0015649869,0.00004078286,0.00027144345,0.00010735142,0.0034685472],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686587,0.00014267325,0.0017448361,0.00054550025,0.00037239198,0.00032875148],"domain_scores_gemma":[0.99838257,0.0002389442,0.0004295873,0.00050310075,0.00008521239,0.00036058543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003602257,0.00043840235,0.0023786398,0.0001380262,0.000042405783,0.000017046976,0.00020636943,0.0005325535,0.001404011],"category_scores_gemma":[0.00007678886,0.0003264745,0.0014959897,0.00028256443,0.00011675251,0.000024577756,0.000033097807,0.0010275355,0.0008302866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012593756,0.00039439503,0.00008985754,0.015870243,0.00032264824,0.0001868633,0.000005565023,4.4086522e-7,4.609908e-7,0.000023285518,0.0036888898,0.97940475],"study_design_scores_gemma":[0.0009389698,0.00010528746,0.00006582596,0.009154972,0.0069107483,0.000049074202,9.201608e-7,0.00013174461,5.340119e-7,0.000028888307,0.98232096,0.00029206942],"about_ca_topic_score_codex":3.7113855e-7,"about_ca_topic_score_gemma":2.3377997e-7,"teacher_disagreement_score":0.9791127,"about_ca_system_score_codex":0.000063740175,"about_ca_system_score_gemma":0.00011006926,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W2089663335","doi":"10.2165/00003088-200140050-00002","title":"Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Rifabutin; Rifamycin; Rifapentine; Pharmacology; Rifampicin; Pharmacokinetics; CYP3A; Pharmacodynamics; Drug interaction; Antibiotics; Bioavailability; Antibacterial agent; Medicine; Mycobacterium tuberculosis; Microbiology; Biology; Latent tuberculosis; Internal medicine; Clarithromycin; Cytochrome P450; Tuberculosis; Metabolism","score_opus":0.2620719895744265,"score_gpt":0.5471323598162761,"score_spread":0.28506037024184955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089663335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035781476,0.98877627,0.00002386224,0.00065640354,0.0018847142,0.0025531359,0.00040241322,0.000054368615,0.0020706605],"genre_scores_gemma":[0.0012178895,0.9943568,0.00037065212,0.0013238674,0.001680415,0.000051978805,0.00016170072,0.0001013712,0.0007352849],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921112,0.0023225583,0.0033527017,0.00089650264,0.00053631444,0.0007806875],"domain_scores_gemma":[0.99323225,0.0034441163,0.0013914403,0.0008615317,0.00034988995,0.0007208004],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020361552,0.00079927803,0.005805046,0.00022079994,0.00010813312,0.000025369533,0.00073770847,0.0006997853,0.00048251837],"category_scores_gemma":[0.001154078,0.00049355585,0.0014835249,0.000844294,0.0015646517,0.000050546725,0.00072643,0.0025042447,0.000065227156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035772286,0.0010993893,0.0014933685,0.01609543,0.0027968357,0.000087746324,0.000039814517,0.0000057695083,0.00031124294,0.00005567894,0.05163498,0.92602205],"study_design_scores_gemma":[0.0024947345,0.00035819804,0.00073650014,0.0038656117,0.0069483817,0.00028009008,0.000007036861,0.0006343165,0.00008400388,0.000029339502,0.9841507,0.0004110763],"about_ca_topic_score_codex":0.000012050023,"about_ca_topic_score_gemma":0.0000017949103,"teacher_disagreement_score":0.93251574,"about_ca_system_score_codex":0.00008229884,"about_ca_system_score_gemma":0.00051348313,"threshold_uncertainty_score":0.99979705},"labels":[],"label_agreement":null},{"id":"W2092225831","doi":"10.2165/00003088-200038040-00004","title":"Pharmacokinetic Drug Interactions Between Oral Contraceptives and Second-Generation Anticonvulsants","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Oxcarbazepine; Lamotrigine; Felbamate; Zonisamide; Vigabatrin; Medicine; Anticonvulsant; Pharmacology; Topiramate; Tiagabine; Pharmacokinetics; Drug interaction; Carbamazepine; Epilepsy","score_opus":0.2758623970161912,"score_gpt":0.5270605067803867,"score_spread":0.25119810976419554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092225831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014461589,0.9768445,0.000012995485,0.00036615023,0.0016437601,0.003583181,0.00031695774,0.00017852972,0.0025923394],"genre_scores_gemma":[0.011677655,0.9781269,0.0001805326,0.0015189591,0.004402504,0.00019612206,0.0003119968,0.000110682086,0.0034746625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947811,0.0009715958,0.002159827,0.0010938793,0.0003609073,0.00063270156],"domain_scores_gemma":[0.99583805,0.0022932368,0.0006082417,0.0003711208,0.00014229862,0.0007470606],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007927178,0.0008985977,0.004029457,0.00024371778,0.00022960179,0.0000853175,0.00027260216,0.00031187653,0.0031502654],"category_scores_gemma":[0.00029057206,0.00067079667,0.00094111584,0.00035413206,0.0007060081,0.00013289739,0.0002452881,0.0023849618,0.000278548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006224944,0.0008057298,0.00010705346,0.0039274194,0.001581569,0.000116128955,0.000026179727,3.8908777e-7,0.000030568546,0.0000033681267,0.028359247,0.96441984],"study_design_scores_gemma":[0.017354252,0.00065957184,0.0003548584,0.0020334662,0.010914851,0.00006911732,0.000005247923,0.00017563796,0.00003414029,0.000013550572,0.9677521,0.0006332108],"about_ca_topic_score_codex":0.0000030610279,"about_ca_topic_score_gemma":0.0000034297466,"teacher_disagreement_score":0.96378666,"about_ca_system_score_codex":0.00007865862,"about_ca_system_score_gemma":0.00016732168,"threshold_uncertainty_score":0.99991655},"labels":[],"label_agreement":null},{"id":"W2097429326","doi":"10.2165/00003088-200342040-00001","title":"Maternal-Fetal Transport of Hypoglycaemic Drugs","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chlorpropamide; Medicine; Tolbutamide; Pregnancy; Placenta; Glibenclamide; Pharmacology; Fetus; Diabetes mellitus; Drug; Insulin; Pharmacodynamics; Pharmacokinetics; Internal medicine; Endocrinology; Biology","score_opus":0.13380008607052357,"score_gpt":0.4533784332183283,"score_spread":0.31957834714780475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097429326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019295246,0.98173785,0.000033980767,0.000037970476,0.0015937199,0.0010067329,0.00015756127,0.00006379864,0.015175415],"genre_scores_gemma":[0.000432025,0.9948765,0.0006649282,0.00032714417,0.00059940753,0.00004855396,0.000095386495,0.000097910786,0.0028581177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99577767,0.00028440784,0.0025472024,0.0005798775,0.0004111594,0.0003996848],"domain_scores_gemma":[0.99756825,0.0006464188,0.0007577157,0.00062404026,0.00011869551,0.00028487184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006845453,0.0005776234,0.0040052957,0.00012682081,0.000037420246,0.0000039597935,0.00034533907,0.0005635402,0.000475094],"category_scores_gemma":[0.00011119636,0.00044056206,0.0019159768,0.00028462385,0.00045237358,0.000028760514,0.00007766336,0.0012944982,0.00014322168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008790913,0.00037852346,0.0014392621,0.03641182,0.001380777,0.00014982223,0.000030736875,2.1712077e-7,0.0000010157065,0.000034437442,0.004392932,0.9556925],"study_design_scores_gemma":[0.0016380466,0.00022781061,0.00025526815,0.017676245,0.009338988,0.000115306604,0.000003065934,0.0000026447024,0.000016193007,0.000050843675,0.9703251,0.00035048148],"about_ca_topic_score_codex":0.0000032814796,"about_ca_topic_score_gemma":2.9846785e-7,"teacher_disagreement_score":0.9659322,"about_ca_system_score_codex":0.000035272333,"about_ca_system_score_gemma":0.000313468,"threshold_uncertainty_score":0.9998046},"labels":[],"label_agreement":null},{"id":"W2142711346","doi":"10.2165/0003088-200847120-00006","title":"Pharmacokinetics of Sapropterin in Patients with Phenylketonuria","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"BioMarin Pharmaceutical","keywords":"Phenylalanine; Medicine; Phenylalanine hydroxylase; Pharmacokinetics; Tetrahydrobiopterin; Phenylketonurias; Placebo; Population; Internal medicine; Hyperphenylalaninemia; Blood sampling; Pharmacotherapy; Pediatrics; Pharmacology; Amino acid; Chemistry; Biochemistry","score_opus":0.023051826954967675,"score_gpt":0.3165657192490158,"score_spread":0.2935138922940481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142711346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632186,0.0005566535,0.0003487758,0.000049856164,0.0004300496,0.00037305648,0.00003790433,0.00001056294,0.0018712938],"genre_scores_gemma":[0.99487275,0.001864494,0.00205616,0.00050708995,0.00024751897,0.00001260835,0.000099549135,0.00004094887,0.00029888455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979847,0.00014498236,0.00078675937,0.00046263653,0.00028858084,0.00033230605],"domain_scores_gemma":[0.9989634,0.000037041616,0.00021476255,0.0004285719,0.00018667369,0.00016956306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026417058,0.00024218434,0.00038344966,0.0000699834,0.000033301323,0.0000049098776,0.00034976003,0.00014534069,0.00013884266],"category_scores_gemma":[0.00010759158,0.00021052544,0.000121732,0.00021139391,0.00043265734,0.0000043748446,0.00014236642,0.00020528035,0.000012626647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012689972,0.0014322876,0.96866035,0.000044728164,0.00010744552,0.000008745179,0.000048212652,0.00046098695,0.008602677,0.00001361655,0.006564259,0.012787663],"study_design_scores_gemma":[0.011069746,0.00095459365,0.8858887,0.000020089416,0.00008143631,0.000003045398,0.000011322951,0.00011694495,0.02615241,0.000027112423,0.07526405,0.00041052754],"about_ca_topic_score_codex":0.0000048551938,"about_ca_topic_score_gemma":0.0000031751024,"teacher_disagreement_score":0.08277166,"about_ca_system_score_codex":0.000002552135,"about_ca_system_score_gemma":0.00008674794,"threshold_uncertainty_score":0.85849786},"labels":[],"label_agreement":null},{"id":"W2185569199","doi":"10.2165/11594550-000000000-00000","title":"Pharmacokinetics of Antimalarials in Pregnancy","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Pharmacokinetics; Lumefantrine; Pregnancy; Proguanil; Sulfadoxine/pyrimethamine; Sulfadoxine; Malaria; Artemether/lumefantrine; Chloroquine; Pharmacology; MEDLINE; Artemisinin; Pyrimethamine; Plasmodium falciparum; Immunology","score_opus":0.30778625613371663,"score_gpt":0.5209147555254692,"score_spread":0.21312849939175255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185569199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015814045,0.98722607,0.000021754797,0.000058170983,0.00168498,0.003052393,0.00013519476,0.000085952975,0.0075773257],"genre_scores_gemma":[0.0007463634,0.99650496,0.00069513114,0.00041271577,0.00083772815,0.00013988175,0.000058934584,0.000122040015,0.00048226313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99317664,0.00085507333,0.0039110226,0.0009474887,0.00039255407,0.00071719434],"domain_scores_gemma":[0.99538547,0.002014468,0.001311822,0.0005947863,0.00022934937,0.00046413328],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012396693,0.00087005796,0.006479118,0.00040144136,0.00003849969,0.000010777136,0.00058283587,0.0008412181,0.0009926581],"category_scores_gemma":[0.0011866181,0.0006334357,0.0017337293,0.0008484573,0.0006787447,0.00005143001,0.0005161816,0.0021230527,0.00012930414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017250757,0.0027151578,0.00040884328,0.030091414,0.0010273908,0.00039786645,0.000023501403,8.4423925e-7,0.000028203618,0.000083210834,0.003935876,0.9611152],"study_design_scores_gemma":[0.0042271093,0.0009960991,0.00038169982,0.024502182,0.007995055,0.000042267315,0.0000021682272,0.000046927547,0.000118499236,0.00006704369,0.96104515,0.00057580194],"about_ca_topic_score_codex":0.0000062909853,"about_ca_topic_score_gemma":5.7662464e-7,"teacher_disagreement_score":0.9605394,"about_ca_system_score_codex":0.00007100643,"about_ca_system_score_gemma":0.0003376715,"threshold_uncertainty_score":0.99992055},"labels":[],"label_agreement":null},{"id":"W2269037162","doi":"10.1007/s40262-015-0352-5","title":"Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug–Drug Interaction Prediction","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Itraconazole; Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Drug; Chemistry; Medicine; Antifungal","score_opus":0.327424888735298,"score_gpt":0.5071408996172214,"score_spread":0.1797160108819234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269037162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958591,0.0024656812,0.027809042,0.0010383072,0.005275179,0.0022570628,0.000721852,0.000287621,0.0015542657],"genre_scores_gemma":[0.95860785,0.0014592021,0.032999575,0.0043305503,0.0012618542,0.00034289787,0.00023357522,0.000119889235,0.00064461713],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9938032,0.00081246137,0.0026852668,0.0011122139,0.00061558175,0.0009713008],"domain_scores_gemma":[0.9947601,0.0014473938,0.0009690223,0.0003963005,0.0010039624,0.0014232503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004010993,0.0007681182,0.0011106661,0.00031422335,0.00028873506,0.000045347995,0.00073248235,0.00041350196,0.00028361083],"category_scores_gemma":[0.0004725656,0.0007427295,0.0004200698,0.0004134747,0.0006849805,0.0002217555,0.00034912679,0.0014544538,0.00004090367],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008133089,0.0057870904,0.00410508,0.00080242066,0.0012524734,0.000023867218,0.0032178022,0.22370969,0.4429493,0.00031948453,0.07818585,0.23151387],"study_design_scores_gemma":[0.011329645,0.0001394676,0.0004970744,0.000036419646,0.00089624646,0.0000070312767,0.00011596395,0.6414244,0.11183193,0.0004495985,0.23272748,0.0005447543],"about_ca_topic_score_codex":0.00000296246,"about_ca_topic_score_gemma":0.0000034948846,"teacher_disagreement_score":0.41771472,"about_ca_system_score_codex":0.00010452852,"about_ca_system_score_gemma":0.0006326602,"threshold_uncertainty_score":0.99950236},"labels":[],"label_agreement":null},{"id":"W2402000540","doi":"10.1007/s40262-016-0408-1","title":"Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent–Metabolite Population Pharmacokinetic Model","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; American Foundation for Pharmaceutical Education; National Center for Advancing Translational Sciences; Howard Hughes Medical Institute","keywords":"Glucuronidation; Pharmacokinetics; Acetaminophen; Metabolite; Urine; Population; Sulfation; Pharmacology; NONMEM; Gestational age; Chemistry; Gestation; Medicine; Endocrinology; Pregnancy; Biochemistry; Microsome; Biology","score_opus":0.1707557073575224,"score_gpt":0.4667549812125988,"score_spread":0.2959992738550764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402000540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94686866,0.00020258922,0.046685576,0.0022046878,0.0017747529,0.0012483664,0.00021958715,0.00016820783,0.0006275551],"genre_scores_gemma":[0.9945728,0.0009451845,0.0012386992,0.0019688427,0.0005417628,0.000109083114,0.00024389043,0.000052153984,0.0003275928],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9957809,0.0011188682,0.0014854667,0.00070553663,0.0004566299,0.00045263895],"domain_scores_gemma":[0.9968812,0.0012186433,0.0008028993,0.00035821376,0.00038788223,0.0003512018],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017584023,0.00041486067,0.0005331576,0.00028563885,0.0002487025,0.00003377373,0.00026556494,0.0005220101,0.00042013547],"category_scores_gemma":[0.000658169,0.00034576046,0.00018775788,0.00038594246,0.00032429522,0.0004403067,0.000075605196,0.00072569423,0.00007613579],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040469673,0.0013799274,0.040596694,0.0002923708,0.00024529203,0.000008511148,0.0002566516,0.055698734,0.31098914,0.003914107,0.0014403666,0.5811312],"study_design_scores_gemma":[0.010002591,0.00045207917,0.07768363,0.00011192919,0.0005962246,0.000008556105,0.000015949074,0.70939964,0.18132971,0.0028833884,0.016822029,0.0006942566],"about_ca_topic_score_codex":0.0000101930345,"about_ca_topic_score_gemma":0.000004160868,"teacher_disagreement_score":0.65370095,"about_ca_system_score_codex":0.00009933249,"about_ca_system_score_gemma":0.000095254276,"threshold_uncertainty_score":0.99989945},"labels":[],"label_agreement":null},{"id":"W2474545910","doi":"10.1007/s40262-016-0425-0","title":"Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Janssen Research and Development","keywords":"Prostate cancer; Abiraterone; Medicine; Oncology; Abiraterone acetate; Prostate; Prostate-specific antigen; Castration; Internal medicine; Cancer; Urology; Hormone; Androgen deprivation therapy; Androgen receptor","score_opus":0.11871878469080704,"score_gpt":0.40642099729193215,"score_spread":0.2877022126011251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474545910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99084055,0.0005623449,0.00026953884,0.005981077,0.000097972115,0.0019428668,0.00024555522,0.000026255744,0.000033836357],"genre_scores_gemma":[0.9976428,0.0008554172,0.0005372218,0.00017394041,0.000113703165,0.00013358693,0.00008521857,0.000041797786,0.00041630675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979017,0.00016623447,0.00069318607,0.00043525614,0.00040948583,0.00039415894],"domain_scores_gemma":[0.9985182,0.0005613788,0.000098467564,0.0002765101,0.00026285838,0.00028254418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005479248,0.00021456495,0.0003602067,0.00010571908,0.000118053766,0.00004503286,0.0001110028,0.00006180075,0.000025859192],"category_scores_gemma":[0.00014244489,0.0001062101,0.000044310575,0.0003302885,0.0002150006,0.00011433673,0.00006465616,0.00033835086,0.000012214282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002915503,0.00019218102,0.9841533,0.000059140406,0.000093047536,0.000019107481,0.0002396365,0.00031861232,0.00023702084,0.000037761227,0.00012560832,0.01160913],"study_design_scores_gemma":[0.01042843,0.0015605553,0.98575914,0.00034154244,0.00013304722,6.481461e-7,0.00009565578,0.00092612696,0.00011283273,0.00014532602,0.00031515045,0.00018154898],"about_ca_topic_score_codex":0.00003930914,"about_ca_topic_score_gemma":0.000099141216,"teacher_disagreement_score":0.01142758,"about_ca_system_score_codex":0.0002247143,"about_ca_system_score_gemma":0.00019578739,"threshold_uncertainty_score":0.43311223},"labels":[],"label_agreement":null},{"id":"W2515414172","doi":"10.1007/s40262-016-0442-z","title":"Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"U.S. Food and Drug Administration","keywords":"Bioequivalence; Pharmacokinetics; Medicine; Pharmacology","score_opus":0.283421452958704,"score_gpt":0.5430172333162642,"score_spread":0.25959578035756015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515414172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80883276,0.0014483429,0.0650649,0.018011674,0.012986317,0.006864345,0.00057034974,0.00066166854,0.08555964],"genre_scores_gemma":[0.9200922,0.0047383322,0.018873597,0.04182834,0.0021519307,0.00040446702,0.00004483141,0.00016834078,0.011697961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923316,0.0019257456,0.0018578718,0.0017111816,0.0006987896,0.0014747888],"domain_scores_gemma":[0.9951775,0.001601005,0.00031504603,0.0008452741,0.00041927688,0.001641897],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0027070954,0.0007529261,0.000920901,0.00019845515,0.00040795255,0.000103863465,0.0033567005,0.000584482,0.009685177],"category_scores_gemma":[0.00080009754,0.0005621385,0.0003709039,0.00057505094,0.0009200365,0.0004340203,0.0022568433,0.0015017166,0.004908957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003995488,0.0035043813,0.005052438,0.0001125122,0.00047908604,0.00018765905,0.00026467806,0.0027265125,0.22894372,0.00045809036,0.0706243,0.68365115],"study_design_scores_gemma":[0.01569582,0.0009412064,0.0018589434,0.00011806333,0.0008370486,0.00010814266,0.00003617546,0.01512684,0.08406031,0.00065749505,0.8792744,0.0012855472],"about_ca_topic_score_codex":0.000013461502,"about_ca_topic_score_gemma":0.000001713731,"teacher_disagreement_score":0.80865014,"about_ca_system_score_codex":0.00017793795,"about_ca_system_score_gemma":0.00026185488,"threshold_uncertainty_score":0.999683},"labels":[],"label_agreement":null},{"id":"W2555438271","doi":"10.1007/s40262-016-0487-z","title":"Erratum to: Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence","year":2016,"lang":"en","type":"erratum","venue":"Clinical Pharmacokinetics","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Medicine; Pharmacokinetics; Pharmacotherapy; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.23016181609948047,"score_gpt":0.5287070725347852,"score_spread":0.2985452564353047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555438271","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009583695,0.0077293827,0.020190835,0.021903303,0.30758017,0.019543214,0.004163726,0.001101887,0.60820377],"genre_scores_gemma":[0.01714723,0.033715677,0.023312427,0.1689966,0.029743621,0.002233278,0.0014995784,0.0010971506,0.72225446],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9840081,0.0035815903,0.0038369473,0.003930762,0.0016300221,0.0030126225],"domain_scores_gemma":[0.9907488,0.0015385436,0.0008505809,0.001913492,0.0010341041,0.0039144414],"candidate_categories":["metaepi_narrow","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.003944296,0.0021690754,0.002744559,0.00061297644,0.0007394355,0.00031376208,0.007847348,0.00296715,0.010842062],"category_scores_gemma":[0.0014676634,0.001893573,0.000947356,0.0011684111,0.001114168,0.00040909127,0.005875626,0.008698573,0.011142028],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029536977,0.0024170312,0.00013152552,0.0003847124,0.0007964849,0.00029905926,0.00025024125,0.0017743756,0.009393673,0.000049214064,0.82908446,0.15246554],"study_design_scores_gemma":[0.008302359,0.0013146586,0.00017619174,0.0005228139,0.0021076663,0.00010088881,0.00003001378,0.008612738,0.004680279,0.00034182466,0.97129786,0.0025127206],"about_ca_topic_score_codex":0.000031394284,"about_ca_topic_score_gemma":0.000006978497,"teacher_disagreement_score":0.27783656,"about_ca_system_score_codex":0.00052319095,"about_ca_system_score_gemma":0.0012881638,"threshold_uncertainty_score":0.999105},"labels":[],"label_agreement":null},{"id":"W2566808867","doi":"10.1007/s40262-016-0496-y","title":"A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"F. Hoffmann-La Roche","keywords":"Trastuzumab emtansine; Medicine; Internal medicine; Pharmacokinetics; Metastatic breast cancer; Breast cancer; Gastroenterology; Endocrinology; Cancer","score_opus":0.08172419646481328,"score_gpt":0.4483246871888897,"score_spread":0.3666004907240764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566808867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949438,0.00011166078,0.000092676986,0.000878567,0.00036167612,0.0029295073,0.0005815899,0.00004896197,0.000051558276],"genre_scores_gemma":[0.99819624,0.00045288607,0.00015729059,0.00035001605,0.00032695383,0.00018692679,0.000039063976,0.00009947523,0.00019116212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952248,0.00064397417,0.0016475972,0.00082900614,0.0009873888,0.00066725345],"domain_scores_gemma":[0.9968616,0.00094556744,0.0004430245,0.000371576,0.0007784434,0.0005998199],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006407059,0.00046459818,0.0011488001,0.00033533596,0.00008904174,0.000021293916,0.00021922641,0.00010779102,0.0022332263],"category_scores_gemma":[0.000367483,0.00028586065,0.00011233244,0.0006720896,0.0005223487,0.00021403572,0.00013171429,0.0006546531,0.000012655229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047113054,0.03309375,0.65971875,0.0007968929,0.0014040958,0.00021530244,0.000870335,0.000008487916,0.027381148,0.0000034613645,0.0014512517,0.22794347],"study_design_scores_gemma":[0.10365732,0.02668233,0.8616557,0.00071825646,0.0012639717,0.0000179563,0.00013503575,0.00020581968,0.0051119043,0.000008153685,0.000114112925,0.00042941913],"about_ca_topic_score_codex":0.00016949972,"about_ca_topic_score_gemma":0.000080813246,"teacher_disagreement_score":0.22751406,"about_ca_system_score_codex":0.00027688968,"about_ca_system_score_gemma":0.0003924067,"threshold_uncertainty_score":0.99995935},"labels":[],"label_agreement":null},{"id":"W2592879858","doi":"10.1007/s40262-017-0521-9","title":"Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia; Providence Health Care","funders":"","keywords":"Leflunomide; Medicine; Pharmacokinetics; Renal transplant; BK virus; Therapeutic drug monitoring; Pharmacotherapy; Pharmacology; Polyomavirus Infections; Metabolic clearance rate; Intensive care medicine; Kidney transplantation; Internal medicine; Transplantation; Rheumatoid arthritis","score_opus":0.1887635868518452,"score_gpt":0.5097140651357156,"score_spread":0.3209504782838704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592879858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030294312,0.9918107,0.0000019418785,0.00015063859,0.0017605835,0.0020965436,0.00033610754,0.000021918342,0.00079212803],"genre_scores_gemma":[0.0013700264,0.9962756,0.00017902024,0.00025627553,0.001189227,0.000063421765,0.00011511375,0.000090705216,0.00046060048],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927101,0.0009694559,0.0044524763,0.00074319355,0.0007240718,0.0004006995],"domain_scores_gemma":[0.9936905,0.0011671402,0.0030649006,0.001340598,0.00034446613,0.0003923969],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017171825,0.0006381657,0.004282256,0.00018889377,0.00006507673,0.000016904549,0.00090210297,0.000706518,0.000075906566],"category_scores_gemma":[0.0010015068,0.0003521832,0.0019690052,0.0006489111,0.0006996311,0.00008117497,0.00015808415,0.0029301408,0.000008963463],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082078093,0.0017445958,0.013627757,0.08711297,0.0012923797,0.000335538,0.00002768026,0.0000017779236,0.000028507433,0.0000034752713,0.0014714357,0.8935331],"study_design_scores_gemma":[0.002667215,0.0002943202,0.0061965017,0.4631051,0.00816031,0.00009318985,6.7161346e-7,0.0000047836315,0.00008290366,0.000002922091,0.51913685,0.00025524222],"about_ca_topic_score_codex":0.000008376531,"about_ca_topic_score_gemma":5.966947e-7,"teacher_disagreement_score":0.8932779,"about_ca_system_score_codex":0.00006739467,"about_ca_system_score_gemma":0.0009347217,"threshold_uncertainty_score":0.999893},"labels":[],"label_agreement":null},{"id":"W2596456348","doi":"10.1007/s40262-017-0526-4","title":"Population Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform Labelling","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Oncology","keywords":"Ixazomib; Pharmacology; Proteasome inhibitor; Pharmacokinetics; Population; Chemistry; Medicine; Proteasome; Biochemistry; Carfilzomib","score_opus":0.23345354210638997,"score_gpt":0.49510047905803145,"score_spread":0.2616469369516415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596456348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952575,0.0001854339,0.0010686327,0.00036378347,0.0006414944,0.0015127998,0.00080941303,0.0000289449,0.00013201164],"genre_scores_gemma":[0.99396616,0.0001471415,0.0011733631,0.0008599235,0.0016399889,0.000044542077,0.0020438274,0.000044646084,0.00008042165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644214,0.00041891378,0.0013697649,0.0008960503,0.00047334298,0.00039978515],"domain_scores_gemma":[0.99570626,0.00016857419,0.00080611574,0.0027008685,0.00026742407,0.00035073218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002511542,0.00034627246,0.0006885927,0.00010964662,0.000552,0.00018653848,0.0024450405,0.00016157882,0.00018227803],"category_scores_gemma":[0.0010633433,0.00028055024,0.00022765754,0.00034906395,0.00018273342,0.000056876746,0.0020069268,0.00041366494,0.000013309468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005371905,0.007996903,0.43690577,0.000060212486,0.006023349,0.000035492187,0.0012497498,0.0045938357,0.4076571,0.000026586242,0.005575105,0.124503985],"study_design_scores_gemma":[0.044773415,0.0077249277,0.36145756,0.00016717776,0.014835028,0.000004969278,0.0010261489,0.19307989,0.30184492,0.0002118447,0.072240174,0.0026339504],"about_ca_topic_score_codex":0.00042287188,"about_ca_topic_score_gemma":0.00029799007,"teacher_disagreement_score":0.18848605,"about_ca_system_score_codex":0.000015670272,"about_ca_system_score_gemma":0.00006943258,"threshold_uncertainty_score":0.99996465},"labels":[],"label_agreement":null},{"id":"W2596528435","doi":"10.1007/s40262-017-0525-5","title":"Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Physiologically based pharmacokinetic modelling; Dosing; Pharmacokinetics; Medicine; Drug development; Clindamycin; Pharmacology; Drug; Antibiotics; Chemistry","score_opus":0.5641180925301839,"score_gpt":0.5241841764360174,"score_spread":0.03993391609416641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596528435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724574,0.0003518423,0.02299511,0.00031820638,0.0010434925,0.0012299182,0.00048875035,0.000093150324,0.0010221483],"genre_scores_gemma":[0.8964094,0.0014269846,0.09995902,0.00068435835,0.0009965531,0.0000066602497,0.00027410587,0.00012214035,0.00012077238],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9928746,0.00019060576,0.0036705234,0.0013149809,0.0010870132,0.00086225296],"domain_scores_gemma":[0.9921136,0.0005003164,0.0026941572,0.0029496136,0.0008396668,0.00090264156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002051899,0.0007205884,0.0018516108,0.00032429243,0.0003674627,0.000050816452,0.0026173685,0.0003536627,0.0004281237],"category_scores_gemma":[0.0011254038,0.0006506619,0.0005174976,0.0003076049,0.0011906727,0.000168968,0.0015901823,0.0010334416,0.00002813821],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004122121,0.010898612,0.043478586,0.0034941419,0.0014369339,0.00020974164,0.00014990086,0.029963586,0.8391882,0.00013339058,0.004671071,0.062253706],"study_design_scores_gemma":[0.012045463,0.00041094754,0.017757013,0.0002304891,0.0038913554,0.000010592696,0.000012890116,0.9214357,0.04108728,0.000058920956,0.0023504358,0.00070890534],"about_ca_topic_score_codex":0.0000063532357,"about_ca_topic_score_gemma":5.894213e-7,"teacher_disagreement_score":0.8914721,"about_ca_system_score_codex":0.000054491094,"about_ca_system_score_gemma":0.0015176594,"threshold_uncertainty_score":0.99959445},"labels":[],"label_agreement":null},{"id":"W2600807646","doi":"10.1007/s40262-017-0535-3","title":"Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn’s Disease","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Pharmacokinetics; Crohn's disease; Disease; Internal medicine; Adalimumab","score_opus":0.02272994562139833,"score_gpt":0.3501091740174944,"score_spread":0.32737922839609607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600807646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971587,0.000028136337,0.00045346,0.00014927317,0.0004617116,0.0011101068,0.00022568164,0.00001219141,0.00040070692],"genre_scores_gemma":[0.9984367,0.00003847868,0.0006217263,0.00015730299,0.00041646685,0.0000827362,0.00011758575,0.0000497641,0.00007927141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978606,0.00015169365,0.00077780936,0.00059251045,0.00023734743,0.00038004512],"domain_scores_gemma":[0.99768317,0.00011002597,0.00052694074,0.000981736,0.0004065646,0.00029154014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003865841,0.0002531154,0.00031729194,0.000042406184,0.00013525327,0.000043547356,0.0006730471,0.00012857489,0.000054134172],"category_scores_gemma":[0.0016967781,0.0002329813,0.00020610481,0.000037838832,0.00042504564,0.000016690925,0.0002784782,0.00018503117,0.000004367721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069825626,0.0008870386,0.9863241,0.00021692389,0.00007462699,0.000065698776,0.000007666959,0.00013155385,0.00063901587,0.000026442698,0.0007361533,0.003908234],"study_design_scores_gemma":[0.009721568,0.00015952988,0.98543686,0.000039901453,0.00017766263,5.120335e-7,0.000002181704,0.0011241216,0.0006624406,0.00012442995,0.0022579553,0.0002928359],"about_ca_topic_score_codex":0.000003334407,"about_ca_topic_score_gemma":0.0000048759953,"teacher_disagreement_score":0.0036153982,"about_ca_system_score_codex":0.000019587433,"about_ca_system_score_gemma":0.00019296957,"threshold_uncertainty_score":0.9500702},"labels":[],"label_agreement":null},{"id":"W2603265703","doi":"10.1007/s40262-017-0537-1","title":"Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Levetiracetam; Medicine; Tolerability; Epilepsy; Pharmacokinetics; Therapeutic drug monitoring; Pharmacotherapy; Antiepileptic drug; Drug; Adverse effect; MEDLINE; Pediatric epilepsy; Broad spectrum; Intensive care medicine; Pediatrics; Pharmacology; Internal medicine; Psychiatry","score_opus":0.3144511538562393,"score_gpt":0.5487371668921875,"score_spread":0.23428601303594826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603265703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074576843,0.98207664,0.000005585507,0.000101738144,0.002926444,0.004487402,0.00012570924,0.00012329665,0.0026955192],"genre_scores_gemma":[0.0028834627,0.98761344,0.00075095746,0.00010554113,0.006166738,0.00032101787,0.0003341647,0.00027928507,0.0015454113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900218,0.0012465093,0.0042927884,0.0018042087,0.0012833694,0.0013512933],"domain_scores_gemma":[0.99177784,0.0025477665,0.0016969711,0.0018264723,0.00046808325,0.0016828544],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024167944,0.0012140202,0.0057441774,0.00059803796,0.00016952168,0.00011421433,0.0010742355,0.0009806056,0.0002831696],"category_scores_gemma":[0.0017637878,0.000851442,0.0017833887,0.0006061788,0.0005978901,0.00014342325,0.00051470514,0.004873669,0.0008426369],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028925607,0.0026591457,0.4589124,0.0048676985,0.00046453462,0.00061209593,0.0000030898123,4.7022394e-7,8.01499e-9,7.5981495e-7,0.0011774331,0.5310131],"study_design_scores_gemma":[0.0124936355,0.0020362716,0.24336037,0.0062821493,0.0070566223,0.000017645882,0.0000012081478,0.000011555681,3.9452917e-7,0.000004382312,0.7280784,0.0006573514],"about_ca_topic_score_codex":0.0000062955364,"about_ca_topic_score_gemma":0.0000020063494,"teacher_disagreement_score":0.726901,"about_ca_system_score_codex":0.00026397768,"about_ca_system_score_gemma":0.0013085763,"threshold_uncertainty_score":0.9999353},"labels":[],"label_agreement":null},{"id":"W2615999950","doi":"10.1007/s40262-017-0548-y","title":"Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of Alberta; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Vancomycin; Ventriculitis; Medicine; Cerebrospinal fluid; Penetration (warfare); Meningitis; Internal medicine; Surgery; Staphylococcus aureus; Bacteria","score_opus":0.1640465031503143,"score_gpt":0.4801198568830462,"score_spread":0.31607335373273193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615999950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013156279,0.9929895,0.000018135252,0.000098769495,0.004262048,0.0022288775,0.000038660757,0.000029765422,0.00032109063],"genre_scores_gemma":[0.000098139404,0.9977176,0.000019284627,0.00013668784,0.00034082518,0.00019640123,0.000170959,0.000034782563,0.0012852853],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517274,0.0015198999,0.0026914624,0.00036142793,0.000034385965,0.00022005608],"domain_scores_gemma":[0.9953596,0.001037108,0.002231648,0.0011346749,0.00020385446,0.000033138003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017423142,0.00039064686,0.0035014239,0.00006274944,0.00024226084,0.000030810173,0.00092488714,0.00050639064,0.0005809431],"category_scores_gemma":[0.001324478,0.00021700242,0.001113792,0.00013378079,0.00030870258,0.000050971274,0.0002138962,0.0008315951,0.0005362014],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009873303,0.0001571482,0.0000036389554,0.7634586,0.0008593392,7.547405e-7,0.000010843131,4.6427328e-8,0.000050570117,0.00008562325,0.015011491,0.22035207],"study_design_scores_gemma":[0.00027244186,0.00013627272,0.0000062114973,0.22182693,0.0071505005,0.00004021878,0.0000015283302,4.3075835e-7,0.000010633962,0.000016293463,0.7703633,0.00017527872],"about_ca_topic_score_codex":0.000022474835,"about_ca_topic_score_gemma":0.0000068502823,"teacher_disagreement_score":0.7553518,"about_ca_system_score_codex":0.000025461988,"about_ca_system_score_gemma":0.00018516739,"threshold_uncertainty_score":0.88491017},"labels":[],"label_agreement":null},{"id":"W2616665343","doi":"10.1007/s40262-017-0544-2","title":"Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Morphine; Medicine; Pharmacokinetics; Glucuronidation; NONMEM; Population; Volume of distribution; Body mass index; Anesthesia; Pharmacology; Internal medicine; Chemistry","score_opus":0.06270001594124372,"score_gpt":0.3873581527800608,"score_spread":0.32465813683881706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616665343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98801047,0.00049391267,0.000108522276,0.006787307,0.00046844856,0.0011031155,0.00006646392,0.00006510726,0.0028966328],"genre_scores_gemma":[0.98849785,0.005923609,0.00078265445,0.0030920114,0.0006033356,0.000021870334,0.000015831962,0.00006774288,0.0009950732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961194,0.00022719908,0.0016069761,0.0006851251,0.00082277955,0.0005385536],"domain_scores_gemma":[0.9947904,0.0012905258,0.0012627936,0.0018146452,0.00043445636,0.00040722595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018230102,0.0005039901,0.0010687434,0.0001625707,0.00027348395,0.000056504396,0.0011494578,0.00020454774,0.00024284648],"category_scores_gemma":[0.002853386,0.0003694331,0.00036397605,0.00022299447,0.0016917918,0.00016719784,0.0007565709,0.001012179,0.00004509629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016492911,0.0024405648,0.8947536,0.0010221758,0.0009028199,0.00023527016,0.00018677839,0.0026962035,0.050184693,0.0024939813,0.037042942,0.006391684],"study_design_scores_gemma":[0.005924211,0.0008548039,0.93581873,0.00036467967,0.0011162714,0.000007558293,0.000023594403,0.012403969,0.02720748,0.0009934403,0.014863931,0.00042133778],"about_ca_topic_score_codex":0.0000754968,"about_ca_topic_score_gemma":0.000004275702,"teacher_disagreement_score":0.041065127,"about_ca_system_score_codex":0.000030223597,"about_ca_system_score_gemma":0.00009933688,"threshold_uncertainty_score":0.9998758},"labels":[],"label_agreement":null},{"id":"W2742972753","doi":"10.1007/s40262-017-0576-7","title":"Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; U.S. Food and Drug Administration; National Institutes of Health","keywords":"Ontogeny; Glycoprotein; Sigmoid function; Biology; Endocrinology; Physiology; Internal medicine; Medicine; Biochemistry; Computer science; Artificial intelligence","score_opus":0.0853104017071708,"score_gpt":0.44299663334826295,"score_spread":0.35768623164109214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742972753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745864,0.00037441324,0.0004329175,0.00013262405,0.00015449703,0.0012839326,0.000013764093,0.000012677805,0.00013651636],"genre_scores_gemma":[0.9974189,0.00023048349,0.0017576397,0.000040770454,0.00032533458,0.000087311724,0.000092110306,0.000024032806,0.000023432145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788564,0.000354043,0.0006391564,0.00045456603,0.0003936463,0.0002729551],"domain_scores_gemma":[0.99844295,0.000034658282,0.00045607728,0.000497256,0.000395052,0.00017401011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023725599,0.00016283871,0.0002307879,0.00012841143,0.00016565464,0.00008668536,0.00025879976,0.0002278797,0.000034456792],"category_scores_gemma":[0.0031006928,0.00016195285,0.00005276325,0.00011493419,0.00015425254,0.000032382526,0.00018795324,0.00028496564,0.000004057874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012417127,0.00025004367,0.04960907,0.00016151277,0.000014993374,0.0000031199454,0.000024537165,0.000088117034,0.9016617,0.000009812101,0.000028982326,0.04690639],"study_design_scores_gemma":[0.010341669,0.002713774,0.38412267,0.00006865611,0.000110552755,0.000007256424,0.000031351323,0.081928566,0.51970494,0.0002297998,0.00026614947,0.00047461147],"about_ca_topic_score_codex":0.00007271505,"about_ca_topic_score_gemma":0.00008511694,"teacher_disagreement_score":0.38195676,"about_ca_system_score_codex":0.000025107802,"about_ca_system_score_gemma":0.0002537508,"threshold_uncertainty_score":0.6604246},"labels":[],"label_agreement":null},{"id":"W2752699676","doi":"10.1007/s40262-017-0593-6","title":"Population Pharmacokinetics of Mycophenolic Acid: An Update","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Pharmacokinetics; Population; Pharmacology; Mycophenolic acid; Population pharmacokinetics; NONMEM; Medicine; Physiologically based pharmacokinetic modelling; Pharmacodynamics; Transplantation; Internal medicine","score_opus":0.3131514110980119,"score_gpt":0.5575333696247633,"score_spread":0.24438195852675137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752699676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004480298,0.9946018,0.00006891832,0.000049061495,0.0016236674,0.0014304507,0.00048494607,0.00008536786,0.0012077701],"genre_scores_gemma":[0.0027204491,0.99074197,0.001629775,0.00026459945,0.0010629026,0.000038319835,0.0028349713,0.00013913112,0.00056789094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955107,0.0003363074,0.0025435367,0.00070045504,0.00051918195,0.00038979345],"domain_scores_gemma":[0.9961364,0.0002851134,0.0017101421,0.00110254,0.00020336482,0.00056241115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050864945,0.00065583957,0.0035487951,0.00024019027,0.00010197734,0.000042984528,0.00053192826,0.0005246949,0.00044530744],"category_scores_gemma":[0.00013623848,0.0005014184,0.0013158481,0.00018954912,0.00021417388,0.00011851502,0.000084686144,0.00087800523,0.00019204435],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013575511,0.000845157,0.0014181692,0.017690277,0.001144393,0.00015375132,0.000010744702,0.0000022813326,0.0000040812715,0.000042919342,0.0002913172,0.9782612],"study_design_scores_gemma":[0.0041878712,0.000537711,0.002116469,0.009327738,0.015015528,0.00011678628,0.0000012512057,0.000083766194,0.000032157197,0.000056590416,0.9680728,0.00045138053],"about_ca_topic_score_codex":0.000013035522,"about_ca_topic_score_gemma":0.0000011852932,"teacher_disagreement_score":0.9778098,"about_ca_system_score_codex":0.000058694077,"about_ca_system_score_gemma":0.0002124683,"threshold_uncertainty_score":0.99974376},"labels":[],"label_agreement":null},{"id":"W2785346493","doi":"10.1007/s40262-017-0624-3","title":"Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Daclatasvir; Pharmacokinetics; Pharmacology; Medicine; CYP3A4; Internal medicine; Cytochrome P450; Hepatitis C virus; Virology; Virus; Metabolism; Ribavirin","score_opus":0.38943379905223147,"score_gpt":0.6186080784491947,"score_spread":0.22917427939696328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785346493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028335839,0.9864231,0.00003928096,0.00054450246,0.0022270356,0.0046736957,0.00064275594,0.00013520013,0.005286098],"genre_scores_gemma":[0.000008463243,0.98580325,0.0027600706,0.0041070106,0.005286674,0.00011694482,0.0005338258,0.00030894586,0.0010748204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.980704,0.0036049369,0.01090561,0.0021136506,0.0015986968,0.0010730936],"domain_scores_gemma":[0.9826337,0.009067313,0.0025947536,0.0022927837,0.0012634525,0.0021479619],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.010685754,0.0012092161,0.009959081,0.00036193134,0.00008885921,0.000041874766,0.0012305595,0.0017380952,0.002597032],"category_scores_gemma":[0.01603802,0.00096209196,0.0036318195,0.0010955351,0.003453784,0.00009331147,0.0015221287,0.005408166,0.0009136098],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011839716,0.0010380421,0.0007437257,0.16345473,0.0013781281,0.00014998848,0.0000025821291,7.2906126e-9,2.2952608e-7,0.000008776957,0.15885408,0.6742513],"study_design_scores_gemma":[0.0028979555,0.0019030342,0.000114111215,0.14589924,0.0148953535,0.00011720118,7.4166184e-7,0.00011074851,0.000002218917,0.000016965592,0.83339864,0.00064380874],"about_ca_topic_score_codex":0.0000056317626,"about_ca_topic_score_gemma":0.0000013310946,"teacher_disagreement_score":0.6745446,"about_ca_system_score_codex":0.000105707106,"about_ca_system_score_gemma":0.0019977808,"threshold_uncertainty_score":0.9998643},"labels":[],"label_agreement":null},{"id":"W2797029234","doi":"10.1007/s40262-018-0657-2","title":"Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre for Addiction and Mental Health; University of Waterloo; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Escitalopram; Breast milk; Breastfeeding; Pharmacokinetics; Physiologically based pharmacokinetic modelling; Population; Medicine; Pharmacology; Breast feeding; Physiology; Chemistry; Internal medicine; Pediatrics; Environmental health; Antidepressant","score_opus":0.045954309247078426,"score_gpt":0.42121145345235644,"score_spread":0.375257144205278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797029234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927738,0.00020250672,0.00010797044,0.0027225341,0.0004872363,0.0005138447,0.000008711591,0.00012032897,0.0030631076],"genre_scores_gemma":[0.99130756,0.00020570807,0.0035983613,0.0035114624,0.0011610498,0.000022166478,0.0000037780683,0.00002494546,0.00016496531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980285,0.000089422894,0.0008920723,0.00039205013,0.0002154226,0.0003824933],"domain_scores_gemma":[0.99880034,0.0003273192,0.00010068056,0.00018846855,0.00010713469,0.000476077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090382097,0.00017830997,0.00039088138,0.00013835011,0.000071093295,0.000028936412,0.000109639426,0.0001464463,0.00008540087],"category_scores_gemma":[0.00079718494,0.0001532036,0.000056976478,0.00025633146,0.00020128698,0.000078225654,0.00017429849,0.0005955455,0.00002350508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008380723,0.00021062058,0.92304015,0.00048680563,0.000021575666,0.000058497822,0.0002491876,5.814211e-7,0.0010781266,0.000051482897,0.00020293002,0.07376194],"study_design_scores_gemma":[0.0022703907,0.0032844038,0.9635123,0.0074579534,0.00010666649,0.0001693049,0.00008462746,0.005721298,0.013292677,0.00012591218,0.0036601245,0.00031433097],"about_ca_topic_score_codex":0.000024878906,"about_ca_topic_score_gemma":0.000012711675,"teacher_disagreement_score":0.07344761,"about_ca_system_score_codex":0.000040552575,"about_ca_system_score_gemma":0.000041722302,"threshold_uncertainty_score":0.62474614},"labels":[],"label_agreement":null},{"id":"W2806025779","doi":"10.1007/s40262-018-0681-2","title":"The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Pharmacokinetics; Pharmacology; Cytochrome P450; Drug; Drug development; Drug metabolism; Medicine; Physiologically based pharmacokinetic modelling; Pharmacotherapy; Glucuronosyltransferase; Bioinformatics; Computational biology; Enzyme; Biology; Metabolism; Internal medicine; Biochemistry; Microsome","score_opus":0.47038958596848207,"score_gpt":0.5852079668511639,"score_spread":0.11481838088268187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806025779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012819422,0.9691257,0.015972724,0.0011767577,0.0072306646,0.0049262955,0.00119722,0.000119818236,0.00012262959],"genre_scores_gemma":[0.00042112928,0.9775055,0.011157834,0.0022821177,0.006299563,0.0015629871,0.00047844986,0.00016886106,0.00012357792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99130696,0.002281568,0.0036726105,0.0013972211,0.00034416752,0.0009974984],"domain_scores_gemma":[0.98675704,0.008757123,0.0017351111,0.00073210895,0.0015589104,0.0004597242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038558617,0.0011369562,0.0028296702,0.00014579708,0.00093757967,0.00005532639,0.0012806078,0.0010528042,0.00007946798],"category_scores_gemma":[0.0006180213,0.0007986346,0.0012892004,0.00054515136,0.0016698814,0.000103273924,0.0003147917,0.0021435176,0.000026556881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005018909,0.00063507183,0.0000062013373,0.0089100525,0.0022469847,0.0000032307191,0.00015352847,0.0010245523,0.00023060532,0.0013181394,0.0184084,0.9665613],"study_design_scores_gemma":[0.0028162745,0.0003203789,7.9854124e-7,0.0006964975,0.007748816,0.000005526586,0.00007469183,0.02900228,0.001743343,0.0016043563,0.9552077,0.0007793035],"about_ca_topic_score_codex":0.0000026485213,"about_ca_topic_score_gemma":0.0000019118638,"teacher_disagreement_score":0.96578205,"about_ca_system_score_codex":0.000076444245,"about_ca_system_score_gemma":0.0004538099,"threshold_uncertainty_score":0.99944645},"labels":[],"label_agreement":null},{"id":"W2808895967","doi":"10.1007/s40262-018-0688-8","title":"Author’s Reply to Woillard et al.: “Population Pharmacokinetics of Mycophenolic Acid: an Update”","year":2018,"lang":"en","type":"letter","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia; University of Alberta","funders":"","keywords":"Population pharmacokinetics; Mycophenolic acid; Pharmacokinetics; Medicine; Pharmacology; Pharmacotherapy; Internal medicine","score_opus":0.10171230293460967,"score_gpt":0.4614130572809739,"score_spread":0.3597007543463643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808895967","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0894749,0.00038125305,0.0007205271,0.89912254,0.0051168585,0.002259659,0.0011470993,0.00029447203,0.0014827164],"genre_scores_gemma":[0.0402816,0.001893729,0.007942723,0.9381563,0.0041607926,0.00004618626,0.0053137024,0.0002310412,0.0019739226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940232,0.00052443513,0.0024562245,0.0011752927,0.0011642784,0.00065657066],"domain_scores_gemma":[0.99629885,0.00041508226,0.0008505401,0.0011650204,0.00060931436,0.0006612229],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008573926,0.0007530288,0.0015971651,0.000385474,0.000076359,0.00005253486,0.00049050123,0.0006950234,0.0010358465],"category_scores_gemma":[0.00023404826,0.0006565171,0.0006322425,0.00047172885,0.00021779696,0.00011499039,0.00012031043,0.002087345,0.00040841624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076705375,0.0005613036,0.010025285,0.00059566245,0.00083955826,0.0005599693,0.00009295546,0.00004584425,0.00065664906,0.000009292959,0.9804713,0.005375128],"study_design_scores_gemma":[0.005044845,0.001759672,0.014714745,0.0005914461,0.0023289714,0.00008352552,0.0000046484674,0.0003269806,0.0025478594,0.00010209948,0.9719087,0.00058653177],"about_ca_topic_score_codex":0.00004531456,"about_ca_topic_score_gemma":0.0000024999529,"teacher_disagreement_score":0.049193304,"about_ca_system_score_codex":0.00009299955,"about_ca_system_score_gemma":0.00016204908,"threshold_uncertainty_score":0.99987733},"labels":[],"label_agreement":null},{"id":"W2886208449","doi":"10.1007/s40262-018-0705-y","title":"Clinical Pharmacokinetics and Pharmacodynamics of Ceftazidime–Avibactam Combination: A Model-Informed Strategy for its Clinical Development","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Ceftazidime/avibactam; Avibactam; Ceftazidime; Population; Pharmacodynamics; Pharmacokinetics; Volume of distribution; Medicine; Pharmacology; Chemistry; Biology; Pseudomonas aeruginosa","score_opus":0.18508382199510282,"score_gpt":0.5016614182682003,"score_spread":0.3165775962730975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886208449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020494541,0.96033806,0.0066246525,0.00005170506,0.005517269,0.0049663987,0.0010684757,0.000089260146,0.00084963226],"genre_scores_gemma":[0.0034118686,0.97569823,0.0143193,0.00040204052,0.0028098463,0.00010782918,0.0016714147,0.00026377608,0.0013156915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9875873,0.000905554,0.008086764,0.0019263384,0.00054174935,0.00095232413],"domain_scores_gemma":[0.9919105,0.0016681427,0.0033849822,0.0010426434,0.0011647737,0.00082896766],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0041837385,0.0012525462,0.003844569,0.00017641264,0.00017892057,0.000088394234,0.0014597308,0.002056393,0.00006720482],"category_scores_gemma":[0.0016303883,0.0011579328,0.0018439867,0.00030185113,0.0015840498,0.00002457024,0.00089822273,0.00130549,0.000036636822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010515408,0.0024160575,0.0010024606,0.015857752,0.0031356704,0.000012882711,0.000019749465,0.0000434879,0.00012449558,0.00011776381,0.042281505,0.93393666],"study_design_scores_gemma":[0.005613778,0.0015789317,0.00016965589,0.0018568991,0.0030711782,0.000022640736,0.000008104638,0.007003956,0.00031128502,0.000049411177,0.979031,0.0012831454],"about_ca_topic_score_codex":3.4493456e-7,"about_ca_topic_score_gemma":0.0000030532988,"teacher_disagreement_score":0.9367495,"about_ca_system_score_codex":0.00006686921,"about_ca_system_score_gemma":0.0025864937,"threshold_uncertainty_score":0.99923915},"labels":[],"label_agreement":null},{"id":"W2904048219","doi":"10.1007/s40262-018-0722-x","title":"Correction to: Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children","year":2018,"lang":"en","type":"erratum","venue":"Clinical Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Posaconazole; Pharmacokinetics; Medicine; Pharmacotherapy; Medical physics; License; Intensive care medicine; Pediatrics; Pharmacology; Computer science; Internal medicine; Itraconazole; Antifungal; Dermatology","score_opus":0.14139106963709672,"score_gpt":0.5155674114102744,"score_spread":0.3741763417731777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904048219","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2349155,0.037889898,0.00077941327,0.14391409,0.51593274,0.020250961,0.0032869668,0.0006961867,0.04233423],"genre_scores_gemma":[0.08222266,0.6226812,0.012548922,0.09966019,0.076733105,0.00066180417,0.0032841733,0.000654762,0.10155322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99478745,0.0004520968,0.002369078,0.0012924699,0.00036636548,0.00073251704],"domain_scores_gemma":[0.9931066,0.004333742,0.00062552304,0.00040949127,0.00041601397,0.001108616],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002555407,0.0006324614,0.001559114,0.00024210352,0.00022134364,0.000100107514,0.00027032918,0.0007551316,0.0003970326],"category_scores_gemma":[0.0043515665,0.00058783405,0.0003192861,0.00038930343,0.0006169614,0.00012812953,0.00059396384,0.0033027455,0.000055478416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017567078,0.0007226343,0.031563856,0.00014248201,0.0004732061,0.000012313181,0.000052185747,7.23647e-7,0.000015664009,0.0000037704535,0.79565203,0.16960442],"study_design_scores_gemma":[0.008433149,0.0017571548,0.11470548,0.00050053035,0.0017694491,0.000056155804,0.0000227861,0.0041844016,0.00003334861,0.00008070735,0.8679013,0.000555484],"about_ca_topic_score_codex":0.0000453795,"about_ca_topic_score_gemma":0.00004554432,"teacher_disagreement_score":0.5847913,"about_ca_system_score_codex":0.00007024348,"about_ca_system_score_gemma":0.00023535172,"threshold_uncertainty_score":0.99965733},"labels":[],"label_agreement":null},{"id":"W2918993549","doi":"10.1007/s40262-019-00745-5","title":"Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"University of Illinois at Chicago; Ministry of Education, Culture, Sports, Science and Technology; University of Chicago","keywords":"Warfarin; Pharmacodynamics; CYP2C9; Medicine; VKORC1; Internal medicine; Dosing; Population; Pharmacokinetics; Cohort; Creatinine; Demography; Atrial fibrillation","score_opus":0.18952589734530464,"score_gpt":0.48143453915943135,"score_spread":0.2919086418141267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918993549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901251,0.0014180475,0.00008322182,0.00036706106,0.0055403435,0.0009762179,0.00018162212,0.000070922506,0.0012374381],"genre_scores_gemma":[0.995933,0.0020843756,0.0002762673,0.0007314254,0.00046894644,0.00003531535,0.000024943789,0.000051846873,0.00039386694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99528325,0.0013707002,0.0016771643,0.0006726635,0.00035854813,0.00063767115],"domain_scores_gemma":[0.9966861,0.0018025396,0.00049577525,0.0003369798,0.00015971942,0.00051890814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029405279,0.00041694538,0.0008852647,0.00033126536,0.00010102919,0.00002315046,0.0005538188,0.0005046285,0.0011325666],"category_scores_gemma":[0.0003987911,0.0004052089,0.00022777623,0.0005085855,0.00078053627,0.00016023371,0.00035862683,0.0015852399,0.00005718432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024597135,0.0007310451,0.95960104,0.000069492104,0.00017460094,0.000022170156,0.0003706079,0.0008169305,0.022915859,0.00031889367,0.00039026173,0.012129384],"study_design_scores_gemma":[0.0072520142,0.00023921777,0.90827453,0.000031968088,0.00037651355,0.00000476254,0.000046179877,0.06290625,0.0039467774,0.0007285014,0.015749542,0.00044371767],"about_ca_topic_score_codex":0.000029208259,"about_ca_topic_score_gemma":0.00004766062,"teacher_disagreement_score":0.06208932,"about_ca_system_score_codex":0.00003777514,"about_ca_system_score_gemma":0.00013293434,"threshold_uncertainty_score":0.99983996},"labels":[],"label_agreement":null},{"id":"W2944551098","doi":"10.1007/s40262-019-00771-3","title":"Population Pharmacokinetics of Mycophenolic Acid Co-Administered with Tacrolimus in Corticosteroid-Free Adult Kidney Transplant Patients","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Vancouver Coastal Health Research Institute; F. Hoffmann-La Roche","keywords":"Tacrolimus; Mycophenolic acid; Medicine; Population pharmacokinetics; Pharmacokinetics; Corticosteroid; Pharmacotherapy; Pharmacology; Kidney transplantation; Population; Kidney transplant; Urology; Kidney; Internal medicine; Transplantation","score_opus":0.03083618280051274,"score_gpt":0.36257030260954565,"score_spread":0.3317341198090329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944551098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576986,0.000052882177,0.000066120534,0.00030806707,0.00050513766,0.0012642678,0.0004699477,0.00004248637,0.0015212552],"genre_scores_gemma":[0.9948118,0.00074087956,0.0008863573,0.0022838884,0.000090978385,0.000021131318,0.0009049442,0.00005816633,0.00020186418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969909,0.00012712642,0.0014329454,0.0004753141,0.00058936083,0.00038433445],"domain_scores_gemma":[0.998203,0.00021021347,0.0004042611,0.0004985343,0.00023648533,0.00044753618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016344535,0.00033670367,0.00084681046,0.00017084234,0.000025183508,0.000014435326,0.0002315615,0.00016023277,0.000310543],"category_scores_gemma":[0.00008458894,0.00026244004,0.00020214634,0.0002898688,0.00010654034,0.00009284879,0.00002636232,0.0003986568,0.000065686494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004924764,0.001792494,0.9865492,0.0007277408,0.0002647003,0.00009782553,0.00016981238,0.00005310191,0.0026730986,0.000019719528,0.00016315137,0.0025643888],"study_design_scores_gemma":[0.05076763,0.002686301,0.9334396,0.00087889767,0.00075596134,0.000030567207,0.000013974687,0.0008088103,0.009751781,0.00003031349,0.00053874,0.0002973947],"about_ca_topic_score_codex":0.000027521948,"about_ca_topic_score_gemma":0.000007136322,"teacher_disagreement_score":0.053109575,"about_ca_system_score_codex":0.000052765303,"about_ca_system_score_gemma":0.000086930115,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2963706042","doi":"10.1007/s40262-019-00802-z","title":"Exposure-Toxicity Relationships of Mycophenolic Acid in Adult Kidney Transplant Patients","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Mycophenolic acid; Toxicity; Adverse effect; Medicine; Mycophenolate; Therapeutic drug monitoring; Pharmacology; Transplantation; Internal medicine; Drug","score_opus":0.16312142743651983,"score_gpt":0.4367971145881044,"score_spread":0.2736756871515845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963706042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008239775,0.9821971,0.000054682874,0.00008434746,0.0016176811,0.0035278571,0.0017774949,0.00005878779,0.0024422621],"genre_scores_gemma":[0.019897493,0.9769661,0.0003709518,0.00036666365,0.00014751032,0.00004499594,0.0018316802,0.000070651404,0.00030398893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99552864,0.0004923751,0.0026714834,0.0005379148,0.00045256512,0.0003169945],"domain_scores_gemma":[0.99732804,0.0008916852,0.0007159733,0.000463842,0.00018745642,0.0004129994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037887448,0.00048265577,0.0027186424,0.00026380274,0.000028481283,0.000008111463,0.00023471042,0.0005697671,0.00015747029],"category_scores_gemma":[0.00037298133,0.00035988662,0.0009813914,0.0004269785,0.00010780895,0.000048728005,0.00002621225,0.0012640617,0.0002096997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062084437,0.0048822383,0.386943,0.100433655,0.0016873361,0.00017130075,0.00018044084,0.000005370655,0.0000046056107,0.000106794796,0.0006278747,0.50433654],"study_design_scores_gemma":[0.040649038,0.0028881265,0.10500094,0.14377917,0.02621918,0.00008324696,0.000011411023,0.00008594169,0.00010135372,0.00006589801,0.6795749,0.0015407469],"about_ca_topic_score_codex":0.000005234961,"about_ca_topic_score_gemma":0.000001908351,"teacher_disagreement_score":0.6789471,"about_ca_system_score_codex":0.000079843805,"about_ca_system_score_gemma":0.00035427252,"threshold_uncertainty_score":0.9998853},"labels":[],"label_agreement":null},{"id":"W2965773521","doi":"10.1007/s40262-019-00807-8","title":"Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Lymphoma; Medicine; Pharmacodynamics; Pharmacokinetics; Rituximab; Concomitant; Hodgkin lymphoma; Monoclonal antibody; Oncology; Drug; Mantle cell lymphoma; Pharmacology; Internal medicine; Immunology; Antibody","score_opus":0.17407227704052403,"score_gpt":0.5115206867791848,"score_spread":0.3374484097386608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965773521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004770722,0.98309624,0.000013606447,0.0002890338,0.0024876306,0.0042260806,0.00018188298,0.00012501127,0.004809777],"genre_scores_gemma":[0.0048831957,0.9882278,0.0014332017,0.0018849492,0.001616407,0.00036998012,0.00032648144,0.00021673864,0.0010412517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905151,0.0010916193,0.005155855,0.0018456848,0.00051154546,0.0008801568],"domain_scores_gemma":[0.9902583,0.006592185,0.0011763345,0.00088370685,0.00017807577,0.0009114378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001687865,0.0012275198,0.0060095983,0.00050855736,0.00011431986,0.00009485533,0.0002869889,0.00095610885,0.0006166811],"category_scores_gemma":[0.00071570405,0.0009987699,0.0017770558,0.000580855,0.0005342831,0.00010859523,0.00038178326,0.0013428346,0.00057791336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007996134,0.0029679202,0.013152794,0.007320986,0.0012195985,0.0010934776,0.000021957683,0.0000043413274,0.0000016406409,0.000032720098,0.0042110286,0.9698936],"study_design_scores_gemma":[0.021014415,0.00087339134,0.007249779,0.010289385,0.014600939,0.0005896009,0.000009213448,0.0020031277,0.0000043351624,0.000028432278,0.94239354,0.00094384345],"about_ca_topic_score_codex":0.000025905552,"about_ca_topic_score_gemma":0.0000056753493,"teacher_disagreement_score":0.96894974,"about_ca_system_score_codex":0.00037146552,"about_ca_system_score_gemma":0.00129173,"threshold_uncertainty_score":0.9992463},"labels":[],"label_agreement":null},{"id":"W2969690755","doi":"10.1007/s40262-019-00809-6","title":"Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Waterloo","funders":"","keywords":"Covariate; Medicine; Population; Bayesian probability; Pharmacokinetics; NONMEM; Statistics; Oncology; Internal medicine; Mathematics","score_opus":0.10386284929754308,"score_gpt":0.4192405470228734,"score_spread":0.3153776977253303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969690755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566627,0.00017103877,0.00011175301,0.0014022716,0.00033597986,0.0020441022,0.000028480183,0.000023335235,0.00021675145],"genre_scores_gemma":[0.99200124,0.0002221084,0.0049106963,0.0002860387,0.00009061083,0.000059352817,0.00014548298,0.00004086789,0.0022436269],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728304,0.00008253408,0.0013147575,0.0004381618,0.00060104387,0.00028045062],"domain_scores_gemma":[0.9981597,0.00040282277,0.0004498315,0.00043637966,0.00030990632,0.00024134111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075235823,0.00022969581,0.0005582121,0.0001281319,0.000061302824,0.000009032602,0.00017051473,0.00016284848,0.000059310816],"category_scores_gemma":[0.00044193774,0.00015643756,0.00021435338,0.0002713426,0.0002120864,0.00004656238,0.000119755474,0.00032363544,0.000008909555],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035586385,0.003782725,0.821593,0.002944213,0.0011767216,0.00007506417,0.0013200258,0.0024276518,0.103877954,0.0003491336,0.0047232523,0.054171637],"study_design_scores_gemma":[0.025633955,0.002155844,0.24239784,0.0011148613,0.0016998353,0.0001213129,0.0000986458,0.18994857,0.51909196,0.0011682352,0.015766533,0.00080236467],"about_ca_topic_score_codex":0.0000038133053,"about_ca_topic_score_gemma":0.0000010330347,"teacher_disagreement_score":0.57919514,"about_ca_system_score_codex":0.000053812346,"about_ca_system_score_gemma":0.00024815655,"threshold_uncertainty_score":0.63793385},"labels":[],"label_agreement":null},{"id":"W2972004072","doi":"10.1007/s40262-019-00817-6","title":"Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ottawa Hospital","funders":"Kidney Foundation of Canada","keywords":"Vancomycin; Dosing; Medicine; Pharmacokinetics; Population; Dialysis; Therapeutic drug monitoring; Pharmacodynamics; Context (archaeology); Renal replacement therapy; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.017857962478946623,"score_gpt":0.36064554506753793,"score_spread":0.3427875825885913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972004072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892953,0.00033669148,0.00041067807,0.0026548614,0.0019327247,0.001736785,0.000036148245,0.00021276293,0.0033840209],"genre_scores_gemma":[0.9893004,0.0017861414,0.0014869515,0.0047398037,0.0011217918,0.000012591988,0.00016411037,0.00014604122,0.0012422192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99410045,0.00027727903,0.0024061017,0.0012288336,0.0007843096,0.0012030451],"domain_scores_gemma":[0.99620515,0.0006583814,0.0003541935,0.00082680734,0.0011400392,0.0008154344],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009712642,0.0006287066,0.001308256,0.0005271348,0.00010347119,0.00006565398,0.00048327932,0.00037834368,0.0015196798],"category_scores_gemma":[0.001458119,0.00061558106,0.00057737174,0.0012191168,0.00024552323,0.0001566538,0.00032100632,0.0014602124,0.00043930754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063677044,0.008301555,0.8868267,0.0022714525,0.00044396782,0.00084697705,0.00032135827,0.00531082,0.05057747,0.00042342744,0.0028042356,0.03550432],"study_design_scores_gemma":[0.03587445,0.0010348004,0.8090202,0.00075265486,0.0009510927,0.00006055006,0.00019934608,0.13312033,0.0097362995,0.00016865593,0.0077300738,0.0013515566],"about_ca_topic_score_codex":0.000032436365,"about_ca_topic_score_gemma":0.0000051501984,"teacher_disagreement_score":0.12780951,"about_ca_system_score_codex":0.00019632543,"about_ca_system_score_gemma":0.00013460785,"threshold_uncertainty_score":0.99962956},"labels":[],"label_agreement":null},{"id":"W2990779432","doi":"10.1007/s40262-019-00832-7","title":"Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Bayer","keywords":"Pharmacokinetics; Medicine; Population; Bay; Volume of distribution; Pharmacology","score_opus":0.14523148684190526,"score_gpt":0.4073626813025908,"score_spread":0.26213119446068556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990779432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904385,0.00078846293,0.000501294,0.0003259166,0.0022934447,0.003276965,0.0001552273,0.00017746381,0.0020426833],"genre_scores_gemma":[0.984839,0.0013672484,0.009100987,0.0005070568,0.0011472654,0.00005558767,0.00070863776,0.00019056193,0.002083614],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9927717,0.000578582,0.0026354906,0.0012512389,0.0014917449,0.0012712802],"domain_scores_gemma":[0.9959579,0.0006157314,0.0008900579,0.0008459726,0.0006147976,0.0010755488],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015443413,0.00076535397,0.0018690852,0.0005121588,0.000183336,0.000086984786,0.0005996161,0.00048020607,0.0017881629],"category_scores_gemma":[0.000555002,0.00065122615,0.00063451484,0.0009662965,0.00032894453,0.00027523233,0.00039612036,0.0016105394,0.0001629228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003967281,0.009801812,0.8138319,0.004176445,0.0021407548,0.00020136574,0.00029315305,0.0028727946,0.119553946,0.000110275105,0.0014790446,0.04157121],"study_design_scores_gemma":[0.044984978,0.004989201,0.31701258,0.0012435481,0.0057251533,0.00025577613,0.00035196697,0.55000615,0.06395772,0.00020200456,0.008753087,0.0025178492],"about_ca_topic_score_codex":0.00004117267,"about_ca_topic_score_gemma":4.1963676e-7,"teacher_disagreement_score":0.5471334,"about_ca_system_score_codex":0.00020487195,"about_ca_system_score_gemma":0.00052387576,"threshold_uncertainty_score":0.9995939},"labels":[],"label_agreement":null},{"id":"W3004945196","doi":"10.1007/s40262-020-00866-2","title":"An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In Adults","year":2020,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Vancomycin; Pharmacokinetics; Dosing; Population; Medicine; Volume of distribution; Intensive care medicine; Pharmacology; Biology","score_opus":0.18300050021748707,"score_gpt":0.5292915664520057,"score_spread":0.34629106623451866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004945196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018904889,0.99332714,0.000039986357,0.00015391655,0.0012843574,0.002242666,0.0003216268,0.000110064546,0.0006297705],"genre_scores_gemma":[0.0109895365,0.9847064,0.00069263077,0.0009969291,0.0015085044,0.000047919573,0.00084675476,0.00016588815,0.00004543549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930251,0.0007920071,0.003916846,0.0011552966,0.00059811655,0.00051261066],"domain_scores_gemma":[0.9959808,0.0008436377,0.001502282,0.0008779271,0.00021046563,0.0005848601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006107903,0.00079171226,0.004561258,0.00044927717,0.000032117103,0.000018430981,0.00057290494,0.0005624565,0.0004426706],"category_scores_gemma":[0.0006775021,0.0006704776,0.0012391579,0.0012269024,0.00025559976,0.00007454624,0.000115603405,0.00184963,0.00015709251],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010943922,0.001366345,0.00077293173,0.01659446,0.00038395202,0.00033562348,0.000013661728,0.00006829657,0.000028643686,0.000019622654,0.005654996,0.9736671],"study_design_scores_gemma":[0.003405862,0.0009648116,0.00079159223,0.023701474,0.004043822,0.000011412548,0.0000053131694,0.00051544886,0.000100927384,0.000019210689,0.9658545,0.0005856218],"about_ca_topic_score_codex":0.000018432658,"about_ca_topic_score_gemma":0.000006066502,"teacher_disagreement_score":0.97308147,"about_ca_system_score_codex":0.00014871966,"about_ca_system_score_gemma":0.00029495326,"threshold_uncertainty_score":0.99957466},"labels":[],"label_agreement":null},{"id":"W3016616745","doi":"10.1007/s40262-020-00888-w","title":"Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Astellas Pharma","keywords":"Pharmacokinetics; Pharmacology; Chemistry; Medicine","score_opus":0.11511771043150763,"score_gpt":0.4183749330103149,"score_spread":0.3032572225788073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016616745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96196264,0.0010442844,0.0023176917,0.022873202,0.0010087275,0.0023790512,0.00045906618,0.00037427113,0.0075810635],"genre_scores_gemma":[0.9727931,0.0007603891,0.0107659185,0.011256709,0.0033808225,0.000052992673,0.00012372986,0.00013518574,0.00073115755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958437,0.00016948013,0.0017341494,0.00078973285,0.0007966581,0.00066626014],"domain_scores_gemma":[0.99674857,0.00053865626,0.0003367455,0.0005202808,0.00058527803,0.0012704986],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006588439,0.0003985757,0.0010576699,0.00012964619,0.000057380777,0.000023528106,0.00049512985,0.00024973846,0.002254609],"category_scores_gemma":[0.0017719856,0.00036220677,0.00045256058,0.00084694475,0.0006733862,0.00009379428,0.00047409846,0.0014018912,0.00038555212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034356455,0.0018841542,0.0059789554,0.0010405121,0.00030591266,0.0003123257,0.00015049233,0.00003175346,0.8355325,0.000074304975,0.12157589,0.029677544],"study_design_scores_gemma":[0.037512597,0.0044923048,0.012054281,0.0003749477,0.001151968,0.0001159735,0.00009333976,0.050239697,0.58913493,0.000030636074,0.3039742,0.0008251022],"about_ca_topic_score_codex":0.0000064007504,"about_ca_topic_score_gemma":1.7113838e-7,"teacher_disagreement_score":0.24639757,"about_ca_system_score_codex":0.000075980395,"about_ca_system_score_gemma":0.00043786882,"threshold_uncertainty_score":0.999883},"labels":[],"label_agreement":null},{"id":"W3027472977","doi":"10.1007/s40262-020-00905-y","title":"Comment on: “An Extension of Janmahasatian’s Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities”","year":2020,"lang":"en","type":"letter","venue":"Clinical Pharmacokinetics","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Extension (predicate logic); Fat free mass; Ethnic group; Mathematics; Computer science; Sociology; Fat mass; Medicine; Anthropology; Body mass index; Programming language; Internal medicine","score_opus":0.23582571544418485,"score_gpt":0.45361702611239585,"score_spread":0.217791310668211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027472977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026781317,0.00004123377,0.32430413,0.66845936,0.00039406918,0.002661827,0.0011610801,0.00017725892,0.00012290265],"genre_scores_gemma":[0.3161217,0.00018136347,0.03133616,0.6470457,0.0020022434,0.000110470515,0.0029832742,0.00011500791,0.00010411611],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9964941,0.00021470188,0.0015789112,0.00062123523,0.0007911039,0.00029992367],"domain_scores_gemma":[0.9966027,0.00040450812,0.00091565447,0.0011959533,0.000691966,0.00018921863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033374742,0.00039625439,0.0011037436,0.00011111093,0.000068572845,0.000009876294,0.0005537606,0.0006243796,0.000023954746],"category_scores_gemma":[0.00020573605,0.00037222845,0.00050907163,0.0001278361,0.00028285114,0.000041807314,0.00013553251,0.0015379533,0.0000020448324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008975331,0.0008695139,0.00015420195,0.00067005376,0.00015723729,0.000011073781,0.000121605,0.0003378665,0.02069377,0.0005789404,0.973077,0.0024311764],"study_design_scores_gemma":[0.015351943,0.00884511,0.0013512388,0.0014794127,0.0035970097,0.0000045683823,0.00007974528,0.73583156,0.04693608,0.023843234,0.16145743,0.0012226856],"about_ca_topic_score_codex":0.0000050715666,"about_ca_topic_score_gemma":0.0000010027366,"teacher_disagreement_score":0.8116196,"about_ca_system_score_codex":0.00013925883,"about_ca_system_score_gemma":0.00007251666,"threshold_uncertainty_score":0.999873},"labels":[],"label_agreement":null},{"id":"W3028663891","doi":"10.1007/s40262-020-00898-8","title":"Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors: An Updated Review","year":2020,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Dolutegravir; Raltegravir; Pharmacology; Elvitegravir; Pharmacokinetics; Pharmacodynamics; Integrase; Integrase inhibitor; Medicine; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","score_opus":0.15606513772846373,"score_gpt":0.4919753380905803,"score_spread":0.3359102003621166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028663891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005355756,0.98975724,0.00020199931,0.0013850156,0.0011366123,0.0050013354,0.00117719,0.00018137218,0.0006236731],"genre_scores_gemma":[0.00037818894,0.9888216,0.0017793734,0.0017517925,0.0014430402,0.00010553145,0.0047427244,0.00021199984,0.0007657459],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9878874,0.0018385018,0.0069873785,0.0017387051,0.0008414094,0.0007066131],"domain_scores_gemma":[0.99438936,0.0012654418,0.001084471,0.00076248194,0.0005381815,0.0019600873],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0018827022,0.0015828119,0.009600187,0.00027759623,0.00009162834,0.000044119734,0.00062368327,0.0007993762,0.001002945],"category_scores_gemma":[0.00021880797,0.0012166321,0.0020409895,0.0009940413,0.0011366142,0.0001534539,0.0002497736,0.0033952896,0.00018550524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006022214,0.0037276328,0.00032105684,0.037678257,0.0059406953,0.0006143641,0.00014529051,8.4763946e-7,0.000011192462,0.000022842285,0.099843495,0.8510921],"study_design_scores_gemma":[0.008189309,0.0008934268,0.000020171052,0.023670906,0.03810016,0.00013142875,0.00002594925,0.0007732112,0.00005618956,0.000007799655,0.9271698,0.00096167583],"about_ca_topic_score_codex":0.0000014742307,"about_ca_topic_score_gemma":0.0000014957577,"teacher_disagreement_score":0.85013044,"about_ca_system_score_codex":0.000113235925,"about_ca_system_score_gemma":0.0011035198,"threshold_uncertainty_score":0.9999103},"labels":[],"label_agreement":null},{"id":"W3124028658","doi":"10.1007/s40262-020-00970-3","title":"Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Université de Montréal","keywords":"Pharmacokinetics; Medicine; Cystic fibrosis; Antibiotics; Volume of distribution; Population; Linezolid; Internal medicine; Therapeutic drug monitoring; Pharmacology; Vancomycin; Biology; Microbiology","score_opus":0.14510540710034442,"score_gpt":0.5453029225007553,"score_spread":0.4001975154004109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124028658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018611968,0.9955868,0.00004545266,0.00008969255,0.00069899077,0.0027198212,0.00039039782,0.000047861307,0.0002348448],"genre_scores_gemma":[0.0002618719,0.99042606,0.0044096014,0.0006642654,0.0004649804,0.000025555128,0.0034894266,0.00014183547,0.000116398616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902983,0.0013943166,0.0052579604,0.0010858995,0.0012906444,0.0006728958],"domain_scores_gemma":[0.9923606,0.0031333095,0.0016202211,0.0010097735,0.0013446106,0.0005314745],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010843236,0.00078467844,0.00640099,0.00056888117,0.00003457216,0.000024856561,0.000509736,0.00044239976,0.00069953984],"category_scores_gemma":[0.013421531,0.0006451265,0.0018642846,0.0024128538,0.0003140712,0.00009508533,0.0003655916,0.0016540163,0.00006113734],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070535025,0.0013443717,0.0013492113,0.31768322,0.00040884863,0.0000833044,0.0000028209345,0.000007102546,0.000010087774,0.0000056236736,0.005284367,0.6737505],"study_design_scores_gemma":[0.002354521,0.0005238367,0.0014777897,0.3937029,0.007950485,0.000023189074,0.0000026283199,0.00023405238,0.000023314347,0.0000063290286,0.5931993,0.0005016356],"about_ca_topic_score_codex":0.000025532501,"about_ca_topic_score_gemma":0.0000022759218,"teacher_disagreement_score":0.6732489,"about_ca_system_score_codex":0.0002525289,"about_ca_system_score_gemma":0.00051057397,"threshold_uncertainty_score":0.9996},"labels":[],"label_agreement":null},{"id":"W3132426811","doi":"10.1007/s40262-020-00956-1","title":"Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of British Columbia","funders":"Universitair Medisch Centrum Groningen; Novo Nordisk Fonden; AstraZeneca","keywords":"Dapagliflozin; Renal function; Medicine; Kidney disease; Diabetes mellitus; Urology; Pharmacokinetics; Confidence interval; Internal medicine; Type 2 diabetes; Proteinuria; Creatinine; Volume of distribution; Endocrinology; Kidney","score_opus":0.052089754498444794,"score_gpt":0.36596830066246133,"score_spread":0.31387854616401656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132426811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962605,0.0015940483,0.000004919121,0.0009098,0.000157364,0.0008520737,0.000030718755,0.000008835693,0.0001817426],"genre_scores_gemma":[0.9987671,0.00033258484,0.00020607488,0.00041779768,0.000048499875,0.000029167926,0.00003497086,0.000019219116,0.00014462801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977608,0.0006344425,0.00056928344,0.00027815654,0.0005916672,0.00016566734],"domain_scores_gemma":[0.9983806,0.00045189704,0.00021627496,0.00030199898,0.0004216,0.00022762171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013775019,0.00015014347,0.0003330289,0.000071776594,0.000027837676,0.000008672153,0.00006710868,0.000049387767,0.00005313789],"category_scores_gemma":[0.0017722356,0.000105564475,0.000063266794,0.00026758778,0.0003042215,0.000049947277,0.00012467561,0.00018017569,7.9081696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084952347,0.0008577999,0.98323476,0.00023526969,0.00019987342,0.0000026852551,0.00005708261,0.0001029288,0.00072633656,0.00001960399,0.00033185573,0.013382258],"study_design_scores_gemma":[0.01672092,0.0005944496,0.97016704,0.00034317834,0.0029900104,2.2828652e-7,0.00001245023,0.0052878847,0.0029713959,0.0001163951,0.00069469464,0.00010134334],"about_ca_topic_score_codex":8.356475e-7,"about_ca_topic_score_gemma":0.0000021442577,"teacher_disagreement_score":0.015871398,"about_ca_system_score_codex":0.00005252295,"about_ca_system_score_gemma":0.000340426,"threshold_uncertainty_score":0.43047944},"labels":[],"label_agreement":null},{"id":"W3133740787","doi":"10.1007/s40262-020-00983-y","title":"The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McGill University; Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; Pfizer","keywords":"Medicine; Tolerability; Renal function; Pharmacokinetics; Cmax; Urology; Dosing; Adverse effect; Internal medicine; Kidney disease","score_opus":0.01753290672712802,"score_gpt":0.3691539646569015,"score_spread":0.35162105792977344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133740787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959729,0.00046274552,0.000033500637,0.00167124,0.00027981825,0.0009611666,0.00004697136,0.000012607778,0.0005590811],"genre_scores_gemma":[0.9970482,0.0017046618,0.000115599134,0.0008722884,0.0001146876,0.000037564645,0.00001883679,0.000028451306,0.000059729053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742836,0.00046471847,0.0010436254,0.00030160058,0.00049830886,0.00026339342],"domain_scores_gemma":[0.9963896,0.0024300695,0.0003916467,0.0004094294,0.00024286077,0.00013636114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010107146,0.00021305098,0.00057562115,0.000040038638,0.00006369049,0.000007839565,0.00014947465,0.0000642883,0.00009838241],"category_scores_gemma":[0.00036916157,0.00011255625,0.00012975848,0.00030816157,0.000605208,0.000024186134,0.00008590895,0.00054824736,0.000002260907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06849856,0.0032250502,0.79229164,0.0005806716,0.0010148551,0.00010282204,0.00030846018,0.0036734978,0.025209041,0.0002523846,0.00642623,0.09841679],"study_design_scores_gemma":[0.050788663,0.012501857,0.509327,0.0011255485,0.0004443861,0.000012013661,0.0000472059,0.0012954231,0.4141425,0.0000951692,0.009934693,0.00028556032],"about_ca_topic_score_codex":0.0000010782952,"about_ca_topic_score_gemma":0.0000011368006,"teacher_disagreement_score":0.38893345,"about_ca_system_score_codex":0.000048858623,"about_ca_system_score_gemma":0.00010415512,"threshold_uncertainty_score":0.45899105},"labels":[],"label_agreement":null},{"id":"W3152798658","doi":"10.1007/s40262-021-01013-1","title":"Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Université de Montréal","keywords":"Piperacillin; Piperacillin/tazobactam; Medicine; Tazobactam; Volume of distribution; Population; Intensive care unit; Dosing; Intensive care medicine; Pharmacokinetics; Intensive care; Pharmacology; Biology","score_opus":0.34170525116520595,"score_gpt":0.5795854406689658,"score_spread":0.23788018950375983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152798658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003499081,0.9940732,0.000023093338,0.00019888805,0.0015260702,0.0026664487,0.00028597118,0.000069336005,0.0008070806],"genre_scores_gemma":[0.0016392901,0.9884991,0.00039569417,0.0036744466,0.0009843839,0.00003611826,0.0043431125,0.00021874109,0.00020912508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99034864,0.001109759,0.005614009,0.001312114,0.00088836235,0.00072711596],"domain_scores_gemma":[0.9907506,0.0013387778,0.0018647051,0.0011375354,0.0042908806,0.0006174986],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009632301,0.0011270217,0.0077558826,0.0006881549,0.000051114086,0.000028391161,0.0005974192,0.00070807425,0.000903367],"category_scores_gemma":[0.0043061837,0.00095642713,0.0021229153,0.0032884309,0.00032319152,0.000066596,0.0004220072,0.0025929916,0.000068937465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005807715,0.00040964203,0.0002978258,0.23913471,0.0009251551,0.00049042335,0.00006495688,0.000022478242,0.000014063811,0.000011450044,0.010035709,0.7485355],"study_design_scores_gemma":[0.0022163908,0.0002582114,0.00014976444,0.23800188,0.014946481,0.00011113538,0.0001038889,0.00018024478,0.000035606008,0.0000020425884,0.7433233,0.00067101436],"about_ca_topic_score_codex":0.00002819421,"about_ca_topic_score_gemma":0.000002013761,"teacher_disagreement_score":0.7478645,"about_ca_system_score_codex":0.00023846408,"about_ca_system_score_gemma":0.0009766127,"threshold_uncertainty_score":0.99970806},"labels":[],"label_agreement":null},{"id":"W3157642871","doi":"10.1007/s40262-021-01016-y","title":"Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; Nuclear export signal; Pharmacology; Population; Concomitant; Cancer research; Volume of distribution; Biology; Medicine; Internal medicine; Cytoplasm; Cell nucleus; Cell biology","score_opus":0.04763893100028567,"score_gpt":0.38458304286342015,"score_spread":0.3369441118631345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157642871","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018069213,0.9941058,0.000020138652,0.00009423183,0.0018872344,0.0007735529,0.00013400667,0.000013561875,0.0011645524],"genre_scores_gemma":[0.005184652,0.9919485,0.00025299515,0.00043007522,0.0016995805,0.0000182927,0.00019134306,0.000118617965,0.00015597712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962613,0.00039452544,0.0020243418,0.0006847906,0.00030631092,0.00032873236],"domain_scores_gemma":[0.99753076,0.000249429,0.0010417221,0.00071127136,0.0003528376,0.00011395277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006709761,0.00047507707,0.0016524324,0.00009730525,0.000047675927,0.000013720892,0.00061100046,0.0006853729,0.0001365336],"category_scores_gemma":[0.00036137737,0.00035542608,0.00101686,0.00049257796,0.00039016086,0.0000038661296,0.0004105199,0.0009239362,0.0000111165255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030323706,0.0010350572,0.000344581,0.0075321994,0.0017414396,0.00004214494,0.00008901545,0.000081578604,0.0022822553,0.00010505524,0.1655685,0.8208749],"study_design_scores_gemma":[0.0008442035,0.00039297692,0.000057256995,0.0009961135,0.0011321696,0.000026069314,0.0000199867,0.00006167741,0.0010896404,0.000009333414,0.99504036,0.0003302231],"about_ca_topic_score_codex":0.0000037130355,"about_ca_topic_score_gemma":0.0000046229748,"teacher_disagreement_score":0.8294718,"about_ca_system_score_codex":0.00002651356,"about_ca_system_score_gemma":0.00028352282,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null},{"id":"W3161390137","doi":"10.1007/s40262-021-01027-9","title":"Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Dosing; Vancomycin; Observational study; Population; Renal function; Creatinine; MEDLINE; Pharmacokinetics; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.09495922480879287,"score_gpt":0.4483391402349466,"score_spread":0.3533799154261537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161390137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057255646,0.9908035,0.000079841004,0.00003582223,0.00089741603,0.0075442167,0.00015884299,0.000050560553,0.0003725786],"genre_scores_gemma":[0.0003436752,0.9965035,0.0005851609,0.0008332788,0.0003494064,0.00027687082,0.00074993435,0.00016618075,0.0001920016],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9886712,0.0016368063,0.00736554,0.00095461664,0.0008227753,0.00054907054],"domain_scores_gemma":[0.99313134,0.0018900248,0.0028766603,0.0010858726,0.0006664678,0.00034961588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017369724,0.0008312289,0.010645622,0.0004809037,0.000026629894,0.00001572754,0.00053131214,0.0005742449,0.0001841018],"category_scores_gemma":[0.0030012932,0.0006839848,0.0022837974,0.0020106633,0.00014668617,0.000094718416,0.00027186077,0.0016183988,0.000045695935],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025455567,0.0010547498,0.0002205577,0.900537,0.00037239687,0.00008501737,0.000005691794,0.000015993224,2.4740484e-7,0.000015661291,0.0041498085,0.09351741],"study_design_scores_gemma":[0.0023127475,0.0001714879,0.000052161588,0.89504254,0.024662383,0.000018605811,0.0000025023778,0.00024090585,8.6610754e-7,0.000025521995,0.076864414,0.0006058418],"about_ca_topic_score_codex":0.0000074246545,"about_ca_topic_score_gemma":0.0000019026622,"teacher_disagreement_score":0.09291157,"about_ca_system_score_codex":0.00029235912,"about_ca_system_score_gemma":0.00046370173,"threshold_uncertainty_score":0.99956113},"labels":[],"label_agreement":null},{"id":"W3164015288","doi":"10.1007/s40262-021-01034-w","title":"Thoroughly Validated Bayesian Estimator and Limited Sampling Strategy for Dose Individualization of Ganciclovir and Valganciclovir in Pediatric Transplant Recipients","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Valganciclovir; Ganciclovir; Statistics; Standard deviation; Estimator; Medicine; Mean squared error; Sampling (signal processing); Bayesian probability; Standard error; Internal medicine; Mathematics; Computer science","score_opus":0.1594833193919147,"score_gpt":0.45629053761875865,"score_spread":0.29680721822684397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164015288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993104,0.0019722607,0.003398872,0.00035936385,0.00014985379,0.000687854,0.00016561711,0.000027672295,0.00013454417],"genre_scores_gemma":[0.9834199,0.01023246,0.005515513,0.0002719874,0.00024874427,0.000020413849,0.00018786472,0.000040356485,0.000062772386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766636,0.0001681023,0.0010079369,0.0004917674,0.00031585587,0.00034997205],"domain_scores_gemma":[0.9980864,0.00093095086,0.00016204678,0.00020554932,0.00028746043,0.00032761812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009694521,0.00019547192,0.00058016175,0.00019595072,0.00005905521,0.000038912163,0.000085231186,0.00022127839,0.000056871573],"category_scores_gemma":[0.0006705542,0.00018655257,0.00009603276,0.0005877961,0.00013287674,0.00008055311,0.000067051755,0.00040797543,0.0000019071828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018456288,0.001139285,0.9270179,0.0011224508,0.00013091363,0.00011815903,0.00032701774,0.00014267764,0.013259393,0.0001756991,0.0003836894,0.054337133],"study_design_scores_gemma":[0.013152346,0.000782502,0.9540568,0.000244032,0.0006405517,0.000047620764,0.000056832472,0.018233463,0.009157186,0.00038368718,0.00292009,0.00032488475],"about_ca_topic_score_codex":0.000012417606,"about_ca_topic_score_gemma":0.00001513644,"teacher_disagreement_score":0.054012246,"about_ca_system_score_codex":0.00002093698,"about_ca_system_score_gemma":0.00025013037,"threshold_uncertainty_score":0.76073927},"labels":[],"label_agreement":null},{"id":"W3171593200","doi":"10.1007/s40262-021-01047-5","title":"Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Phenylacetic acid; Medicine; Adverse effect; Urea cycle; Internal medicine; Hepatic encephalopathy; Gastroenterology; Pharmacokinetics; Encephalopathy; Pharmacology; Renal function; Hyperammonemia; Fractional excretion of sodium; Endocrinology; Cirrhosis; Chemistry; Arginine","score_opus":0.03546143010461324,"score_gpt":0.3685889158129184,"score_spread":0.3331274857083052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171593200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968429,0.0007822927,0.001563989,0.00028452463,0.00013078284,0.00023603268,0.000058523347,0.00002058438,0.00008034799],"genre_scores_gemma":[0.99709725,0.0016815321,0.00060485717,0.00018567726,0.000094758296,0.0000062095646,0.00015891307,0.00001490066,0.00015592483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894387,0.00008150987,0.0004050915,0.00024191666,0.00019402837,0.00013360499],"domain_scores_gemma":[0.9992355,0.0001752201,0.00011280864,0.00013930518,0.00014493265,0.00019221823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106359636,0.00012429335,0.00028201882,0.000023445544,0.00005029641,0.000004366442,0.000025241268,0.00006792866,0.000063387815],"category_scores_gemma":[0.00003815705,0.0000988068,0.000056494504,0.000098699566,0.00014737005,0.00006144825,0.000029785364,0.0001546415,0.000002310624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073522446,0.00040047377,0.9897772,0.00028317168,0.00026511328,0.000040849718,0.00039675637,0.00004833904,0.0052206432,0.000039087958,0.00002847953,0.002764664],"study_design_scores_gemma":[0.0070612035,0.00030751695,0.981277,0.00015638242,0.001435473,0.00003948256,0.0001799505,0.0021556085,0.007136549,0.00008048285,0.00006120399,0.000109174674],"about_ca_topic_score_codex":0.0000031072866,"about_ca_topic_score_gemma":0.0000093802,"teacher_disagreement_score":0.008500225,"about_ca_system_score_codex":0.000008487943,"about_ca_system_score_gemma":0.000035556248,"threshold_uncertainty_score":0.40292245},"labels":[],"label_agreement":null},{"id":"W3174954811","doi":"10.1007/s40262-021-01046-6","title":"Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Minority Health and Health Disparities; National Institute of Allergy and Infectious Diseases; National Institute on Alcohol Abuse and Alcoholism; U.S. Food and Drug Administration; National Institute of General Medical Sciences; American Foundation for Pharmaceutical Education","keywords":"Meropenem; Physiologically based pharmacokinetic modelling; Dosing; Pharmacokinetics; Medicine; Population; Pharmacology; Antibiotics; Biology; Microbiology","score_opus":0.08503266443552253,"score_gpt":0.4117128196927645,"score_spread":0.326680155257242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174954811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372286,0.0014896368,0.0008729359,0.0007561119,0.0003693403,0.0004813276,0.000023423268,0.000047054826,0.0022373106],"genre_scores_gemma":[0.98840547,0.0040311855,0.0045265625,0.0025659332,0.0002648923,0.00000590488,0.000046537276,0.000050442653,0.00010308787],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99679637,0.00022705432,0.001448065,0.0006984851,0.00036643806,0.00046359835],"domain_scores_gemma":[0.9981619,0.00041979513,0.0002243709,0.00043113646,0.00034944303,0.00041332596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005758361,0.0003281044,0.0009318475,0.00014013822,0.000039458057,0.000022181244,0.00020687723,0.00020515472,0.00041573786],"category_scores_gemma":[0.00045686567,0.00029411007,0.0002506228,0.00042259548,0.0003207138,0.000054304674,0.00026000757,0.00073139614,0.0000117278605],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031810484,0.005510308,0.2356708,0.0015216913,0.0005169761,0.0012523622,0.00015639627,0.0198518,0.6566887,0.00012918415,0.00095455756,0.07456615],"study_design_scores_gemma":[0.014845833,0.00062679494,0.18005821,0.0005280946,0.0007038689,0.000047803198,0.000020438054,0.75744474,0.043922767,0.00013688183,0.0011797945,0.00048474988],"about_ca_topic_score_codex":0.0000039328374,"about_ca_topic_score_gemma":9.727439e-7,"teacher_disagreement_score":0.73759294,"about_ca_system_score_codex":0.00002170247,"about_ca_system_score_gemma":0.00020120366,"threshold_uncertainty_score":0.9999511},"labels":[],"label_agreement":null},{"id":"W3203265145","doi":"10.1007/s40262-021-01072-4","title":"Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development; University of North Carolina at Chapel Hill; Duke Clinical Research Institute; National Institute of General Medical Sciences; Penn State College of Medicine; Wichita Medical Research and Education Foundation; Texas Christian University; American Foundation for Pharmaceutical Education; Pennsylvania State University; University of Louisville; Health Science Center, University of North Texas; University of Pennsylvania; Children's Hospital of Philadelphia","keywords":"Pharmacokinetics; Population; Dosing; Clindamycin; Medicine; Obesity; Volume of distribution; Trimethoprim; Pharmacology; Sulfamethoxazole; Internal medicine; Antibiotics; Chemistry; Environmental health","score_opus":0.12479444056124293,"score_gpt":0.4197282748783461,"score_spread":0.2949338343171031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203265145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870032,0.00029646402,0.011386773,0.00013076453,0.000111309426,0.00095109246,0.00002686625,0.000022373173,0.0000711404],"genre_scores_gemma":[0.9692206,0.00016980346,0.029835062,0.00030710656,0.00015505016,0.000012090151,0.0002564968,0.000029162553,0.00001465893],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976241,0.00014987314,0.0010046175,0.00043192698,0.0005699867,0.00021952491],"domain_scores_gemma":[0.9978303,0.00023805747,0.00032119648,0.00021705,0.0012073388,0.00018606591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011048417,0.00020908362,0.00059889565,0.00007502046,0.00005257167,0.000007715967,0.00008960047,0.00011537922,0.000072947034],"category_scores_gemma":[0.00032611305,0.00017267447,0.00014459065,0.00021446416,0.0001414865,0.000031284762,0.0000674857,0.00021306571,8.405558e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005711752,0.00854577,0.2941117,0.0011695873,0.0019123646,0.000013606104,0.00023991888,0.18437132,0.22620235,0.00037662344,0.00032143347,0.27702355],"study_design_scores_gemma":[0.011574783,0.0006215444,0.25865945,0.00016053143,0.0017557585,0.000008182441,0.00001686414,0.6617396,0.06512436,0.00005309357,0.00008816839,0.0001976627],"about_ca_topic_score_codex":0.0000028476034,"about_ca_topic_score_gemma":9.875952e-7,"teacher_disagreement_score":0.47736827,"about_ca_system_score_codex":0.00002686356,"about_ca_system_score_gemma":0.00032992498,"threshold_uncertainty_score":0.704146},"labels":[],"label_agreement":null},{"id":"W3205056750","doi":"10.1007/s40262-021-01050-w","title":"An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","keywords":"Vancomycin; Pharmacokinetics; Medicine; Population; Volume of distribution; Therapeutic drug monitoring; Renal function; Interquartile range; Intensive care medicine; Internal medicine; Biology","score_opus":0.1711546406325141,"score_gpt":0.520506627416482,"score_spread":0.34935198678396795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205056750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04282723,0.952549,0.000009457647,0.0000350939,0.002041835,0.0018040078,0.00028677168,0.000065429485,0.0003811928],"genre_scores_gemma":[0.0150301205,0.98018426,0.00046565395,0.0005091841,0.0015520195,0.00004437917,0.0019561735,0.00015136936,0.00010686811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926169,0.000924473,0.004037463,0.0011312461,0.0007271419,0.00056277384],"domain_scores_gemma":[0.9956215,0.00080948975,0.001672516,0.0009909706,0.00045210362,0.0004534226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073452113,0.00077004515,0.0042462726,0.0006637194,0.00006102218,0.000020913189,0.0004915538,0.00060476863,0.0004885039],"category_scores_gemma":[0.0008370466,0.00067052885,0.00127325,0.0016122811,0.00015770106,0.00008321991,0.00019744805,0.0016096587,0.000051986906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002949787,0.0061321366,0.02805869,0.01413045,0.00040674774,0.00014751033,0.000013111181,0.00013007714,0.000009026366,0.000012516263,0.013198377,0.9374664],"study_design_scores_gemma":[0.0047006398,0.0012519928,0.013209793,0.010136325,0.010439326,0.000004158264,0.000003213264,0.00010710464,0.00004863258,0.000013182314,0.959224,0.00086166005],"about_ca_topic_score_codex":0.000008358127,"about_ca_topic_score_gemma":0.000003908948,"teacher_disagreement_score":0.9460256,"about_ca_system_score_codex":0.00016967974,"about_ca_system_score_gemma":0.00036268137,"threshold_uncertainty_score":0.9995746},"labels":[],"label_agreement":null},{"id":"W3213170615","doi":"10.1007/s40262-021-01075-1","title":"Population Pharmacokinetic Analysis to Assist Dose Selection of the l-Ornithine Salt of Phenylacetic Acid","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Phenylacetic acid; Hepatic encephalopathy; Population; Medicine; Pharmacokinetics; Cirrhosis; Pharmacology; Gastroenterology; Internal medicine; Endocrinology; Chemistry; Biochemistry","score_opus":0.022781168796576056,"score_gpt":0.36372316424518,"score_spread":0.34094199544860393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213170615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299824,0.0010919798,0.0038740956,0.00046000557,0.00072510605,0.00026206244,0.000060234237,0.000009074914,0.00051922293],"genre_scores_gemma":[0.9953799,0.00058826705,0.0019134881,0.0010376667,0.00029167446,0.000011123098,0.00012427867,0.00002461446,0.0006289881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759114,0.000405586,0.0009713822,0.00046372102,0.00033470386,0.0002334564],"domain_scores_gemma":[0.9984801,0.000058070837,0.0003629154,0.0005390322,0.00042334863,0.00013654066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050461566,0.00019733331,0.00047213843,0.00008905859,0.000054359196,0.000011830961,0.00034865225,0.00014789663,0.00035586927],"category_scores_gemma":[0.0005986113,0.00016501002,0.0004995521,0.0012637477,0.00013566905,0.00000333444,0.00024307796,0.00017834984,0.0000063127964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024249594,0.00059290254,0.251627,0.00007117896,0.0010261501,0.0000010091588,0.00003422358,0.008736502,0.7152264,0.000033003504,0.004509686,0.017899442],"study_design_scores_gemma":[0.0013439441,0.0001227336,0.45553282,0.000011997725,0.0017084201,0.0000026200205,0.00001659078,0.0010129719,0.5252909,0.00007065076,0.014691326,0.00019501409],"about_ca_topic_score_codex":0.000016248627,"about_ca_topic_score_gemma":0.000049636234,"teacher_disagreement_score":0.20390584,"about_ca_system_score_codex":0.0000045433612,"about_ca_system_score_gemma":0.000102370905,"threshold_uncertainty_score":0.6728913},"labels":[],"label_agreement":null},{"id":"W3214830958","doi":"10.1007/s40262-021-01085-z","title":"Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development","keywords":"Pharmacokinetics; Renal replacement therapy; Medicine; Current (fluid); Intensive care medicine; Pharmacology; Engineering","score_opus":0.09726544620092836,"score_gpt":0.47280531129273345,"score_spread":0.3755398650918051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214830958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029396385,0.9902146,0.0000866631,0.00021199595,0.0009007607,0.007627796,0.00044714805,0.000051126666,0.00016594047],"genre_scores_gemma":[0.00064324413,0.995445,0.0004782083,0.0006201791,0.00061883335,0.00012884421,0.0017489038,0.00018100564,0.00013577037],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9864537,0.0020128628,0.008462716,0.0011191171,0.0013021457,0.0006494371],"domain_scores_gemma":[0.99029696,0.0019567315,0.004336407,0.0017452504,0.0011107825,0.00055386993],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0038377936,0.001066084,0.010006248,0.0005695148,0.00004815209,0.00003452989,0.0010081923,0.00057689945,0.00036542604],"category_scores_gemma":[0.0019411107,0.0008356293,0.0023611458,0.002109079,0.00046754742,0.00005010281,0.00042988264,0.0028849128,0.000015747955],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007294297,0.003324292,0.00069766876,0.87494874,0.0027608369,0.000053828364,0.00007695466,0.0000019853771,0.000024056051,0.00004035538,0.007521499,0.110476844],"study_design_scores_gemma":[0.0042615524,0.00042156334,0.000114234484,0.8007057,0.016667603,0.0001667436,0.0000055800924,0.000082731,0.00006819437,0.0000040970035,0.17693156,0.0005704957],"about_ca_topic_score_codex":0.000003038697,"about_ca_topic_score_gemma":3.37958e-7,"teacher_disagreement_score":0.16941006,"about_ca_system_score_codex":0.00012668008,"about_ca_system_score_gemma":0.0010462081,"threshold_uncertainty_score":0.99941546},"labels":[],"label_agreement":null},{"id":"W325467568","doi":"10.2165/00003088-200039040-00007","title":"The Authors?? Reply","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Case Reports on Hematomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacotherapy; Intensive care medicine; Medicine; Internal medicine","score_opus":0.06736476604610528,"score_gpt":0.4457189541299193,"score_spread":0.37835418808381405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W325467568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8852559,0.0015831409,0.00003312323,0.022522109,0.0015278932,0.00069302693,0.0000056732283,0.00032637257,0.08805278],"genre_scores_gemma":[0.9024126,0.0055130376,0.0008392052,0.013027043,0.0023207222,0.000025904123,0.000011957819,0.00006786834,0.075781666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978405,0.000104403836,0.0010203406,0.00033760665,0.00037332813,0.00032380162],"domain_scores_gemma":[0.99783885,0.0007720422,0.00012518767,0.00072932563,0.00012020565,0.00041439667],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012327436,0.0001484206,0.00032083836,0.000021598178,0.00013452109,0.000032091404,0.00013776781,0.000099784585,0.0033182532],"category_scores_gemma":[0.0007818261,0.00009559371,0.00029790177,0.00018946156,0.00032751865,0.000026974141,0.00004288231,0.0006033562,0.00082302815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006126732,0.0005046184,0.011609814,0.000035925816,0.00017323048,0.0014056147,0.00003066057,0.000007058418,0.00036556594,0.00019194456,0.42088783,0.56417507],"study_design_scores_gemma":[0.0013110529,0.00018275033,0.015994499,0.00002918451,0.00021624248,0.0007528925,0.0000072560365,0.00091437384,0.0007801306,0.00029828594,0.9793979,0.00011544171],"about_ca_topic_score_codex":0.00000409071,"about_ca_topic_score_gemma":6.9661075e-7,"teacher_disagreement_score":0.5640596,"about_ca_system_score_codex":0.000024728904,"about_ca_system_score_gemma":0.0001096096,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W4210255115","doi":"10.1007/s40262-022-01107-4","title":"A Scoping Review of the Clinical Pharmacokinetics of Bedaquiline","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Bedaquiline; Medicine; Tuberculosis; Dosing; Pharmacokinetics; Drug; Intensive care medicine; Pharmacology; Pharmacotherapy; Mycobacterium tuberculosis; Drug resistance; Demographics; Internal medicine; Pathology; Biology","score_opus":0.4066103404580077,"score_gpt":0.6118421131518271,"score_spread":0.20523177269381943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210255115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029593362,0.9886202,0.0000133874755,0.0014928819,0.0025460727,0.005366326,0.00027999585,0.000040341787,0.0016112035],"genre_scores_gemma":[0.000008968544,0.9900351,0.000533404,0.006789234,0.0017204781,0.00019408562,0.00023283093,0.00013551903,0.00035038643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9808668,0.0061868634,0.009909344,0.0010488558,0.0012100202,0.00077814236],"domain_scores_gemma":[0.97968847,0.01317874,0.003842579,0.00206904,0.00048540323,0.0007357949],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011028451,0.00071383925,0.008960884,0.00020545707,0.000082873856,0.000005287682,0.0016430245,0.000633716,0.0050018416],"category_scores_gemma":[0.022551227,0.00045532687,0.0056034946,0.0013172898,0.0015527257,0.00003044441,0.0017595949,0.0047268993,0.00005283685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008988912,0.0009114155,0.00040311055,0.3611331,0.0009060673,0.000028846624,0.0000023427676,9.882864e-7,0.0000016817456,0.000011588819,0.058637116,0.5778739],"study_design_scores_gemma":[0.0013169047,0.0006560697,0.00005351752,0.276234,0.0069184774,0.00007500519,0.000001454658,0.00004511475,0.000005894976,0.000009079286,0.71443814,0.00024631148],"about_ca_topic_score_codex":0.0000066224547,"about_ca_topic_score_gemma":9.918933e-7,"teacher_disagreement_score":0.65580106,"about_ca_system_score_codex":0.00009225889,"about_ca_system_score_gemma":0.002532883,"threshold_uncertainty_score":0.99978983},"labels":[],"label_agreement":null},{"id":"W4220788072","doi":"10.1007/s40262-022-01118-1","title":"Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Dosing; Piperacillin; Medicine; Nomogram; Population; Pharmacokinetics; Intensive care medicine; Intensive care; Piperacillin/tazobactam; Pharmacodynamics; Pharmacology; Internal medicine","score_opus":0.12337187482512263,"score_gpt":0.4499413502026235,"score_spread":0.32656947537750086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220788072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8324749,0.00007892643,0.15807135,0.002611828,0.001522091,0.0035828352,0.0014419878,0.000095943265,0.000120135235],"genre_scores_gemma":[0.91690564,0.0001881107,0.07495485,0.0056844135,0.00037143542,0.00008647769,0.0014667502,0.00011240597,0.00022991252],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99618024,0.00018534176,0.0019672643,0.0006184237,0.00050578447,0.00054292934],"domain_scores_gemma":[0.9947607,0.000839605,0.00057441165,0.00033771596,0.0031467078,0.0003408875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087598275,0.0003374622,0.00081371213,0.00023248422,0.0003998426,0.000027284545,0.0002656177,0.00013602867,0.00014218687],"category_scores_gemma":[0.0018781512,0.00035766786,0.0005211341,0.00036614452,0.00014107248,0.000083310624,0.00023964784,0.0005256215,0.0000018837887],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017904317,0.028911198,0.08985799,0.0032899636,0.0018385715,0.000019393125,0.001252644,0.35674062,0.22447278,0.003973061,0.085627176,0.18611228],"study_design_scores_gemma":[0.016822157,0.0012200724,0.0018623468,0.00009733867,0.0015296121,0.0000064592755,0.000055259927,0.965356,0.0031773276,0.00044606256,0.0090415,0.00038584913],"about_ca_topic_score_codex":0.000011901929,"about_ca_topic_score_gemma":4.0675667e-7,"teacher_disagreement_score":0.6086154,"about_ca_system_score_codex":0.00012584541,"about_ca_system_score_gemma":0.0001359058,"threshold_uncertainty_score":0.9998875},"labels":[],"label_agreement":null},{"id":"W4225824162","doi":"10.1007/s40262-021-01092-0","title":"Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Mount Sinai Hospital; Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Tocilizumab; Dosing; Medicine; Pharmacodynamics; Pharmacokinetics; Pharmacology; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Internal medicine; Disease","score_opus":0.2582153043745333,"score_gpt":0.5585727688912274,"score_spread":0.3003574645166941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225824162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002964549,0.99002683,0.00023837235,0.00019386972,0.0009606497,0.002251986,0.0002646012,0.00007492515,0.0030242442],"genre_scores_gemma":[0.008278674,0.98226005,0.000615398,0.007888722,0.0005571797,0.0001344577,0.00009430438,0.00014081718,0.000030385048],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911704,0.0013304047,0.0046765427,0.0010904286,0.0010026724,0.000729526],"domain_scores_gemma":[0.99206746,0.004731411,0.0013379601,0.00088856433,0.00062983704,0.00034478688],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018752586,0.0007858175,0.00481362,0.0008434752,0.00006538316,0.00007267883,0.0005945089,0.0006191285,0.0005114488],"category_scores_gemma":[0.0023965354,0.0007207393,0.0016125825,0.0012849548,0.0010140908,0.00014712663,0.0004514752,0.0023592305,0.000032383337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058254047,0.0036444715,0.00089016266,0.10004842,0.00275577,0.0034238896,0.00023135098,0.0001242299,0.004174165,0.0011689775,0.004137484,0.8788185],"study_design_scores_gemma":[0.0093232915,0.00042283372,0.000016220589,0.012286432,0.004048316,0.00035845162,0.00011534409,0.0014585807,0.0018231807,0.00039767803,0.96912414,0.0006255319],"about_ca_topic_score_codex":0.00013055488,"about_ca_topic_score_gemma":0.000022715807,"teacher_disagreement_score":0.9649867,"about_ca_system_score_codex":0.000357266,"about_ca_system_score_gemma":0.007871272,"threshold_uncertainty_score":0.99994236},"labels":[],"label_agreement":null},{"id":"W4229020407","doi":"10.1007/s40262-022-01121-6","title":"Determining the Effects of Chronic Kidney Disease on Organic Anion Transporter1/3 Activity Through Physiologically Based Pharmacokinetic Modeling","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Probenecid; Kidney disease; Organic anion transporter 1; Pharmacokinetics; Renal function; Pharmacology; Renal physiology; Medicine; Kidney; Renal blood flow; Furosemide; Internal medicine; Chemistry; Transporter; Biochemistry","score_opus":0.04074870510808417,"score_gpt":0.3466240286725328,"score_spread":0.30587532356444863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229020407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871535,0.00029622833,0.007820183,0.0013885397,0.0016400672,0.0013274179,0.000084800835,0.00012874886,0.00016051407],"genre_scores_gemma":[0.99225193,0.00054614095,0.0001997172,0.006063086,0.0005180225,0.00010696039,0.0001337242,0.00007301329,0.00010738698],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969409,0.00038307998,0.000826057,0.0006411543,0.0007409393,0.00046783136],"domain_scores_gemma":[0.9979937,0.00061035575,0.0002890243,0.0005597234,0.0001112962,0.00043590929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005320468,0.0003673119,0.0006951593,0.000061661645,0.00028229205,0.000009500676,0.00044226664,0.000076655226,0.00072134536],"category_scores_gemma":[0.0001793931,0.00025742166,0.00057820097,0.0003749028,0.00022224722,0.000052682775,0.000072939685,0.0011552006,0.000008037114],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018891176,0.019201115,0.012844298,0.00573281,0.0008651255,0.0011649509,0.00033208614,0.050725408,0.8392957,0.00016286655,0.00263797,0.048146486],"study_design_scores_gemma":[0.048043672,0.01279112,0.06731205,0.0013486804,0.0060109934,0.000010298367,0.000047529422,0.73623544,0.10909662,0.00073615334,0.016880766,0.00148671],"about_ca_topic_score_codex":0.0000017030097,"about_ca_topic_score_gemma":3.9217488e-7,"teacher_disagreement_score":0.7301991,"about_ca_system_score_codex":0.0001088927,"about_ca_system_score_gemma":0.00041276816,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W4236581453","doi":"10.2165/11634200-000000000-00000","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacokinetics; Population pharmacokinetics; Computer science; Medicine; Pharmacology","score_opus":0.37905310127943986,"score_gpt":0.5525052629288641,"score_spread":0.17345216164942429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236581453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694597,0.0076272166,0.002446949,0.00034778684,0.009206787,0.0007660503,0.00016083533,0.00016468042,0.0098199705],"genre_scores_gemma":[0.9843999,0.005298735,0.0025524208,0.004057415,0.0029114503,0.000041573592,0.0001042621,0.00009111922,0.00054310146],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99477416,0.0010766018,0.0020222492,0.0005062679,0.0005003336,0.0011204093],"domain_scores_gemma":[0.99642587,0.0010357774,0.00070299476,0.00041565174,0.00031124352,0.0011084877],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031847393,0.0004879242,0.0008409204,0.00022875103,0.00018815018,0.000018141116,0.0005997952,0.00045858434,0.003686406],"category_scores_gemma":[0.0002038168,0.00048376524,0.00048695673,0.00049967674,0.0004067739,0.000277649,0.00027220734,0.0013145746,0.0003182741],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015433109,0.0076767933,0.4010251,0.0004453419,0.001528008,0.00002426743,0.0010576914,0.08096462,0.15255274,0.0036089648,0.029616129,0.31995705],"study_design_scores_gemma":[0.008125225,0.0002125509,0.022338359,0.00004076256,0.001943446,0.000032713753,0.00008881704,0.11945528,0.11306572,0.0010027242,0.73257333,0.0011210599],"about_ca_topic_score_codex":0.000021994447,"about_ca_topic_score_gemma":3.9658448e-7,"teacher_disagreement_score":0.7029572,"about_ca_system_score_codex":0.000053407228,"about_ca_system_score_gemma":0.00004712787,"threshold_uncertainty_score":0.9997614},"labels":[],"label_agreement":null},{"id":"W4245167824","doi":"10.1007/s40262-019-00839-0","title":"Acknowledgement to Referees","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Lausanne; Université Paris Diderot; Università degli Studi di Udine; Radboud Universiteit; Università degli Studi di Pavia; Universiteit Utrecht; Rijksuniversiteit Groningen; University of Otago; Universiteit Leiden; Universität Heidelberg; University of Waterloo; Karolinska Institutet; University of South Carolina; King's College London; University of Alberta; University of Washington; Helsingin Yliopisto; East Tennessee State University; University of Southern California","keywords":"Pharmacotherapy; Acknowledgement; Medicine; Internal medicine; Computer science","score_opus":0.2598516706215862,"score_gpt":0.5568679580104303,"score_spread":0.2970162873888441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245167824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8801448,0.0011136545,0.00020824405,0.0023688858,0.016199945,0.0013255574,0.00009018487,0.00023450007,0.09831427],"genre_scores_gemma":[0.9511181,0.00183237,0.001314175,0.028659057,0.0024665298,0.000076455144,0.000030409135,0.00008951837,0.014413371],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584115,0.0007280347,0.0012428855,0.00087542983,0.00039029517,0.0009222023],"domain_scores_gemma":[0.9967552,0.0007825255,0.00021134752,0.00061936164,0.0003507229,0.0012808819],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0021742214,0.00043526207,0.00067850994,0.00019386147,0.00014089196,0.00004333848,0.00096820906,0.00040602777,0.019491924],"category_scores_gemma":[0.00031207944,0.00042529713,0.000343149,0.00051216036,0.00016894353,0.00008694102,0.0005774808,0.0014391531,0.026344469],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012876889,0.0023419233,0.084988974,0.00013543955,0.00076952827,0.00006283512,0.0004397203,0.0034209448,0.13207254,0.0026958415,0.3985791,0.37320548],"study_design_scores_gemma":[0.0038657065,0.00029005212,0.010063573,0.0000150459455,0.00027408006,0.000005005189,0.00003112438,0.00285043,0.02954258,0.0004676224,0.9520464,0.0005483616],"about_ca_topic_score_codex":0.0000024813428,"about_ca_topic_score_gemma":0.0000022737133,"teacher_disagreement_score":0.55346733,"about_ca_system_score_codex":0.000056102894,"about_ca_system_score_gemma":0.00011493242,"threshold_uncertainty_score":0.9998199},"labels":[],"label_agreement":null},{"id":"W4247852028","doi":"10.2165/11634080-000000000-00000","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Computer science; Usability; Population; Software; Context (archaeology); Variety (cybernetics); Data science; Risk analysis (engineering); Artificial intelligence; Medicine; Human–computer interaction; Biology","score_opus":0.9077627310124843,"score_gpt":0.7051695231200288,"score_spread":0.2025932078924555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247852028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016985472,0.9554203,0.03465593,0.000020241507,0.0056159175,0.002370764,0.00052411587,0.00017893821,0.001196795],"genre_scores_gemma":[0.00005284596,0.7303368,0.26613507,0.00010755526,0.0027526452,0.00008674423,0.000060042385,0.00023499156,0.00023329911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.983573,0.0045163305,0.009006326,0.0010402087,0.000977359,0.0008867279],"domain_scores_gemma":[0.90653527,0.08730275,0.0039990395,0.0011544361,0.00033382318,0.00067468366],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0091296015,0.0010401479,0.0072859363,0.00028411552,0.00007790951,0.000037766687,0.0011527186,0.001190355,0.0020107583],"category_scores_gemma":[0.019878281,0.00086326833,0.002544611,0.00067882746,0.0005040525,0.00009986925,0.0005312286,0.0020866562,0.000208625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004322931,0.00096473657,0.00001847271,0.023812026,0.00072098087,0.000007811625,0.000009380868,0.000023827539,5.503449e-7,0.0034122304,0.0023963081,0.96859044],"study_design_scores_gemma":[0.0012978602,0.00017009668,0.0000028616328,0.0063244146,0.016638463,0.000013445707,0.0000028773193,0.0011234215,0.0000067378332,0.10517152,0.86831796,0.0009303692],"about_ca_topic_score_codex":0.0000062787562,"about_ca_topic_score_gemma":1.8802426e-7,"teacher_disagreement_score":0.96766007,"about_ca_system_score_codex":0.00012762232,"about_ca_system_score_gemma":0.00012250197,"threshold_uncertainty_score":0.9993818},"labels":[],"label_agreement":null},{"id":"W4293561164","doi":"10.1007/s40262-022-01171-w","title":"Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Valproic Acid; Therapeutic drug monitoring; Internal medicine; Observational study; Clinical trial; Phenytoin; Pharmacology; Randomized controlled trial; Therapeutic index; Pharmacokinetics; Drug; Epilepsy; Psychiatry","score_opus":0.3780545239990777,"score_gpt":0.5462363506908153,"score_spread":0.16818182669173765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293561164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002699242,0.9832447,0.000027051121,0.00024243958,0.004559615,0.009861602,0.0003447379,0.0002386622,0.0014541661],"genre_scores_gemma":[0.00006575344,0.99190235,0.000628673,0.0023911863,0.0024863011,0.0012867529,0.00007405219,0.00022941953,0.0009355186],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98144734,0.004635483,0.0097724395,0.001608945,0.0015719255,0.00096388697],"domain_scores_gemma":[0.98280036,0.009745494,0.004040993,0.0020305035,0.00036298245,0.00101964],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.007958325,0.001418889,0.016350282,0.00031129146,0.00019304351,0.000025297972,0.002002767,0.00068393577,0.0023480754],"category_scores_gemma":[0.014404886,0.001004849,0.0060338546,0.001350397,0.0007710069,0.00007403538,0.0020423012,0.0050521567,0.00017318926],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058305923,0.0015371247,0.00006416897,0.7328199,0.0036111255,0.0003385235,0.0000064118162,2.962785e-7,0.000005714588,0.0000067745677,0.008000817,0.25355083],"study_design_scores_gemma":[0.0025915229,0.001210291,0.000029194634,0.34545553,0.06154936,0.00014056754,0.000006165553,0.000018440893,0.000014485723,0.000014150526,0.58832,0.0006502566],"about_ca_topic_score_codex":0.0000016252455,"about_ca_topic_score_gemma":6.6231664e-8,"teacher_disagreement_score":0.5803192,"about_ca_system_score_codex":0.00023860377,"about_ca_system_score_gemma":0.0006333648,"threshold_uncertainty_score":0.9998561},"labels":[],"label_agreement":null},{"id":"W4318946156","doi":"10.1007/s40262-023-01213-x","title":"Pharmacokinetic Alterations Associated with Critical Illness","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacokinetics; Intensive care medicine; Pharmacotherapy; Pharmacology; Drug; Polypharmacy; Dosing; Therapeutic drug monitoring; Renal replacement therapy; Drug metabolism; Amiodarone; Internal medicine; Atrial fibrillation","score_opus":0.2557920563187516,"score_gpt":0.5341036489901199,"score_spread":0.27831159267136824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318946156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008937507,0.987847,0.00049189373,0.0007005968,0.0034479746,0.0030046138,0.0005459766,0.0009520659,0.0029205217],"genre_scores_gemma":[0.0006585063,0.9884656,0.00048047648,0.0011729902,0.0030560715,0.0001241982,0.0013329637,0.00063514925,0.0040740515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99199307,0.00072679075,0.0032770133,0.0016025143,0.0010912177,0.0013093974],"domain_scores_gemma":[0.99066925,0.0053135036,0.00078755047,0.0010436667,0.00074919907,0.0014368144],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0013232523,0.0013531678,0.004700748,0.00056512735,0.00031435725,0.00016592219,0.0007179345,0.00096485915,0.00094881037],"category_scores_gemma":[0.0028847493,0.001028885,0.0016904922,0.0019396564,0.0011601382,0.000089070774,0.00039393702,0.003418115,0.0016453243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018859786,0.00320981,0.000067234134,0.021257104,0.0043684663,0.0023845092,0.000038278322,0.000034755125,0.0000057508223,0.0003744732,0.06417895,0.90389204],"study_design_scores_gemma":[0.0034085917,0.00077756937,0.000078200974,0.018637696,0.022828829,0.00022238347,0.000007949563,0.0016183152,0.000008251766,0.00004158277,0.9510796,0.0012910119],"about_ca_topic_score_codex":0.000002257079,"about_ca_topic_score_gemma":0.0000013389863,"teacher_disagreement_score":0.90260106,"about_ca_system_score_codex":0.00017690781,"about_ca_system_score_gemma":0.0009848714,"threshold_uncertainty_score":0.9999645},"labels":[],"label_agreement":null},{"id":"W4322493875","doi":"10.1007/s40262-023-01212-y","title":"Clinical Evidence on the Purported Pharmacokinetic Interactions between Corticosteroids and Mycophenolic Acid","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacokinetics; Prednisone; Prednisolone; Pharmacology; Mycophenolic acid; Adverse effect; Corticosteroid; Immunosuppression; Drug; Expert opinion; Pharmacotherapy; Intensive care medicine; Internal medicine; Transplantation","score_opus":0.31071969442141706,"score_gpt":0.5126108093168591,"score_spread":0.20189111489544204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322493875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98656654,0.00025090156,0.00013456248,0.009817513,0.0012140636,0.0008465236,0.000048177255,0.00020374662,0.00091796636],"genre_scores_gemma":[0.983215,0.008883991,0.00016300412,0.005336778,0.00090130226,0.000051713432,0.000069378875,0.000042790976,0.0013360383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704653,0.00035048675,0.0013089882,0.0005286379,0.00040516,0.00036019456],"domain_scores_gemma":[0.9938067,0.0049224123,0.00024526074,0.00043521656,0.00012316773,0.00046724363],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094753545,0.00026844608,0.00057104183,0.00011935209,0.00014934546,0.000046001194,0.00020170124,0.00011165219,0.00040902453],"category_scores_gemma":[0.000748781,0.00017270718,0.0003142068,0.00049965194,0.00034737834,0.00008278508,0.00009245084,0.0008934462,0.00085574976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006654921,0.00047595304,0.88625157,0.0001388013,0.00087879464,0.00029767293,0.000082781975,0.000008980175,0.0017884759,0.000056945493,0.007849789,0.101504765],"study_design_scores_gemma":[0.0043275934,0.0009522625,0.97716576,0.00056477316,0.0014563631,0.00004337682,0.000027510177,0.0010827708,0.001438486,0.00013267752,0.012614251,0.00019419643],"about_ca_topic_score_codex":0.000003764396,"about_ca_topic_score_gemma":8.491703e-7,"teacher_disagreement_score":0.101310566,"about_ca_system_score_codex":0.00002424222,"about_ca_system_score_gemma":0.0000595866,"threshold_uncertainty_score":0.9999222},"labels":[],"label_agreement":null},{"id":"W4362506207","doi":"10.1007/s40262-023-01233-7","title":"External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Polytechnique Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Confusion; Dosing; Computer science; Population; Risk analysis (engineering); Management science; Medicine; Pharmacology; Engineering; Psychology; Environmental health","score_opus":0.23623025221709973,"score_gpt":0.5167920882786811,"score_spread":0.28056183606158136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362506207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835872,0.004708079,0.0068941684,0.0002676407,0.0018655197,0.0020682476,0.000082160936,0.00009506784,0.00043192806],"genre_scores_gemma":[0.98749197,0.009640197,0.0015041688,0.00010247796,0.00071858865,0.000032704862,0.00017964044,0.00006923143,0.00026104602],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99660784,0.00025558923,0.0013823856,0.00059321045,0.0007366145,0.00042435396],"domain_scores_gemma":[0.9971736,0.0007806277,0.00038690414,0.00030707225,0.00096950977,0.00038225448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032735616,0.00029336676,0.00060798373,0.00030707588,0.00009084745,0.000028983051,0.00016345992,0.00010465001,0.00007645319],"category_scores_gemma":[0.0005196149,0.00026951014,0.00026788085,0.0004941161,0.00017663534,0.00010278634,0.00017607489,0.0003822241,0.00003276998],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001036163,0.0010081909,0.0062166844,0.0007380844,0.00014195246,0.0000034535292,0.00019329434,0.017969247,0.01740156,0.00011555365,0.008254271,0.9469215],"study_design_scores_gemma":[0.010412242,0.00044267118,0.08301415,0.00038358587,0.0015054732,0.0000075105536,0.000007532616,0.88698554,0.005308781,0.0055704345,0.006097601,0.00026446348],"about_ca_topic_score_codex":0.0000030792335,"about_ca_topic_score_gemma":6.111138e-7,"teacher_disagreement_score":0.94665706,"about_ca_system_score_codex":0.000052893767,"about_ca_system_score_gemma":0.00013959488,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W4380201598","doi":"10.1007/s40262-023-01264-0","title":"Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Health and Medical Research Council; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Medical Research Council; University of Queensland","keywords":"Dosing; Extracorporeal membrane oxygenation; Medicine; Critically ill; Intensive care medicine; Antifungal; Population; Drug; Antifungal drugs; Extracorporeal; Antifungal drug; Pharmacokinetics; Therapeutic drug monitoring; Critical illness; Volume of distribution; Pharmacology; Anesthesia; Internal medicine","score_opus":0.18065330493342838,"score_gpt":0.48318815209861776,"score_spread":0.3025348471651894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380201598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045632,0.965322,0.00012546232,0.0011516198,0.009371009,0.0068805907,0.0006334321,0.0006827093,0.011269943],"genre_scores_gemma":[0.0014891551,0.9906098,0.0004944883,0.0032324342,0.0018697373,0.000024119061,0.0011013376,0.00032069578,0.0008582254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930011,0.0004578326,0.0034717962,0.0012504634,0.00093860266,0.00088018965],"domain_scores_gemma":[0.9947871,0.0020785136,0.00064816716,0.0006665343,0.0011189877,0.00070067827],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013566674,0.0008706043,0.0030891492,0.00071997655,0.000082743296,0.00007173963,0.00047427622,0.00088646694,0.00026944364],"category_scores_gemma":[0.00402254,0.0007463202,0.0011564734,0.0010793272,0.0003176897,0.00005651541,0.0002502229,0.0027585125,0.0010003444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025034626,0.0033411565,0.00068009907,0.014721574,0.00039094733,0.0006462453,0.00001311999,0.000017850176,0.000010871669,0.00016399681,0.01312628,0.9666375],"study_design_scores_gemma":[0.005647543,0.0008709882,0.0043902285,0.017929418,0.003328281,0.000023658771,0.000004381344,0.0014930674,0.00002173728,0.000048340506,0.96531874,0.0009236461],"about_ca_topic_score_codex":0.000005042555,"about_ca_topic_score_gemma":0.0000012356829,"teacher_disagreement_score":0.96571386,"about_ca_system_score_codex":0.00018887424,"about_ca_system_score_gemma":0.0003514418,"threshold_uncertainty_score":0.9997775},"labels":[],"label_agreement":null},{"id":"W4381714962","doi":"10.1007/s40262-023-01272-0","title":"Authors’ Reply to Lv et al.: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”","year":2023,"lang":"en","type":"letter","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Dosing; Pharmacokinetics; Current (fluid); Medicine; Population; Intensive care medicine; Pharmacology; Physics","score_opus":0.24955563005409886,"score_gpt":0.5216436640067018,"score_spread":0.27208803395260295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381714962","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2148723,0.012519446,0.03189001,0.69680494,0.022520863,0.01812894,0.0018821846,0.00049352244,0.0008877826],"genre_scores_gemma":[0.22423658,0.026080133,0.009892771,0.7188774,0.011409879,0.0003450587,0.0039548483,0.0010052735,0.004198111],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99193126,0.00088177196,0.0029776616,0.0016031557,0.0017742444,0.00083189877],"domain_scores_gemma":[0.99350095,0.0019448084,0.0010849005,0.00080618326,0.0020259025,0.00063726667],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0062941364,0.00082152244,0.001583626,0.000706154,0.00011575778,0.00009366678,0.00043890518,0.00043896353,0.000096444215],"category_scores_gemma":[0.0014636348,0.000781829,0.0006400866,0.0005961265,0.00021261346,0.00011923661,0.0004665342,0.0026891949,0.000069429894],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007157746,0.0004966465,0.0002426951,0.0010215023,0.00024955758,0.000018745854,0.00014257002,0.005635033,0.0015091308,0.000009113901,0.78594893,0.20401032],"study_design_scores_gemma":[0.0071472917,0.00083734514,0.0040879543,0.0016846445,0.0033165298,0.000015493128,0.0000026707678,0.35568327,0.00080906897,0.002015289,0.62375677,0.0006436675],"about_ca_topic_score_codex":0.00001884194,"about_ca_topic_score_gemma":0.0000015756378,"teacher_disagreement_score":0.3500482,"about_ca_system_score_codex":0.00017060622,"about_ca_system_score_gemma":0.0004044695,"threshold_uncertainty_score":0.9996116},"labels":[],"label_agreement":null},{"id":"W4385264387","doi":"10.1007/s40262-023-01280-0","title":"Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Mycophenolic acid; Population; Renal function; Pharmacokinetics; Kidney transplantation; Transplantation; Covariate; Urology; Internal medicine; Statistics; Mathematics","score_opus":0.04037206805120482,"score_gpt":0.35286892244369455,"score_spread":0.31249685439248975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385264387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996929,0.000083957086,0.00095106737,0.0001593433,0.000729525,0.00081396074,0.000038297363,0.00009962973,0.00019521207],"genre_scores_gemma":[0.9961659,0.0024473793,0.00020083616,0.00040250915,0.00030724498,0.00004357483,0.00027355558,0.000048570106,0.000110480396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759007,0.00014478901,0.00091422064,0.00046854198,0.0005309445,0.00035144904],"domain_scores_gemma":[0.99890304,0.00030086553,0.00018855152,0.00021039363,0.000079193924,0.00031795964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028355542,0.00026806007,0.0005365838,0.00033995177,0.000043267253,0.000009218786,0.00008928144,0.00012243158,0.000031985488],"category_scores_gemma":[0.000072175484,0.00020912933,0.00017493493,0.00084012706,0.000042611653,0.00006807729,0.000012077175,0.00042885126,0.00006218484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021346534,0.002396483,0.8421232,0.002315079,0.000508269,0.00078581896,0.00027705944,0.10409294,0.012204212,0.000046818168,0.00019345961,0.013710116],"study_design_scores_gemma":[0.017353851,0.0023200705,0.9044789,0.0011281889,0.0012447219,0.00001523334,0.000004754188,0.06913467,0.0040044207,0.00004440881,0.000021146616,0.00024965403],"about_ca_topic_score_codex":0.000017257062,"about_ca_topic_score_gemma":0.0000010695031,"teacher_disagreement_score":0.062355675,"about_ca_system_score_codex":0.00004474869,"about_ca_system_score_gemma":0.00005894225,"threshold_uncertainty_score":0.85280466},"labels":[],"label_agreement":null},{"id":"W4386916058","doi":"10.1007/s40262-023-01307-6","title":"Cannabidiol Exposure Through Maternal Marijuana Use: Predictions in Breastfed Infants","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Waterloo; Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; University of Waterloo; Canadian Institutes of Health Research; University of California, San Diego; National Institutes of Health; Gerber Foundation","keywords":"Breastfeeding; Medicine; Cannabidiol; Breast milk; Infant formula; Pediatrics; Pharmacokinetics; Breast feeding; Cannabis; Internal medicine","score_opus":0.09265376675567326,"score_gpt":0.43400183017477656,"score_spread":0.3413480634191033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386916058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811681,0.00018823877,0.00005609935,0.014484489,0.0012110841,0.0007151479,0.00013602995,0.00024473493,0.0017960591],"genre_scores_gemma":[0.96540684,0.0020334488,0.00014151429,0.0018787667,0.0010805137,0.000104113955,0.0000992971,0.00006591514,0.029189585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701816,0.00018275507,0.0009651205,0.00051789684,0.00062654767,0.00068951206],"domain_scores_gemma":[0.99864745,0.00010463741,0.00010062973,0.00047652418,0.00023434544,0.00043643935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007483633,0.0002287787,0.00049727014,0.00022101482,0.0000811799,0.00006276276,0.00023095527,0.00023271705,0.0007987495],"category_scores_gemma":[0.00063079706,0.00020345044,0.00024175923,0.0010850087,0.00027916813,0.00015245075,0.000232311,0.0010136169,0.00031140365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042305165,0.0003400782,0.5691157,0.00009931777,0.00009170615,0.0004384708,0.00009802249,0.0001367429,0.00080790115,0.000045001492,0.41534293,0.013061087],"study_design_scores_gemma":[0.0036121975,0.00032715756,0.78840464,0.0000898574,0.00007235294,0.00005718175,0.00003712364,0.0028252762,0.00026548243,0.000101947415,0.20404758,0.00015919987],"about_ca_topic_score_codex":0.0003478886,"about_ca_topic_score_gemma":0.00005566373,"teacher_disagreement_score":0.21928895,"about_ca_system_score_codex":0.00008977726,"about_ca_system_score_gemma":0.00030093506,"threshold_uncertainty_score":0.87457466},"labels":[],"label_agreement":null},{"id":"W4388627262","doi":"10.1007/s40262-023-01319-2","title":"Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"Vir Biotechnology","keywords":"Medicine; Tolerability; Placebo; Pharmacokinetics; Confidence interval; Adverse effect; Anesthesia; Internal medicine","score_opus":0.0855138984506186,"score_gpt":0.4492437812063357,"score_spread":0.36372988275571705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388627262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406976,0.00088566664,0.00008600014,0.0026739712,0.00048561892,0.0013390342,0.00011147012,0.00013067854,0.000217827],"genre_scores_gemma":[0.98117,0.0024183902,0.00042568735,0.015440331,0.0003809434,0.000021320748,0.000041289128,0.000080265956,0.000021750691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947316,0.00046783983,0.0020335652,0.0010615949,0.0007453667,0.00096004416],"domain_scores_gemma":[0.99730146,0.0011958315,0.0002561071,0.00056916714,0.00040316474,0.0002742553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022839855,0.0004780733,0.0014775723,0.00048344446,0.00010794931,0.00005192383,0.0003668896,0.00036338813,0.000033304914],"category_scores_gemma":[0.0012259681,0.0004229683,0.00023457028,0.0011653062,0.0012999817,0.0001414486,0.00046559708,0.0013254078,0.000034979308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015936198,0.0025551948,0.5713625,0.002479679,0.00051417877,0.001508483,0.0017708755,0.000029096265,0.35467154,0.000041026215,0.0017751862,0.047356073],"study_design_scores_gemma":[0.050615866,0.007698814,0.6856277,0.0006630597,0.0009876892,0.00047565793,0.0012256086,0.11556047,0.06973264,0.00030061477,0.06549625,0.001615638],"about_ca_topic_score_codex":0.0006813012,"about_ca_topic_score_gemma":0.00014722926,"teacher_disagreement_score":0.28493887,"about_ca_system_score_codex":0.00011829646,"about_ca_system_score_gemma":0.00054013816,"threshold_uncertainty_score":0.9998222},"labels":[],"label_agreement":null},{"id":"W4390060918","doi":"10.1007/s40262-023-01329-0","title":"Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Dosing; Vancomycin; Nomogram; Population; NONMEM; Oncology; Renal function; Internal medicine; Intensive care medicine; Staphylococcus aureus","score_opus":0.0982444757694802,"score_gpt":0.42612978322872697,"score_spread":0.32788530745924677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390060918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484986,0.00017554643,0.0019772775,0.000835132,0.00056464894,0.0008730349,0.00006763676,0.00010079628,0.0005560734],"genre_scores_gemma":[0.9939499,0.0014178692,0.0033247499,0.0010072888,0.000079635334,0.000042844316,0.00003879034,0.00003538686,0.00010353111],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99737775,0.00006419989,0.0014064481,0.00035845162,0.0003918334,0.00040130023],"domain_scores_gemma":[0.9977062,0.0011821678,0.00034223244,0.0003029882,0.00028296976,0.0001834765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044931044,0.0002143698,0.00071596395,0.00022916339,0.000034459987,0.000008956771,0.00022060594,0.00020728666,0.00010427567],"category_scores_gemma":[0.0015496798,0.00018458781,0.00022704595,0.00083425536,0.00024357572,0.000060996776,0.00012627173,0.0004487076,0.000031697997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043496275,0.0021880213,0.86131424,0.0022756828,0.000103870516,0.00010650906,0.00034930147,0.038464025,0.0026723256,0.000028166909,0.05152246,0.036625784],"study_design_scores_gemma":[0.030078983,0.0011700894,0.29976523,0.0044474946,0.00039700497,0.0000017630066,0.00009269567,0.6286656,0.017006936,0.00036391238,0.017260058,0.0007502341],"about_ca_topic_score_codex":0.000018513028,"about_ca_topic_score_gemma":0.000046984827,"teacher_disagreement_score":0.59020156,"about_ca_system_score_codex":0.00013329057,"about_ca_system_score_gemma":0.0003225045,"threshold_uncertainty_score":0.75272727},"labels":[],"label_agreement":null},{"id":"W4391251185","doi":"10.1007/s40262-023-01345-0","title":"Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; Université de Montréal; University of Manitoba; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Ezetimibe; Breast milk; Breastfeeding; Pharmacokinetics; Physiologically based pharmacokinetic modelling; Infant formula; Breast feeding; Medicine; Active metabolite; Chemistry; Chromatography; Pharmacology; Food science; Internal medicine; Cholesterol; Biochemistry; Pediatrics","score_opus":0.07768222101468013,"score_gpt":0.3914468204472543,"score_spread":0.3137645994325742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391251185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98624766,0.0034818908,0.00022783798,0.0077711996,0.0010725647,0.00052221236,0.00013971863,0.00012263695,0.0004142664],"genre_scores_gemma":[0.99439687,0.0038722425,0.00016457957,0.0007962584,0.00042868033,0.000036330788,0.000029801995,0.00002330025,0.00025195905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815977,0.000115566625,0.0008121121,0.00034660415,0.0002718036,0.000294124],"domain_scores_gemma":[0.99893385,0.00037884686,0.000060792376,0.00015142754,0.000095039046,0.00038002248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006022257,0.00015865386,0.00030512002,0.00019357151,0.00003311949,0.0000579088,0.000079326994,0.00015836139,0.00019143362],"category_scores_gemma":[0.0005247871,0.00014082452,0.000078696765,0.00037330986,0.00012491744,0.00025444076,0.00004377883,0.0006878062,0.000021543898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031427058,0.00046431253,0.9729401,0.00028367768,0.00011514694,0.00033470496,0.00042236745,0.00013027366,0.007006184,0.00034263794,0.003933034,0.013713324],"study_design_scores_gemma":[0.0033684785,0.00011391042,0.9624811,0.0017586531,0.00016664514,0.0004351012,0.000022761262,0.02607322,0.00044874207,0.0000449518,0.004949897,0.0001365771],"about_ca_topic_score_codex":0.000035277164,"about_ca_topic_score_gemma":0.000022287333,"teacher_disagreement_score":0.025942946,"about_ca_system_score_codex":0.00006276599,"about_ca_system_score_gemma":0.00021770236,"threshold_uncertainty_score":0.5742657},"labels":[],"label_agreement":null},{"id":"W4392880216","doi":"10.1007/s40262-024-01362-7","title":"Optimization of Ganciclovir and Valganciclovir Starting Dose in Children by Machine Learning","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Ganciclovir; Valganciclovir; Pharmacokinetics; Algorithm; Test set; Confidence interval; Medicine; Receiver operating characteristic; Population; Mathematics; Set (abstract data type); Computer science; Machine learning; Artificial intelligence; Statistics; Pharmacology","score_opus":0.038260621678176045,"score_gpt":0.39887686622556584,"score_spread":0.3606162445473898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392880216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98402494,0.012817055,0.00086970546,0.0007199753,0.00012100763,0.00043731282,0.000040353192,0.00008143948,0.0008881967],"genre_scores_gemma":[0.9904569,0.0071323346,0.0012684822,0.00035332193,0.00021445163,0.000006830538,0.000066372304,0.00004492614,0.00045637198],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998099,0.00014338856,0.00079278566,0.00037558784,0.00030124292,0.000287981],"domain_scores_gemma":[0.999087,0.0003979444,0.000080519356,0.00014292778,0.0000731176,0.00021853753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011226109,0.00015488655,0.00040077834,0.00017009025,0.00003617224,0.000036073252,0.00008330391,0.00012834702,0.00028891832],"category_scores_gemma":[0.00045046167,0.00013679027,0.00010038357,0.00044457146,0.00017937596,0.00007997991,0.00010389741,0.00095155626,0.000019286548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007016871,0.0006150676,0.79978013,0.0004480268,0.00026237124,0.00007600836,0.00020729298,0.0047430852,0.02001804,0.00008294748,0.004120819,0.16894451],"study_design_scores_gemma":[0.006823887,0.0010550775,0.089943886,0.00042710462,0.00035047275,0.00004147612,0.000030399564,0.8603264,0.007351625,0.00009388513,0.033167012,0.0003887737],"about_ca_topic_score_codex":0.00007440059,"about_ca_topic_score_gemma":0.0000030776278,"teacher_disagreement_score":0.8555833,"about_ca_system_score_codex":0.000032358847,"about_ca_system_score_gemma":0.00009254458,"threshold_uncertainty_score":0.55781454},"labels":[],"label_agreement":null},{"id":"W4399172435","doi":"10.1007/s40262-024-01367-2","title":"Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Duke Clinical Research Institute; National Institute of Child Health and Human Development; National Institutes of Health","keywords":"Levetiracetam; Pharmacokinetics; Medicine; Obesity; Disposition; Pediatrics; Population; Age groups; Pharmacology; Epilepsy; Internal medicine; Demography; Psychology; Psychiatry; Environmental health","score_opus":0.06324273030691942,"score_gpt":0.3990396598029761,"score_spread":0.3357969294960567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399172435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946676,0.00036030856,0.0010332875,0.0022135314,0.000087457025,0.0015765658,0.0000191877,0.000011124336,0.00003092609],"genre_scores_gemma":[0.99815375,0.0008258113,0.00009066211,0.0006128093,0.00017124953,0.000095322815,0.000034604247,0.00001004497,0.000005733645],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983699,0.0004098504,0.00054061454,0.0002176167,0.00032689428,0.00013517847],"domain_scores_gemma":[0.9969172,0.0025647606,0.00011052605,0.00025905226,0.0000870456,0.00006143687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009298471,0.000116629366,0.00027847386,0.0000724367,0.000032092717,0.000008747647,0.00015676377,0.000054349908,0.0000105170775],"category_scores_gemma":[0.00043358703,0.000053261756,0.0001128044,0.00042719368,0.00009959611,0.00001961675,0.000044145305,0.00032471624,0.0000031958273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043298346,0.0069923936,0.36720082,0.0059447703,0.00035690243,0.00011161135,0.0009334697,0.005828608,0.49396464,0.0014987942,0.0006301531,0.112207994],"study_design_scores_gemma":[0.0011763454,0.0013521329,0.85903317,0.00018680326,0.0003621906,0.0000013617199,0.000012046495,0.1329711,0.0045340713,0.0002833145,0.000029487817,0.000057982284],"about_ca_topic_score_codex":0.000024477891,"about_ca_topic_score_gemma":8.7107264e-7,"teacher_disagreement_score":0.49183235,"about_ca_system_score_codex":0.000015657886,"about_ca_system_score_gemma":0.000026187696,"threshold_uncertainty_score":0.21719514},"labels":[],"label_agreement":null},{"id":"W4402634804","doi":"10.1007/s40262-024-01418-8","title":"Physiologically-Based Pharmacokinetic Modeling of Total and Unbound Valproic Acid to Evaluate Dosing in Children With and Without Hypoalbuminemia","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; National Institute of Child Health and Human Development; GlaxoSmithKline","keywords":"Hypoalbuminemia; Dosing; Valproic Acid; Pharmacokinetics; Pharmacology; Medicine; Chemistry; Internal medicine; Epilepsy; Psychiatry","score_opus":0.06425689875237436,"score_gpt":0.4134818528070195,"score_spread":0.34922495405464515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402634804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304193,0.0032386705,0.00086147425,0.001200272,0.00015324929,0.0012311405,0.000019693216,0.00009643223,0.00015715731],"genre_scores_gemma":[0.99457824,0.0008254096,0.0023756481,0.0018084558,0.00028539138,0.000047703095,0.000009415872,0.000039722312,0.000030034944],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975837,0.0001821437,0.00074959587,0.0007368723,0.00033324142,0.00041443287],"domain_scores_gemma":[0.99885815,0.00039068353,0.000080623366,0.00016341251,0.00011422971,0.0003928773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079521886,0.0003555314,0.00084996666,0.00017866584,0.000059897957,0.000040831266,0.00009584371,0.00012811476,0.000046684614],"category_scores_gemma":[0.00027722956,0.0002367556,0.00010928363,0.00043357938,0.0004257478,0.000061511055,0.00018949687,0.0006956419,0.000005719447],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063990946,0.0019583972,0.38725612,0.0016793365,0.0015859738,0.0001845472,0.00025755903,0.028638886,0.47749886,0.000047043282,0.000570519,0.09392367],"study_design_scores_gemma":[0.010810233,0.003632289,0.23850189,0.00083466683,0.0015288477,0.000097514225,0.000015329104,0.73050016,0.013283458,0.00015349273,0.00012587849,0.00051621714],"about_ca_topic_score_codex":0.000010596538,"about_ca_topic_score_gemma":0.0000010043836,"teacher_disagreement_score":0.7018613,"about_ca_system_score_codex":0.000034907556,"about_ca_system_score_gemma":0.00008809625,"threshold_uncertainty_score":0.9654613},"labels":[],"label_agreement":null},{"id":"W4402925791","doi":"10.1007/s40262-024-01424-w","title":"Physiologically Based Pharmacokinetic Modelling in Critically Ill Children Receiving Anakinra While on Extracorporeal Life Support","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"University of Waterloo; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Foundation for the National Institutes of Health","keywords":"Critically ill; Anakinra; Extracorporeal; Life support; Medicine; Intensive care medicine; Pharmacokinetics; Extracorporeal membrane oxygenation; Anesthesia; Pharmacology; Internal medicine; Disease","score_opus":0.09297391029454456,"score_gpt":0.3993955792869996,"score_spread":0.30642166899245504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402925791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95612603,0.0011575745,0.014804847,0.009122374,0.0026595236,0.0019081736,0.0001730263,0.0008274572,0.013220985],"genre_scores_gemma":[0.962168,0.0023566578,0.00570155,0.026569957,0.0023259777,0.000026275817,0.00026652217,0.000195977,0.00038912293],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99360555,0.00033224188,0.0023494496,0.0016147015,0.00088605616,0.0012120185],"domain_scores_gemma":[0.99573565,0.0015463886,0.00019432916,0.0006743225,0.0005778234,0.0012714928],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015623727,0.0007689042,0.001206581,0.0005266477,0.00011305445,0.00016399033,0.00054960354,0.00046073273,0.0023977442],"category_scores_gemma":[0.0009844262,0.0006718716,0.0007223837,0.0009801728,0.00051412237,0.00012536148,0.00018736422,0.0026196768,0.00055819197],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010219507,0.023082463,0.12675817,0.00302871,0.0022470087,0.009063812,0.00035204232,0.32186845,0.054505292,0.0035356055,0.15508236,0.2902566],"study_design_scores_gemma":[0.007390303,0.0022333134,0.10714616,0.0009199865,0.0009187492,0.0000674421,0.000013664946,0.8513789,0.0021897084,0.00033774326,0.026335582,0.0010684533],"about_ca_topic_score_codex":0.000012423508,"about_ca_topic_score_gemma":8.1655054e-7,"teacher_disagreement_score":0.52951044,"about_ca_system_score_codex":0.000115453775,"about_ca_system_score_gemma":0.00049701123,"threshold_uncertainty_score":0.9996813},"labels":[],"label_agreement":null},{"id":"W4404706680","doi":"10.1007/s40262-024-01447-3","title":"Coupling Pre- and Postnatal Infant Exposures with Physiologically Based Pharmacokinetic Modeling to Predict Cumulative Maternal Levetiracetam Exposure During Breastfeeding","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Physiologically based pharmacokinetic modelling; Breastfeeding; Breast milk; Medicine; Infant formula; Population; Pharmacokinetics; Breast feeding; NONMEM; Physiology; Obstetrics; Pediatrics; Environmental health; Pharmacology; Chemistry","score_opus":0.04698075393296283,"score_gpt":0.37706661241123657,"score_spread":0.33008585847827376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404706680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140584,0.0013743624,0.0017334245,0.0032810494,0.0007027114,0.0008113802,0.000054043052,0.00038517764,0.0002519773],"genre_scores_gemma":[0.9931551,0.00047211582,0.0036249806,0.0010132331,0.0014136956,0.00005467232,0.00001792547,0.00008829075,0.00015994362],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9965364,0.000083753606,0.0010862915,0.001003709,0.00067205395,0.0006177985],"domain_scores_gemma":[0.997967,0.0005764899,0.00018058739,0.00027277382,0.00029537754,0.00070776336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081929,0.0004941626,0.00069639046,0.00021510484,0.00018073879,0.00025287422,0.00024515687,0.00019540549,0.0002185603],"category_scores_gemma":[0.00024926334,0.00035704309,0.00018679233,0.00039238427,0.0002515022,0.00039161544,0.00022291433,0.0011242955,0.00002663154],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016899953,0.00090604415,0.26275188,0.0028505244,0.0016516678,0.0020339543,0.0009885749,0.40906647,0.26661393,0.00007058583,0.00054121716,0.035625223],"study_design_scores_gemma":[0.003054545,0.0017267474,0.3952262,0.0013564635,0.00067094475,0.0004573953,0.000038988757,0.59338856,0.0032199293,0.000010358764,0.0004544898,0.00039538596],"about_ca_topic_score_codex":0.000043527707,"about_ca_topic_score_gemma":0.0000011290638,"teacher_disagreement_score":0.263394,"about_ca_system_score_codex":0.000050888513,"about_ca_system_score_gemma":0.00014087374,"threshold_uncertainty_score":0.9998882},"labels":[],"label_agreement":null},{"id":"W4405775005","doi":"10.1007/s40262-024-01460-6","title":"A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the Elderly","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"China Scholarship Council","keywords":"Dosing; Pharmacokinetics; Medicine; Pharmacodynamics; Piperacillin; Piperacillin/tazobactam; Population; Tazobactam; Pharmacology; Covariate; Internal medicine; Biology; Statistics; Mathematics; Genetics","score_opus":0.0778859544124117,"score_gpt":0.44332378971303554,"score_spread":0.36543783530062385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405775005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600579,0.003376338,0.013745124,0.010742104,0.003909504,0.0030665505,0.0045703375,0.00032694614,0.00020519122],"genre_scores_gemma":[0.98508435,0.00090464455,0.002861668,0.0059126485,0.002584535,0.00015283858,0.0015679932,0.00012592624,0.0008053841],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995241,0.00019750113,0.001762808,0.0011834272,0.0007457724,0.00086948555],"domain_scores_gemma":[0.9959019,0.0017317391,0.00022513962,0.0008779065,0.00042784566,0.00083549746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005574705,0.00061784254,0.0010861417,0.00025366424,0.00027895148,0.0003016565,0.00051584095,0.00029020908,0.0018588031],"category_scores_gemma":[0.0006725403,0.0004098589,0.0013162824,0.0014784032,0.00017578746,0.000080569174,0.00029674833,0.0011010607,0.00023639678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033995644,0.0033771025,0.021895388,0.0005838125,0.014237132,0.00024283161,0.002477477,0.013467617,0.014121844,0.00018470341,0.37488347,0.55112904],"study_design_scores_gemma":[0.0049909474,0.0020175138,0.14501247,0.00048932625,0.019094566,0.000017973269,0.0001576908,0.2609678,0.004510732,0.00035454414,0.5613727,0.0010137793],"about_ca_topic_score_codex":0.000026354901,"about_ca_topic_score_gemma":0.00002565178,"teacher_disagreement_score":0.5501153,"about_ca_system_score_codex":0.000087698616,"about_ca_system_score_gemma":0.0000975433,"threshold_uncertainty_score":0.9998353},"labels":[],"label_agreement":null},{"id":"W4406588759","doi":"10.1007/s40262-025-01478-4","title":"Identifying the Optimal Sampling Strategy for the Bayesian Estimation of Vancomycin AUC0–24 in Adult Hematologic Cancer Patients","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université de Montréal","funders":"","keywords":"Vancomycin; Bayesian probability; Hematologic Neoplasms; Sampling (signal processing); Estimation; Medicine; Hematologic malignancy; Cancer; Pediatric cancer; Computer science; Oncology; Statistics; Intensive care medicine; Internal medicine; Mathematics; Artificial intelligence; Biology; Engineering","score_opus":0.0969544238168686,"score_gpt":0.46395671915262554,"score_spread":0.36700229533575696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406588759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8496107,0.00096046785,0.14256611,0.0027364849,0.0015573789,0.0021843517,0.0000597641,0.000035818102,0.0002889512],"genre_scores_gemma":[0.99150985,0.0007420958,0.006137273,0.0012151347,0.00010727408,0.0001018065,0.000014564438,0.000017773402,0.0001542196],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980866,0.00009020294,0.0010685831,0.00028465327,0.00019494658,0.00027501787],"domain_scores_gemma":[0.99677634,0.002242279,0.0003088624,0.00029026365,0.00032954323,0.00005269183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056424184,0.00016516472,0.00042308026,0.00006892127,0.000107358144,0.00002359541,0.00028933308,0.0001227638,0.000039831564],"category_scores_gemma":[0.001318658,0.000101508085,0.00020061084,0.00037161945,0.0002922018,0.000043953496,0.00008602793,0.0004465487,0.0000020692594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005657401,0.0030203147,0.5092958,0.003511836,0.00096758397,0.000018838004,0.000705548,0.1485285,0.005741118,0.004031743,0.03900643,0.27951488],"study_design_scores_gemma":[0.018906834,0.00072610227,0.46960914,0.0029531997,0.002071386,0.0000031126363,0.0007887034,0.47550994,0.019581072,0.003598803,0.0056630606,0.0005886553],"about_ca_topic_score_codex":0.000034400393,"about_ca_topic_score_gemma":0.000041380536,"teacher_disagreement_score":0.32698143,"about_ca_system_score_codex":0.000063470456,"about_ca_system_score_gemma":0.00016354777,"threshold_uncertainty_score":0.41393796},"labels":[],"label_agreement":null},{"id":"W4406801161","doi":"10.1007/s40262-025-01476-6","title":"Population Pharmacokinetic Modelling of Apixaban in End-Stage Kidney Disease Patients with Atrial Fibrillation Receiving Haemodialysis","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Apixaban; Atrial fibrillation; Medicine; End stage renal disease; Cardiology; Internal medicine; Population pharmacokinetics; Stage (stratigraphy); Pharmacokinetics; Kidney disease; End-stage kidney disease; Population; Disease; Warfarin; Rivaroxaban","score_opus":0.08437348808330872,"score_gpt":0.39597506357501255,"score_spread":0.31160157549170386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406801161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890435,0.00017497869,0.0068395054,0.001266089,0.00079710886,0.001169971,0.000052815332,0.000067321955,0.0005887434],"genre_scores_gemma":[0.99526113,0.000382291,0.0016504307,0.00037127003,0.0008720789,0.0000015193358,0.0005740559,0.000029804996,0.00085744617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972721,0.00020180205,0.0013549404,0.00044485292,0.0004644662,0.0002618377],"domain_scores_gemma":[0.9982844,0.0005174118,0.00040472185,0.0003096642,0.00021124817,0.00027253776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056273065,0.00023844413,0.0006792771,0.00043025883,0.000055427136,0.000021786904,0.00011166681,0.00010457217,0.0003221184],"category_scores_gemma":[0.00063368364,0.00021240112,0.0003847482,0.00081609905,0.00008972479,0.00014670027,0.00008735222,0.00024030855,0.000006380346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026625406,0.00003769084,0.8396675,0.00021749451,0.00017796551,0.0000041870935,0.000021251462,0.14222942,0.000024703551,0.00009905349,0.00023168467,0.014626494],"study_design_scores_gemma":[0.0102748135,0.00010325985,0.7641726,0.00023331601,0.001144172,6.291976e-8,0.0000058300184,0.21591976,0.000058277605,0.00014712136,0.00775107,0.00018972481],"about_ca_topic_score_codex":0.000035877754,"about_ca_topic_score_gemma":0.0000025979564,"teacher_disagreement_score":0.07549492,"about_ca_system_score_codex":0.00007954904,"about_ca_system_score_gemma":0.00011793977,"threshold_uncertainty_score":0.8661466},"labels":[],"label_agreement":null},{"id":"W4408075922","doi":"10.1007/s40262-025-01490-8","title":"Pharmacokinetics of Opioid Infusions in the Adult Intensive Care Unit Setting—A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University of Toronto; Mount Sinai Hospital; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Opioid; Intensive care unit; Medicine; Pharmacokinetics; Intensive care medicine; Anesthesia; Pharmacology; Internal medicine","score_opus":0.09064926341637812,"score_gpt":0.4697981256625187,"score_spread":0.3791488622461406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408075922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018631397,0.9848185,0.00001726875,0.0007897894,0.00094976946,0.010639423,0.0001500515,0.00006167879,0.0025548595],"genre_scores_gemma":[0.000037171947,0.97588307,0.00018289768,0.021423684,0.00040829575,0.0005000739,0.00056692766,0.00007365858,0.0009241941],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9909081,0.0021870658,0.0048700785,0.000722014,0.0007848999,0.0005278767],"domain_scores_gemma":[0.9888821,0.0056662383,0.001714484,0.0015701115,0.0019471566,0.00021986927],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023026427,0.0008240965,0.006009008,0.00048026067,0.000069609894,0.00002740983,0.0014178222,0.00044012125,0.00012810102],"category_scores_gemma":[0.012428679,0.00051680807,0.0017877936,0.0018192525,0.00031016392,0.000034353907,0.0005664922,0.0023413992,0.000083692576],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001859808,0.00020293314,0.00016845815,0.9108432,0.00051990105,0.0001297877,0.00019643539,6.6519254e-7,1.9871123e-7,0.000054057473,0.035145678,0.052720115],"study_design_scores_gemma":[0.0010361832,0.00012706904,0.00003865701,0.578265,0.026621731,0.0000082918505,0.00038251167,0.000038178958,6.012375e-7,0.000010465895,0.39317918,0.00029215188],"about_ca_topic_score_codex":0.0000053794734,"about_ca_topic_score_gemma":0.0000023777027,"teacher_disagreement_score":0.35803348,"about_ca_system_score_codex":0.00008102619,"about_ca_system_score_gemma":0.00063742866,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4409609531","doi":"10.1007/s40262-025-01505-4","title":"Anti-infectives in Pediatric Patients with Cystic Fibrosis: A Comprehensive Review of Population Pharmacokinetic Analyses","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Faculté de pharmacie, Université de Montréal; Fonds de Recherche du Québec - Santé","keywords":"Cystic fibrosis; Pharmacokinetics; Medicine; Intensive care medicine; Internal medicine","score_opus":0.09632779977673878,"score_gpt":0.5106266570309735,"score_spread":0.41429885725423476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409609531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011462118,0.99326605,0.000044416374,0.00003458775,0.00037669565,0.0046090004,0.00029351766,0.000056533627,0.0001729839],"genre_scores_gemma":[0.00093062804,0.9953323,0.001467145,0.00026142204,0.0003421532,0.00019123525,0.0013376625,0.00008716567,0.000050275998],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99270433,0.00121152,0.0034450288,0.0010205271,0.0010394438,0.0005791558],"domain_scores_gemma":[0.99134415,0.0051320363,0.0014683325,0.00074029516,0.00095305213,0.00036214493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005829261,0.0007914894,0.005807687,0.0010102022,0.000040643758,0.000018112907,0.00043415543,0.00029428842,0.0001850576],"category_scores_gemma":[0.0035785777,0.00057370745,0.0010137404,0.0030464851,0.00028124402,0.000104254796,0.00028089524,0.0014043634,0.00002585129],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024202881,0.0012655709,0.020536162,0.5652221,0.00044867027,0.00003642708,0.0000031319687,0.000028532759,0.0000018563657,0.0000012076505,0.0015186367,0.4106957],"study_design_scores_gemma":[0.006764741,0.001570782,0.15271302,0.46546224,0.023771787,0.000011033055,0.0000027290728,0.00009327633,0.000004463661,0.000013995833,0.34871987,0.0008720745],"about_ca_topic_score_codex":0.000013663159,"about_ca_topic_score_gemma":0.0000010750525,"teacher_disagreement_score":0.40982363,"about_ca_system_score_codex":0.0001762837,"about_ca_system_score_gemma":0.00063444144,"threshold_uncertainty_score":0.99967146},"labels":[],"label_agreement":null},{"id":"W4410702741","doi":"10.1007/s40262-025-01526-z","title":"Pharmacokinetic/Pharmacodynamic Modelling and Monte Carlo Simulations to Predict Cytomegalovirus Viral Load in Pediatric Transplant Recipients Treated with (val)Ganciclovir","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Université de Limoges; Association Nationale de la Recherche et de la Technologie; Agence Nationale de la Recherche","keywords":"Ganciclovir; Pharmacokinetics; Pharmacodynamics; Monte Carlo method; Viral load; Cytomegalovirus; Medicine; Pharmacology; Virology; Human cytomegalovirus; Human immunodeficiency virus (HIV); Mathematics; Statistics; Viral disease; Herpesviridae; Virus","score_opus":0.04303018919637127,"score_gpt":0.3813096390639319,"score_spread":0.33827944986756064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410702741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99145573,0.001240946,0.0016767958,0.0009926937,0.0003383353,0.0021058202,0.00027341658,0.00016388376,0.001752377],"genre_scores_gemma":[0.9896279,0.0055006673,0.00084575097,0.0016686409,0.00043825293,0.00009041272,0.00003801791,0.000089583715,0.0017007462],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9952742,0.0002602202,0.0015172347,0.0011294527,0.0008556393,0.00096326595],"domain_scores_gemma":[0.9973723,0.00070407905,0.00015106224,0.00048682385,0.0004075053,0.0008782098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008805855,0.00056305714,0.0010173195,0.0008905488,0.00016301792,0.00008074281,0.00034544233,0.0002787156,0.00015100875],"category_scores_gemma":[0.00013356554,0.00049293693,0.00020603689,0.0018173426,0.00024242146,0.00017244434,0.00016994248,0.0014593859,0.00005060136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0119416425,0.0018139066,0.7940681,0.00041276534,0.0004412999,0.0006093433,0.00035301282,0.16435201,0.0047912956,0.000017620316,0.0019906214,0.019208403],"study_design_scores_gemma":[0.024258804,0.001179433,0.18860678,0.0004275599,0.0016696433,0.000030429892,0.000018833607,0.76351696,0.0020597475,0.000036608628,0.017453942,0.0007412241],"about_ca_topic_score_codex":0.0002797259,"about_ca_topic_score_gemma":0.00011149558,"teacher_disagreement_score":0.6054613,"about_ca_system_score_codex":0.00034630432,"about_ca_system_score_gemma":0.0005292567,"threshold_uncertainty_score":0.9997522},"labels":[],"label_agreement":null},{"id":"W4413114046","doi":"10.1007/s40262-025-01559-4","title":"Double Peaking Phenomena in Pharmacokinetic Disposition Revisited","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Mitacs","keywords":"Bioequivalence; Pharmacokinetics; Physiologically based pharmacokinetic modelling; Drug; Pharmacology; Dosing; Identification (biology); Medicine; Biology","score_opus":0.32786920923996526,"score_gpt":0.5741244713611369,"score_spread":0.2462552621211716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413114046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006126306,0.94840187,0.00007606391,0.00013985488,0.008807416,0.0037800798,0.0004492651,0.00033298423,0.037951186],"genre_scores_gemma":[0.0004118825,0.98520476,0.00007847854,0.0022147156,0.0042737774,0.00048954936,0.000844519,0.00015174951,0.0063305986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98673016,0.0044354736,0.0050533186,0.001826167,0.0005162751,0.0014386006],"domain_scores_gemma":[0.9919319,0.004666053,0.0014657128,0.0009392749,0.00024753,0.0007495172],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.004562521,0.0014172903,0.0047223377,0.0009820448,0.00028605424,0.00012490235,0.0016953015,0.0021722217,0.002171107],"category_scores_gemma":[0.00036507737,0.0013686703,0.0017292029,0.0021662307,0.0005258044,0.00022524418,0.0007248498,0.0062325173,0.001271003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045554645,0.0013463462,0.00015615729,0.030223802,0.00078696763,0.00031202857,0.00009019819,0.00015723462,0.0000043713776,0.0003305694,0.023987532,0.9421492],"study_design_scores_gemma":[0.005797639,0.00012580305,0.00001707121,0.011107186,0.004680523,0.00003886028,0.000014931343,0.0012573196,0.000009470565,0.0000666719,0.97567797,0.0012065554],"about_ca_topic_score_codex":0.000025719799,"about_ca_topic_score_gemma":0.000008710079,"teacher_disagreement_score":0.95169044,"about_ca_system_score_codex":0.00046087225,"about_ca_system_score_gemma":0.00067212025,"threshold_uncertainty_score":0.9998577},"labels":[],"label_agreement":null},{"id":"W4414167921","doi":"10.1007/s40262-025-01571-8","title":"Population Pharmacokinetic Modeling of Canagliflozin in Advanced Chronic Kidney Disease","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; Université de Montréal; McGill University Health Centre","funders":"Kidney Foundation of Canada","keywords":"Kidney disease; Canagliflozin; Population; Pharmacokinetics; Population pharmacokinetics; Clinical trial","score_opus":0.03396655612676739,"score_gpt":0.39832007449921975,"score_spread":0.36435351837245233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414167921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859651,0.0022041702,0.0007906118,0.0027194875,0.0010587419,0.0012584276,0.000024160014,0.000080246136,0.005899063],"genre_scores_gemma":[0.9941027,0.0015569114,0.00056134776,0.002133544,0.00015451795,0.000049517792,0.0001436176,0.000022218988,0.0012755819],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980756,0.00007850198,0.00094218133,0.00037957463,0.00021980696,0.00030430427],"domain_scores_gemma":[0.999033,0.0001060006,0.00011895068,0.00032341047,0.00008649208,0.00033219418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030228123,0.00019590139,0.0005039992,0.00026159696,0.000023124529,0.0000075133576,0.00013816806,0.00006226535,0.00015765773],"category_scores_gemma":[0.0002891388,0.00018681554,0.0001866892,0.0004586322,0.00006197215,0.00006151141,0.00010516886,0.00024248462,0.000011013132],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023507124,0.0033124445,0.6099961,0.0024308185,0.0007482618,0.00014157791,0.000033623026,0.099031985,0.0023133866,0.0012318305,0.010641637,0.26776764],"study_design_scores_gemma":[0.018081326,0.00033150896,0.15994436,0.0010428464,0.0017562632,2.8221464e-7,0.000012795904,0.799098,0.0006424186,0.00097030343,0.017839665,0.00028024625],"about_ca_topic_score_codex":0.000050376864,"about_ca_topic_score_gemma":0.000012173212,"teacher_disagreement_score":0.70006603,"about_ca_system_score_codex":0.00017337591,"about_ca_system_score_gemma":0.00020907665,"threshold_uncertainty_score":0.7618117},"labels":[],"label_agreement":null},{"id":"W4415664795","doi":"10.1007/s40262-025-01565-6","title":"Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Hospital for Sick Children","funders":"","keywords":"Infliximab; Dosing; Therapeutic drug monitoring; Pharmacokinetics; Inflammatory bowel disease; Trough Concentration; Drug; Population","score_opus":0.014184174384500365,"score_gpt":0.33171271131038105,"score_spread":0.3175285369258807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415664795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649245,0.00014575402,0.0007767746,0.0003712265,0.0004953062,0.0013064798,0.0002625716,0.000029224178,0.00012020694],"genre_scores_gemma":[0.9947857,0.00011900625,0.0005582539,0.0029087763,0.00017182007,0.00009517632,0.0010687578,0.000041593114,0.00025087947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967462,0.00042545015,0.0012631589,0.00071405276,0.00040039726,0.00045075745],"domain_scores_gemma":[0.9980247,0.00012252392,0.0003282531,0.0006026073,0.000444755,0.0004771571],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005332724,0.00036836808,0.00048418995,0.00039555048,0.000059010792,0.000045771645,0.00042119084,0.000190651,0.00014995944],"category_scores_gemma":[0.00035379414,0.0003636264,0.00022467852,0.001161418,0.00008033383,0.000023845614,0.00023233605,0.00024012974,0.000017558816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007606986,0.0007219115,0.9589755,0.000098705175,0.0007861101,0.000009912736,0.00006733149,0.023530701,0.0026478877,0.00007039308,0.0024343014,0.0030502845],"study_design_scores_gemma":[0.0065571447,0.00032326713,0.98149014,0.000034021792,0.0012763274,3.613918e-8,0.000019671583,0.005662612,0.001125749,0.00005652033,0.0030408762,0.0004136285],"about_ca_topic_score_codex":0.0000053216986,"about_ca_topic_score_gemma":0.00002392435,"teacher_disagreement_score":0.02251467,"about_ca_system_score_codex":0.00007574674,"about_ca_system_score_gemma":0.000182167,"threshold_uncertainty_score":0.99988157},"labels":[],"label_agreement":null},{"id":"W4416279814","doi":"10.1007/s40262-025-01579-0","title":"Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institutes of Health","keywords":"Dosing; Active metabolite; Pharmacokinetics; Oxcarbazepine; Population; Obesity; Population pharmacokinetics","score_opus":0.0378900662495074,"score_gpt":0.3981287839557906,"score_spread":0.3602387177062832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416279814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956093,0.0008146066,0.0004894219,0.0008050839,0.00012694088,0.0014013161,0.000032737513,0.000044644716,0.0006759523],"genre_scores_gemma":[0.9962465,0.00064007397,0.001079176,0.0016276647,0.00009308784,0.00003979588,0.00006946346,0.000020091928,0.00018411982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979893,0.0001419636,0.00085500436,0.00045720462,0.00022312286,0.0003334195],"domain_scores_gemma":[0.9989418,0.00021176103,0.00017827486,0.00018172468,0.00023218141,0.00025429417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003992235,0.00028791573,0.00079345435,0.00035449,0.000079042075,0.000009063192,0.00012633363,0.00014875032,0.00007348763],"category_scores_gemma":[0.000192102,0.00024641666,0.000098572666,0.0007925424,0.0000947125,0.00014198577,0.00015973617,0.0004688376,0.000007408874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006918841,0.0028550914,0.91332984,0.00028366453,0.002082358,0.000035196386,0.0005158189,0.016788535,0.014936171,0.000249333,0.00016031427,0.041844863],"study_design_scores_gemma":[0.011159699,0.00053781085,0.84277743,0.00023043607,0.0015282986,0.000012766154,0.00002369946,0.106349155,0.03677038,0.00014469329,0.0002160144,0.0002496176],"about_ca_topic_score_codex":0.00003982701,"about_ca_topic_score_gemma":0.000005050172,"teacher_disagreement_score":0.08956062,"about_ca_system_score_codex":0.00009748525,"about_ca_system_score_gemma":0.000103215934,"threshold_uncertainty_score":0.9999988},"labels":[],"label_agreement":null},{"id":"W4416295471","doi":"10.1007/s40262-025-01587-0","title":"Clinical Pharmacokinetic-Pharmacodynamic Relationships of Pharmacological Strategies for Attenuating p-Cresyl Sulfate in Patients with Kidney Disease","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Kidney disease; Dialysis; Renal function; Incidence (geometry); Kidney; Hemodialysis","score_opus":0.06037596835360987,"score_gpt":0.4167906962477419,"score_spread":0.35641472789413203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416295471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857246,0.00035138344,0.0034694131,0.0024245777,0.001067265,0.0031021228,0.00021920126,0.00009537982,0.0035460093],"genre_scores_gemma":[0.9921094,0.0006425237,0.0019740018,0.003746214,0.00034619885,0.00016785113,0.00039378676,0.00004799838,0.0005720217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949078,0.00067501253,0.0024891947,0.00084627006,0.00052941364,0.00055233523],"domain_scores_gemma":[0.9961757,0.0015492862,0.00055349397,0.0004049501,0.00045399964,0.0008625427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019491686,0.0004127853,0.0010803615,0.00035808375,0.0001141863,0.000041118434,0.0003593888,0.00017309174,0.00020261641],"category_scores_gemma":[0.001374602,0.00031872132,0.0005968563,0.0008116785,0.0005604436,0.00013792164,0.00020257846,0.0009292114,0.000012348061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011348249,0.006525381,0.9376732,0.00065117737,0.0014764994,0.00004754121,0.000021506543,0.0013731362,0.00036944108,0.000860888,0.013146307,0.026506666],"study_design_scores_gemma":[0.033418182,0.0007132971,0.9101119,0.0005201818,0.0060310066,2.0432373e-7,0.000045497305,0.030536555,0.00008961995,0.0005086441,0.017654194,0.0003707114],"about_ca_topic_score_codex":0.0000036842719,"about_ca_topic_score_gemma":0.0000014515604,"teacher_disagreement_score":0.029163418,"about_ca_system_score_codex":0.00007060257,"about_ca_system_score_gemma":0.0005967308,"threshold_uncertainty_score":0.9999265},"labels":[],"label_agreement":null},{"id":"W4416790434","doi":"10.1007/s40262-025-01599-w","title":"Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children","funders":"","keywords":"Infliximab; Inflammatory bowel disease; Pharmacokinetics; Inflammatory Bowel Diseases; Population; Ulcerative colitis; Population pharmacokinetics","score_opus":0.01345729761559701,"score_gpt":0.3281512136513812,"score_spread":0.3146939160357842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416790434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955203,0.00012488705,0.0010828049,0.00031747375,0.0013499728,0.0012252113,0.0001681787,0.000033480606,0.00017769205],"genre_scores_gemma":[0.99526536,0.000115166076,0.0003518035,0.0024395543,0.00022440484,0.00009837759,0.00095328345,0.00003858232,0.00051347073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969095,0.00041173538,0.0011990155,0.00069148216,0.00038002644,0.0004082455],"domain_scores_gemma":[0.99806935,0.00014054423,0.0003269718,0.00054914283,0.0004774998,0.00043651607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004813427,0.00035128844,0.00044435915,0.00039650817,0.00006799559,0.000047044974,0.00035676634,0.00018874872,0.00016476693],"category_scores_gemma":[0.00038936414,0.00035253534,0.00021501684,0.0012471898,0.00007633707,0.000025158515,0.00019490173,0.00026198872,0.000017091128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075720856,0.0006882094,0.94561774,0.00007357042,0.0007094931,0.000008539526,0.000069008165,0.033220597,0.0014346199,0.000033698616,0.006382919,0.0041895537],"study_design_scores_gemma":[0.005561912,0.00035245158,0.97590303,0.000038291124,0.0012012376,6.406038e-8,0.000025257856,0.011584944,0.0010596524,0.00003275014,0.0038455285,0.0003948617],"about_ca_topic_score_codex":0.0000060328593,"about_ca_topic_score_gemma":0.000029368024,"teacher_disagreement_score":0.030285342,"about_ca_system_score_codex":0.0000874542,"about_ca_system_score_gemma":0.00019078206,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W4416990044","doi":"10.1007/s40262-025-01602-4","title":"Guidance for External Evaluation and Selection of Population Pharmacokinetic Models for Precision Dosing","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Dosing; Selection (genetic algorithm); Population; Key (lock); Model selection; Clinical trial","score_opus":0.6026922687554581,"score_gpt":0.6569799012189769,"score_spread":0.054287632463518753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416990044","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08364405,0.0003202528,0.91070575,0.00023308262,0.0014816074,0.003243953,0.000091151735,0.000054612316,0.00022554953],"genre_scores_gemma":[0.3680148,0.00016643647,0.6307947,0.00020144881,0.00044442527,0.00023745008,0.0000063697853,0.000028861534,0.00010549378],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99554914,0.00086519093,0.0023440912,0.0005709361,0.00039757564,0.0002730639],"domain_scores_gemma":[0.9439886,0.05402952,0.00071591267,0.0002040386,0.00095225906,0.00010961705],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010139697,0.00022087622,0.00074455794,0.00012643758,0.000107179345,0.00003261564,0.00020970943,0.00023387794,0.000050228682],"category_scores_gemma":[0.06352926,0.00020961254,0.0002623373,0.0002553589,0.00014576956,0.00010679954,0.00008594224,0.00023442006,4.1309121e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030641095,0.00074310886,0.002254671,0.0014965812,0.00023575348,2.073648e-7,0.000034864246,0.004144603,0.01392503,0.053088423,0.006874636,0.914138],"study_design_scores_gemma":[0.004001602,0.00020231589,0.0017168561,0.00022995022,0.0007115264,4.3546962e-7,0.0000024059325,0.44597226,0.0044022156,0.54235893,0.00029146747,0.000110027664],"about_ca_topic_score_codex":0.0000029788441,"about_ca_topic_score_gemma":0.000001066876,"teacher_disagreement_score":0.914028,"about_ca_system_score_codex":0.00006283191,"about_ca_system_score_gemma":0.00006758883,"threshold_uncertainty_score":0.944359},"labels":[],"label_agreement":null},{"id":"W571503340","doi":"10.1007/s40262-015-0275-1","title":"The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Olanzapine; Sertraline; NONMEM; Population; Pharmacokinetics; Pharmacology; Medicine; Risperidone; Internal medicine; Psychology; Psychiatry; Antidepressant; Schizophrenia (object-oriented programming)","score_opus":0.13186095647084783,"score_gpt":0.4922751442849211,"score_spread":0.36041418781407325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W571503340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429387,0.0005201138,0.00007520571,0.0023904177,0.00050695665,0.0011783899,0.0001893744,0.00003161074,0.0008140614],"genre_scores_gemma":[0.99804527,0.0007327888,0.00013401118,0.00029788952,0.0002847902,0.00002140516,0.00012720218,0.000040320632,0.00031630186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99544257,0.00076534424,0.0019360575,0.00037484124,0.0011527265,0.00032843996],"domain_scores_gemma":[0.9947117,0.0018684358,0.0014476288,0.0010527,0.00064664986,0.00027290534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016936425,0.00036137167,0.0009179511,0.00018871395,0.00010078884,0.000017189073,0.00060326076,0.00016353808,0.00020615051],"category_scores_gemma":[0.0011423051,0.00016681351,0.0011278363,0.0013488822,0.0005927345,0.000053553384,0.00012181852,0.00059400033,0.0000062623553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013092568,0.0065407134,0.8144701,0.0002212964,0.010626675,0.000020219504,0.00048702885,0.030776773,0.055632602,0.00035611342,0.039661076,0.02811483],"study_design_scores_gemma":[0.00895805,0.0028339026,0.8381978,0.0001714504,0.010598552,0.00001192679,0.000078293335,0.054092035,0.08250815,0.00018390354,0.0021205992,0.00024532023],"about_ca_topic_score_codex":0.000079353056,"about_ca_topic_score_gemma":0.0000063093803,"teacher_disagreement_score":0.037540477,"about_ca_system_score_codex":0.00009757724,"about_ca_system_score_gemma":0.00024639725,"threshold_uncertainty_score":0.68024576},"labels":[],"label_agreement":null},{"id":"W572885427","doi":"10.1007/s40262-015-0297-8","title":"Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Voriconazole; Therapeutic drug monitoring; CYP2C19; Medicine; Intensive care medicine; Adverse effect; Drug; Pharmacogenetics; Internal medicine; Aspergillosis; Pharmacotherapy; Pharmacology; Antifungal; Immunology; Biology; Genotype","score_opus":0.2798601075472593,"score_gpt":0.532563529680355,"score_spread":0.2527034221330957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W572885427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003030224,0.99549556,0.000015745532,0.0002094377,0.000615699,0.0018353586,0.000028515373,0.000013623917,0.0014830298],"genre_scores_gemma":[0.0064952336,0.99238116,0.00021366551,0.00029277438,0.00033611464,0.00010440491,0.000017205748,0.000031732397,0.00012772928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953668,0.00088356383,0.002423469,0.00042040335,0.00063174043,0.00027399985],"domain_scores_gemma":[0.99554235,0.0026272214,0.0005199061,0.0007672878,0.0003931151,0.00015009797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034908052,0.0003322673,0.0025658244,0.000096965516,0.00002478238,0.0000066845814,0.00042184023,0.00019554718,0.00007322676],"category_scores_gemma":[0.000835029,0.00021020282,0.0009011586,0.0006924041,0.00042219827,0.00003814819,0.00013701372,0.0011355936,0.000026049034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059053487,0.0018029733,0.009942269,0.28651336,0.00056269695,0.00011662666,0.000043829612,2.6053712e-7,6.398093e-7,0.0002549992,0.0027156472,0.6979877],"study_design_scores_gemma":[0.0012037704,0.00046154897,0.005433814,0.1777647,0.012806238,0.000034729994,0.0001716159,0.0000030137019,0.000006376543,0.00028517816,0.80151683,0.0003121758],"about_ca_topic_score_codex":0.0000037765535,"about_ca_topic_score_gemma":0.0000010233244,"teacher_disagreement_score":0.7988012,"about_ca_system_score_codex":0.00008231287,"about_ca_system_score_gemma":0.00040061728,"threshold_uncertainty_score":0.85718226},"labels":[],"label_agreement":null},{"id":"W604589405","doi":"10.1007/s40262-015-0281-3","title":"A Critical Review on the Clinical Pharmacokinetics, Pharmacodynamics, and Clinical Trials of Ceftaroline","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Medicine; Clinical trial; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.7822683514772697,"score_gpt":0.7117794201885322,"score_spread":0.07048893128873746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W604589405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012950503,0.963791,0.00006398359,0.007497729,0.014353362,0.007418632,0.0038227323,0.00019022699,0.0027328457],"genre_scores_gemma":[0.00016574998,0.9649739,0.00030693755,0.022957547,0.009438579,0.00034861703,0.0006032263,0.00033665288,0.00086873554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.902996,0.069106266,0.020765645,0.0027631728,0.0022470236,0.0021219028],"domain_scores_gemma":[0.7619493,0.2216107,0.006735117,0.0023313805,0.0023727126,0.0050008087],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.17501353,0.0022231268,0.016080642,0.00055613334,0.00034939524,0.000084135216,0.003699173,0.0035384463,0.0050646933],"category_scores_gemma":[0.15259345,0.0014417962,0.0056809774,0.0012965405,0.008062463,0.00015066667,0.0015967095,0.021427246,0.0011422859],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011032723,0.0027721722,0.00012987286,0.019869633,0.002705736,0.0004387513,0.000008797561,0.0000022221186,0.0000033067738,0.0003245468,0.34052068,0.632121],"study_design_scores_gemma":[0.006627686,0.0021046652,0.000018784309,0.019791592,0.030986246,0.00020932141,0.000012279363,0.001974003,0.000011661735,0.0002503463,0.9368056,0.0012078237],"about_ca_topic_score_codex":0.000009411242,"about_ca_topic_score_gemma":0.0000032536484,"teacher_disagreement_score":0.6309132,"about_ca_system_score_codex":0.00023316102,"about_ca_system_score_gemma":0.0035450077,"threshold_uncertainty_score":0.99963546},"labels":[],"label_agreement":null},{"id":"W84398271","doi":"10.2165/00003088-200342090-00002","title":"Selecting Antibacterials for Outpatient Parenteral Antimicrobial Therapy","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Pharmacokinetics; Medicine; Dosing; Antimicrobial; Pharmacodynamics; Therapeutic drug monitoring; Antibiotics; Regimen; Pharmacology; Pharmacotherapy; Minimum inhibitory concentration; Intensive care medicine; Drug; Internal medicine; Microbiology","score_opus":0.2975076247802764,"score_gpt":0.5252368200846177,"score_spread":0.22772919530434127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W84398271","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014154013,0.98422533,0.0004220645,0.00010772783,0.0075672516,0.005261363,0.00038730624,0.00014943923,0.00046413994],"genre_scores_gemma":[0.00040111048,0.9887822,0.0027404467,0.0019118598,0.0040721004,0.00004980946,0.0009443896,0.00032235423,0.0007756889],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938094,0.0004952062,0.0032221652,0.0011765386,0.00035040613,0.00094627525],"domain_scores_gemma":[0.99597883,0.0011169759,0.0012348534,0.0006504851,0.00043100026,0.0005878592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012763994,0.0010084149,0.004236363,0.0002350801,0.00016477291,0.00011187829,0.0004328224,0.0008297315,0.00031652907],"category_scores_gemma":[0.0004759544,0.00080758455,0.0025092552,0.0003944943,0.00023738,0.00004213833,0.00013758341,0.0013959288,0.00011647773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003501613,0.0019163052,0.000118510296,0.010469572,0.0012366915,0.000036689613,0.000020362264,0.0000016362541,0.000114007606,0.000014028112,0.05476578,0.93095624],"study_design_scores_gemma":[0.0057748696,0.0011413852,0.000020913525,0.0046761883,0.004064118,0.000094558454,0.00000192316,0.00007857259,0.00021104104,0.0000054103434,0.9831608,0.0007702167],"about_ca_topic_score_codex":0.0000010171484,"about_ca_topic_score_gemma":8.920482e-8,"teacher_disagreement_score":0.93018603,"about_ca_system_score_codex":0.000094013536,"about_ca_system_score_gemma":0.0005444777,"threshold_uncertainty_score":0.9994375},"labels":[],"label_agreement":null},{"id":"W927468184","doi":"10.1007/s40262-015-0303-1","title":"A Critical Review of the Current Evidence for Measuring Drug Concentrations of First-Line Agents Used to Treat Tuberculosis in Children","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pyrazinamide; Tuberculosis; Ethambutol; Intensive care medicine; Drug; Dosing; Pharmacotherapy; Isoniazid; Adverse effect; Disease; Therapeutic drug monitoring; Psychological intervention; Rifapentine; Mycobacterium tuberculosis; Pharmacology; Latent tuberculosis; Internal medicine; Pathology; Psychiatry","score_opus":0.6292262917620522,"score_gpt":0.6064996879856832,"score_spread":0.022726603776369037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W927468184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021791007,0.98892087,0.000027953396,0.0048269765,0.00070504704,0.0048820027,0.00029588173,0.000011821143,0.000111522764],"genre_scores_gemma":[0.001349524,0.99676704,0.00013652378,0.0008633661,0.0005257588,0.00026314688,0.00003227574,0.000038535032,0.000023849569],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951229,0.000701402,0.0026730874,0.0005039499,0.0006369643,0.0003616997],"domain_scores_gemma":[0.99096954,0.0067573893,0.0006443036,0.0005290957,0.0006656873,0.0004339737],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026401451,0.00038327844,0.0028142785,0.0000643729,0.00005634525,0.000010087553,0.0004927523,0.00012345034,0.00009699747],"category_scores_gemma":[0.019900234,0.00024054621,0.0011043207,0.0006333063,0.000289297,0.00006846222,0.00032590656,0.0009406061,0.000010153141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010851845,0.001041301,0.003948693,0.16184354,0.00032568676,0.0000018284301,0.000032007632,0.0000031640661,5.563075e-7,0.000012803767,0.01788258,0.8147993],"study_design_scores_gemma":[0.0011784706,0.00017881076,0.00045637725,0.17828749,0.010270223,0.0000064180313,0.0000014742295,0.00006131267,0.000012886667,0.000016044072,0.8093383,0.00019224403],"about_ca_topic_score_codex":0.000010705465,"about_ca_topic_score_gemma":0.0000053727463,"teacher_disagreement_score":0.8146071,"about_ca_system_score_codex":0.00013270271,"about_ca_system_score_gemma":0.0003818027,"threshold_uncertainty_score":0.9883556},"labels":[],"label_agreement":null},{"id":"W973722855","doi":"10.1007/s40262-015-0301-3","title":"Population Pharmacokinetics of Intravenous Paracetamol (Acetaminophen) in Preterm and Term Neonates: Model Development and External Evaluation","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Child Health and Human Development; National Institutes of Health; National Center for Advancing Translational Sciences; Children's National Hospital; Fonds Wetenschappelijk Onderzoek; American Foundation for Pharmaceutical Education; Vlaamse regering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Howard Hughes Medical Institute","keywords":"NONMEM; Gestational age; Medicine; Acetaminophen; Population; Volume of distribution; Confidence interval; Coefficient of variation; Birth weight; Standard error; Anesthesia; Pharmacokinetics; Statistics; Internal medicine; Pregnancy; Mathematics","score_opus":0.3384928192421123,"score_gpt":0.5012615931518831,"score_spread":0.16276877390977085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W973722855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417835,0.0015901863,0.0011010318,0.0001657086,0.0010708832,0.001294136,0.000023678287,0.00005094373,0.0005250565],"genre_scores_gemma":[0.9947467,0.0010180554,0.0031317302,0.00059170974,0.00025099135,0.00009946284,0.000037817274,0.000035881993,0.00008765345],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99615324,0.000996636,0.0014039604,0.0005624939,0.00044811456,0.000435537],"domain_scores_gemma":[0.9981532,0.00043157136,0.00047070577,0.00019008438,0.00026840865,0.00048601272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004126067,0.00034302677,0.0005683379,0.00021409748,0.000110420944,0.0000299085,0.00021529326,0.00049210724,0.00006490947],"category_scores_gemma":[0.000363351,0.00035620105,0.000068202695,0.0002235723,0.00029716405,0.00021835964,0.00017952108,0.0011577077,0.0000099745685],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013390767,0.0010235518,0.13378705,0.00028495886,0.00017115219,0.000025250532,0.0042535057,0.021776324,0.021374632,0.00014284845,0.00010911228,0.8157125],"study_design_scores_gemma":[0.012668444,0.00040705138,0.105749145,0.00013214075,0.00059471634,0.000048528513,0.00009032792,0.8250756,0.04721236,0.0035101653,0.0038543367,0.0006571915],"about_ca_topic_score_codex":0.000023570035,"about_ca_topic_score_gemma":0.000022735592,"teacher_disagreement_score":0.8150553,"about_ca_system_score_codex":0.00014434877,"about_ca_system_score_gemma":0.00021381816,"threshold_uncertainty_score":0.999889},"labels":[],"label_agreement":null}]}